
<html lang="en"     class="pb-page"  data-request-id="fe9e0b89-9e61-43aa-80ba-8b2acec4a9c0"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2008.51.issue-24;website:website:acspubs;article:article:10.1021/jm8007823;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Synthesis, Modeling, and RET Protein Kinase Inhibitory Activity of 3- and 4-Substituted β-Carbolin-1-ones" /></meta><meta name="dc.Creator" content="Raffaella  Cincinelli" /></meta><meta name="dc.Creator" content="Giuliana  Cassinelli" /></meta><meta name="dc.Creator" content="Sabrina  Dallavalle" /></meta><meta name="dc.Creator" content="Cinzia  Lanzi" /></meta><meta name="dc.Creator" content="Lucio  Merlini" /></meta><meta name="dc.Creator" content="Maurizio  Botta" /></meta><meta name="dc.Creator" content="Tiziano  Tuccinardi" /></meta><meta name="dc.Creator" content="Adriano  Martinelli" /></meta><meta name="dc.Creator" content="Sergio  Penco" /></meta><meta name="dc.Creator" content="Franco  Zunino" /></meta><meta name="dc.Description" content="A series of β-carbolin-2-ones and 3,10-dihydro-2H-azepino[3,4-b]indol-1-ones have been designed, synthesized, and evaluated as RET protein kinase inhibitors on the basis of their structural similar..." /></meta><meta name="Description" content="A series of β-carbolin-2-ones and 3,10-dihydro-2H-azepino[3,4-b]indol-1-ones have been designed, synthesized, and evaluated as RET protein kinase inhibitors on the basis of their structural similar..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 19, 2008" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm8007823" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2008 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm8007823" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm8007823" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm8007823" /></link>
        
    
    

<title>Synthesis, Modeling, and RET Protein Kinase Inhibitory Activity of 3- and 4-Substituted β-Carbolin-1-ones | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm8007823" /></meta><meta property="og:title" content="Synthesis, Modeling, and RET Protein Kinase Inhibitory Activity of 3- and 4-Substituted β-Carbolin-1-ones" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0013.jpeg" /></meta><meta property="og:description" content=" A series of β-carbolin-2-ones and 3,10-dihydro-2H-azepino[3,4-b]indol-1-ones have been designed, synthesized, and evaluated as RET protein kinase inhibitors on the basis of their structural similarity with the prototype indolin-2-one RPI-1. Some β-carbolin-2-ones (structure 2) showed an ability to inhibit RET enzymatic activity in vitro and proliferation of RETC634R oncogene-transformed NIH3T3 cells comparable to that of the reference compound. The docking analysis of the interaction of these compounds with the crystallographic structure of RET tyrosine kinase domain suggested a new binding interaction scheme different from the one proposed during their design. The rigid structure of the compounds of this series represents a new scaffold with potential advantages in the design of RET protein kinase inhibitors." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm8007823"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm8007823">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm8007823&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm8007823&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm8007823&amp;href=/doi/10.1021/jm8007823" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2008</span><span class="cit-fg-volume">, 51</span><span class="cit-fg-issue">, 24</span><span class="cit-fg-pageRange">, 7777-7787</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/51/24" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm800733h" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm800781a" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis, Modeling, and RET Protein Kinase Inhibitory Activity of 3- and 4-Substituted β-Carbolin-1-ones</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Raffaella++Cincinelli">Raffaella Cincinelli</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Giuliana++Cassinelli">Giuliana Cassinelli</a></span><span class="author-xref-symbol "><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sabrina++Dallavalle">Sabrina Dallavalle</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cinzia++Lanzi">Cinzia Lanzi</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lucio++Merlini">Lucio Merlini</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maurizio++Botta">Maurizio Botta</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tiziano++Tuccinardi">Tiziano Tuccinardi</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Adriano++Martinelli">Adriano Martinelli</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sergio++Penco">Sergio Penco</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Franco++Zunino">Franco Zunino</a></span><span class="author-xref-symbol "><sup>¶</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Dipartimento di Scienze Molecolari Agroalimentari, Università di Milano, Via Celoria 2, 20133 Milano, Italy, Unità di Chemioterapia e Farmacologia Antitumorale Preclinica, Dipartimento di Oncologia Sperimentale e Laboratori, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milano, Italy, Dipartimento Farmaco Chimico Tecnologico, Università degli Studi di Siena, Via De Gasperi 2, 53100 Siena, Italy, and Dipartimento di Scienze Farmaceutiche, Università di Pisa, Via Bonanno 6, 56126 Pisa, Italy</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. For S.D.: phone, +39(0)250316818; fax, +39(0)250316801; e-mail, <a href="/cdn-cgi/l/email-protection#2a594b485843444b044e4b46464b5c4b46464f6a5f4443474304435e"><span class="__cf_email__" data-cfemail="e89b898a9a818689c68c898484899e8984848da89d86818581c6819c">[email protected]</span></a>. For C.L.: phone, +39(0)223902627; fax, +39(0)223902692; e-mail: <a href="/cdn-cgi/l/email-protection#98fbf1f6e2f1f9b6f4f9f6e2f1d8f1ebecf1ecedecf7ecedf5f7eaf1b6f5f1b6f1ec"><span class="__cf_email__" data-cfemail="fc9f959286959dd2909d928695bc958f889588">[email protected]</span>utotumori.mi.it</a>. For M.B.: phone, +39(0)577234306; fax, +39(0)577234333; e-mail, <a href="/cdn-cgi/l/email-protection#6f0d001b1b0e2f1a01061c0641061b"><span class="__cf_email__" data-cfemail="6e0c011a1a0f2e1b00071d0740071a">[email protected]</span></a></div><div class="corresp-fn" id="afn1">§Università di Milano.</div><div class="corresp-fn" id="afn2">¶Istituto Nazionale dei Tumori.</div><div class="corresp-fn" id="afn3">#Università di Siena.</div><div class="corresp-fn" id="afn4">†Università di Pisa.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm8007823&amp;href=/doi/10.1021%2Fjm8007823" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2008</span></span><span class="cit-volume">, 51</span><span class="cit-issue">, 24</span><span class="cit-pageRange">, 7777–7787</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 19, 2008</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 June 2008</li><li><span class="item_label"><b>Published</b> online</span>19 November 2008</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 December 2008</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm8007823" title="DOI URL">https://doi.org/10.1021/jm8007823</a></div><div class="article_header-article-copyright"><strong>Copyright © 2008 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7777%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRaffaella%2BCincinelli%252C%2BGiuliana%2BCassinelli%252C%2BSabrina%2BDallavalle%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D51%26issueNum%3D24%26contentID%3Djm8007823%26title%3DSynthesis%252C%2BModeling%252C%2Band%2BRET%2BProtein%2BKinase%2BInhibitory%2BActivity%2Bof%2B3-%2Band%2B4-Substituted%2B%25CE%25B2-Carbolin-1-ones%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7787%26publicationDate%3DDecember%2B2008">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm8007823"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2273</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">28</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm8007823" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis, Modeling, and RET Protein Kinase Inhibitory Activity of 3- and 4-Substituted β-Carbolin-1-ones&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Raffaella&quot;,&quot;last_name&quot;:&quot;Cincinelli&quot;},{&quot;first_name&quot;:&quot;Giuliana&quot;,&quot;last_name&quot;:&quot;Cassinelli&quot;},{&quot;first_name&quot;:&quot;Sabrina&quot;,&quot;last_name&quot;:&quot;Dallavalle&quot;},{&quot;first_name&quot;:&quot;Cinzia&quot;,&quot;last_name&quot;:&quot;Lanzi&quot;},{&quot;first_name&quot;:&quot;Lucio&quot;,&quot;last_name&quot;:&quot;Merlini&quot;},{&quot;first_name&quot;:&quot;Maurizio&quot;,&quot;last_name&quot;:&quot;Botta&quot;},{&quot;first_name&quot;:&quot;Tiziano&quot;,&quot;last_name&quot;:&quot;Tuccinardi&quot;},{&quot;first_name&quot;:&quot;Adriano&quot;,&quot;last_name&quot;:&quot;Martinelli&quot;},{&quot;first_name&quot;:&quot;Sergio&quot;,&quot;last_name&quot;:&quot;Penco&quot;},{&quot;first_name&quot;:&quot;Franco&quot;,&quot;last_name&quot;:&quot;Zunino&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2008&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;19&quot;,&quot;issue&quot;:&quot;24&quot;,&quot;volume&quot;:&quot;51&quot;,&quot;pages&quot;:&quot;7777-7787&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm8007823&quot;},&quot;abstract&quot;:&quot;A series of β-carbolin-2-ones and 3,10-dihydro-2H-azepino[3,4-b]indol-1-ones have been designed, synthesized, and evaluated as RET protein kinase inhibitors on the basis of their structural similarity with the prototype indolin-2-one RPI-1. Some β-carbolin-2-ones (structure 2) showed an ability to inhibit RET enzymatic activity in vitro and proliferation of RETC634R oncogene-transformed NIH3T3 cells comparable to that of the reference compound. The docking analysis of the interaction of these compounds with the crystallographic structure of RET tyrosine kinase domain suggested a new binding interaction scheme different from the one proposed during their design. The rigid structure of the compounds of this series represents a new scaffold with potential advantages in the design of RET protein kinase inhibitors.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm8007823&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm8007823" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm8007823&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm8007823" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm8007823&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm8007823" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm8007823&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm8007823&amp;href=/doi/10.1021/jm8007823" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm8007823" /></input><a href="/doi/pdf/10.1021/jm8007823" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm8007823&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm8007823%26sid%3Dliteratum%253Aachs%26pmid%3D19053769%26genre%3Darticle%26aulast%3DCincinelli%26date%3D2008%26atitle%3DSynthesis%252C%2BModeling%252C%2Band%2BRET%2BProtein%2BKinase%2BInhibitory%2BActivity%2Bof%2B3-%2Band%2B4-Substituted%2B%25CE%25B2-Carbolin-1-ones%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D51%26issue%3D24%26spage%3D7777%26epage%3D7787%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290976" title="Free energy">Free energy</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291862" title="Indoles">Indoles</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291864" title="Fluorescence resonance energy transfer">Fluorescence resonance energy transfer</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/51/24" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/medium/jm-2008-007823_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8007823&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A series of β-carbolin-2-ones and 3,10-dihydro-2<i>H</i>-azepino[3,4-<i>b</i>]indol-1-ones have been designed, synthesized, and evaluated as RET protein kinase inhibitors on the basis of their structural similarity with the prototype indolin-2-one RPI-1. Some β-carbolin-2-ones (structure <b>2</b>) showed an ability to inhibit RET enzymatic activity in vitro and proliferation of RETC634R oncogene-transformed NIH3T3 cells comparable to that of the reference compound. The docking analysis of the interaction of these compounds with the crystallographic structure of RET tyrosine kinase domain suggested a new binding interaction scheme different from the one proposed during their design. The rigid structure of the compounds of this series represents a new scaffold with potential advantages in the design of RET protein kinase inhibitors.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40835" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40835" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Gain-of-function mutations of the RET gene have been implicated as driving oncogenic alterations in thyroid cancer.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> RET encodes the receptor tyrosine kinase for glial cell line-derived neurotrophic family factors. Chromosomal rearrangements known as RET/PTCs are specifically detected in a subset of papillary thyroid carcinomas, whereas missense point mutations are associated with the medullary variant (MTC<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a>) <div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: MTC, medullary variant carcinoma; MEN 2, multiple endocrine neoplasia type 2; rmsd, root-mean-square deviation; MD, molecular dynamics; MM-GBSA, molecular mechanics generalized Born surface area; MBP, myelin basic protein; CG, conjugate gradient; PME, particle mesh Ewald; GAFF, general Amber force field.</p></div> occurring either sporadically or in a familial pattern.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> In particular, somatic mutations of RET are found in sporadic cases and germline mutations have been identified as the cause of multiple endocrine neoplasia type 2 (MEN 2) inherited cancer syndromes which include MTC as a main component of the disease. Both germline and somatic RET mutations produce dominant-acting oncogenic proteins endowed with constitutive tyrosine kinase activity.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a></div><div class="NLM_p">Activated oncogenes involved in tumor pathogenesis are attractive targets for new selective therapies.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The potential role of RET oncogenes and their products as targets for thyroid cancer therapy has been supported by several preclinical studies using both gene therapy and pharmacological approaches.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> In such studies, the inhibition of RET activity has been shown to cause in vitro reversion of the cell transformed phenotype and to produce an antitumor effect against in vivo human MTC xenografts. The occurrence of tumor regressions associated with apoptosis and reduced angiogenesis in animals treated with anti-Ret targeted therapy has also been documented.<a onclick="showRef(event, 'ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9">(7-9)</a> These effects are indeed consistent with the concept of “oncogene addiction” whereby RET oncogene-harboring thyroid cancers may depend on RET oncogenic pathways for their sustained proliferation and survival.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> RET targeting thus appears to be a promising approach for the treatment of specific thyroid cancers, although a clinically useful option is still not available.</div><div class="NLM_p">Among the different strategies developed to abrogate RET oncogenic activity, the use of small molecule inhibitors is currently the most suitable for clinical testing. Several tyrosine kinase inhibitors have been reported to inhibit RET activity including natural<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and synthetic compounds belonging to different structural classes.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> A few of these compounds, all characterized by multikinase inhibitory activity, have recently entered phase II clinical trials, such as the anilinoquinazoline ZD6474 (vandetanib), the nicotinamide AMG706 (motesanib), the bis-arylurea BAY43-9006 (sorafenib), and the indolinone SU11248 (sunitinib).<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12-14)</a></div><div class="NLM_p">The indolinone-based structure represents a useful scaffold for the design of tyrosine kinase inhibitors.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> We previously reported the in vitro and in vivo activity profile of the indolin-2-one compound RPI-1 (formerly Cpd1),<a onclick="showRef(event, 'ref7 ref9 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref7 ref9 ref16 ref17">(7, 9, 16, 17)</a> an orally available inhibitor of the RET and MET tyrosine kinases.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_p">Similar to other indolin-2-ones,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> it undergoes configurational equilibrium. In polar solvents the RPI-1 <i>E</i> configuration (Chart <a class="ref internalNav" href="#cht1" aria-label=""></a>) is favored. However, in a recent modeling study of the RET TK binding domain,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> RPI-1 interacted with the model only in the <i>Z</i> configuration. This finding is consistent with crystallographic studies showing that other indolin-2-ones bind to ATP binding site of some kinases (e.g., FGFR) in the <i>Z</i> configuration.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The equilibrium favoring the <i>E</i> configuration could account for the low potency of RPI-1. In an attempt to improve the inhibitory properties of indolinone-related compounds, this study was undertaken to modify the indolinone scaffold maintaining the critical interactions within the RET kinase domain.</div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/medium/jm-2008-007823_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0001.jpeg" id="gc1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Configurational Equilibrium of RPI-1</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8007823&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On these bases, we designed a series of 3,10-dihydro-2<i>H</i>-azepino[3,4-<i>b</i>]indol-1-ones (<b>1</b>) and of 4- (<b>2</b>) and 3-substituted β-carbolin-2-ones (<b>3</b>) that showed a satisfactory superimposition of the structural features deemed important for activity with those of both diastereoisomers of RPI-1, i.e., the 5,6-dimethoxyindole moiety and the carbonyl group. Furthermore, for the compounds of the <b>1</b> and <b>2</b> series there was also a good superimposition for the phenyl group. Some 3-aryl β-carbolin-1-ones derivatives have already been reported by Wang and co-workers as potent inhibitors of tumor cell proliferation, when substituted with electron-withdrawing substituents in the indole ring.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The general structure of compounds in this series is reported in Chart <a class="ref internalNav" href="#cht2" aria-label=""></a>, and the three-dimensional models of representative compounds appear in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>. The new compounds were evaluated as RET inhibitors using cell-based and biochemical assays, and the docking mode of selected compounds was investigated by molecular modeling.</div><figure id="cht2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/medium/jm-2008-007823_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0002.jpeg" id="gc2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. General Structure of the New Compounds</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8007823&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/medium/jm-2008-007823_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Superimposition between RPI-1 (colored green) and the new compounds (<b>1a</b>, <b>2a</b>, and <b>3a</b>, colored cyan, magenta, and gray, respectively). The most important pharmacophoric features are also reported (aromatic and hydrogen bond acceptor and donor features are reported as orange, red, and cyan spheres, respectively).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8007823&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86623" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86623" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">For the synthesis of the 3,10-dihydro-2<i>H</i>-azepino[3,4-<i>b</i>]indol-1-ones (<b>1</b>) we first followed a procedure described by Mérour<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> that was based on a palladium-mediated Suzuki reaction of an appropriate arylboronic acid with the enol triflate of an azepino[3,4-<i>b</i>]indole-1,5-dione (<b>9</b>) (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). The latter was obtained by PPA cyclization of the acid <b>6</b>, in turn prepared by amidation of a substituted indole-2-carboxylic acid (<b>4</b>) with β-alanine ethyl ester hydrochloride, followed by hydrolysis with lithium hydroxide.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/medium/jm-2008-007823_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0011.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. <sup>a</sup><sup>,</sup><sup>b</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8007823&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p><span class="fn-label">Scheme a</span>Reagents and conditions: (a) β-alanine ethyl ester hydrochloride, WSC, HOBT, TEA, THF, room temp, 24 h, 96%; (b) Mel, CH<sub>3</sub>CN, K<sub>2</sub>C0<sub>3</sub>, reflux, 30 h, 72%; (c) LiOH·H<sub>2</sub>O, EtOH, room temp, 48 h, 89−94%; (d) PPA, 95 °C, 90 min to 6 h, 45−68%; (e) NaH, DMF, PMBCI, room temp, 4 h, 50%. (f) For <b>8b</b>: <b>7a</b>, Mel, NaH, DMF, room temp, 2 h, 40%. For <b>8c</b>: <b>7b</b>, PMBCI, NaH, DMF, room temp, overnight, 33%. (g) (CF<sub>3</sub>SO<sub>2</sub>)<sub>2</sub>O, Na<sub>2</sub>CO<sub>3</sub>, CH<sub>2</sub>CI<sub>2</sub>, room temp, 3−12 h, 26−75%; (h) <i>p</i>-HO-PhB(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, toluene, NaHCO<sub>3</sub>, EtOH, 60−90 min, 12−78%; (i) TFA, reflux, 5 h, 49%.</p><p class="last"><span class="fn-label">Scheme b</span>See Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</p></p></figure><div class="NLM_p">In our hands, triflation of the azepinedione <b>7a</b> gave a mixture of compounds triflated on the amide and indole NHs. Therefore compounds <b>1a</b>−<b>d</b> were only obtained by protecting the amide or the indole NH with a methyl or a 4-methoxybenzyl group (<b>8b</b>,<b>c</b>). Because of these difficulties, we designed a more straightforward and general method that could be applied also to the synthesis of 5-alkyl substituted azepinoindol-1-ones and to the synthesis of compounds <b>2</b> and <b>3</b>. Appropriate indole-2-carboxylic acids were coupled with β- or a γ-aminoalcohols to obtain, after IBX oxidation, β- or a γ-oxoamides that were cyclized via an intramolecular Friedel−Crafts reaction to give directly the expected compounds <b>1</b>−<b>3</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Alternatively, condensation with β- or γ-aminoketones gave directly the oxoamides ready for cyclization. This approach has been recently disclosed and used for the synthesis of compounds <b>2</b> and <b>3</b>.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The synthesis of N-unsubsituted derivatives required the use of an appropriate R<sub>1</sub> protecting group.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/medium/jm-2008-007823_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0012.jpeg" id="gs2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8007823&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>For R<sub>1</sub>−R<sub>6</sub>, see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. Reagents and conditions: (a) WSC, HOBT, THF, room temp; (b) IBX, EtOAc, 80°C or PCC, CH<sub>2</sub>Cl<sub>2</sub>, 40−50 °C; (c) TFA, CH<sub>3</sub>CN, 80 °C.</p></p></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17771" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17771" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Cellular and Biochemical Studies</h3><div class="NLM_p">To assess the effect of the new compounds on RET-driven cellular transformation, we tested their ability to affect the proliferation and/or the transformed morphologic phenotype of NIH3T3 cells stably transfected with the C634R mutant of RET associated with the MEN2A syndrome (NIH3T3<sup>MEN2A</sup>).<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> Compounds that showed an antiproliferative activity comparable to that displayed by the reference molecule RPI-1 or showed an ability to revert the morphology of the transformed phenotype were further tested on NIH3T3 and NIH3T3 cells transformed with a non-tyrosine kinase oncogene (NIH3T3<sup>H-RAS</sup>) to assess the drug selectivity against RET-oncogene-expressing cells. Compounds exhibiting these features belong to the series <b>2</b>. Compounds of the series <b>1</b> and <b>3</b> were characterized by a lower potency and by lack of revertant activity. Therefore, only compounds of the series <b>2</b> were further subjected to a RET kinase assay to assess direct enzyme inhibition. The inhibition of RET activation in treated NIH3T3<sup>MEN2A</sup> cells was eventually examined by Western blotting.</div><div class="NLM_p">The results of the cell-based screening with the new compounds are reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, together with RET kinase inhibition data for selected molecules.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro Activity of Compounds <b>1</b>−<b>3</b></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th colspan="3" align="center" valign="middle">antiproliferative activity (IC<sub>50</sub> μM)<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a> (72 h)</th><th align="char" valign="middle"> </th></tr><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle">NIH3T3<sup>MEN2A</sup></th><th align="center" valign="middle">NIH3T3</th><th align="center" valign="middle">NIH3T3<sup>H-RAS</sup></th><th align="center" valign="middle">RET KA<a class="ref internalNav" href="#tbl2-fn4" aria-label="d">d</a>(IC<sub>50</sub> μM)</th></tr></thead><tbody><tr valign="top"><td align="left">RPI-1</td><td align="left">3.6 ± 1.6<a class="ref internalNav" href="#tbl2-fn2" aria-label="b">b</a></td><td align="left">16.3 ± 3.7</td><td align="left">19.7 ± 2</td><td align="left">0.16 ± 0.05</td></tr><tr valign="top"><td align="left"><b>1a</b></td><td align="left">19.8 ± 7.1</td><td align="left"> </td><td align="left"> </td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>1b</b></td><td align="left">14.4 ± 5.5</td><td align="left"> </td><td align="left"> </td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>1c</b></td><td align="left">18.4 ± 3</td><td align="left"> </td><td align="left"> </td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>1d</b></td><td align="left">6.8 ± 2.5</td><td align="left"> </td><td align="left"> </td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>1e</b></td><td align="left">7.8 ± 2</td><td align="left"> </td><td align="left"> </td><td align="left">>0.6</td></tr><tr valign="top"><td align="left"><b>1f</b></td><td align="left">16.7 ± 5.4</td><td align="left"> </td><td align="left"> </td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>1g</b></td><td align="left">9.9 ± 1.2</td><td align="left"> </td><td align="left"> </td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>2a</b></td><td align="left">4.7 ± 0.3<a class="ref internalNav" href="#tbl2-fn3" aria-label="c">c</a></td><td align="left">13.9 ± 2</td><td align="left">13.5 ± 0.3</td><td align="left">0.11 ± 0.04</td></tr><tr valign="top"><td align="left"><b>2b</b></td><td align="left">1.95 ± 0.2<a class="ref internalNav" href="#tbl2-fn3" aria-label="c">c</a></td><td align="left">7.2 ± 2.2</td><td align="left">6.6 ± 2</td><td align="left">0.06 ± 0.02</td></tr><tr valign="top"><td align="left"><b>2c</b></td><td align="left">17.3 ± 1.1</td><td align="left">>30</td><td align="left">>30</td><td align="left">0.48 ± 0.12</td></tr><tr valign="top"><td align="left"><b>2d</b></td><td align="left">12.2 ± 1<a class="ref internalNav" href="#tbl2-fn3" aria-label="c">c</a></td><td align="left">25 ± 8</td><td align="left">>30</td><td align="left">0.60 ± 0.01</td></tr><tr valign="top"><td align="left"><b>2e</b></td><td align="left">15.9 ± 2.6</td><td align="left"> </td><td align="left"> </td><td align="left">>0.6</td></tr><tr valign="top"><td align="left"><b>2f</b></td><td align="left">5.6 ± 0.04</td><td align="left">10.6 ± 2.5</td><td align="left"> </td><td align="left">>0.6</td></tr><tr valign="top"><td align="left"><b>2g</b></td><td align="left">3.3 ± 0.6</td><td align="left">17.8 ± 0.1</td><td align="left">13.8 ± 2.8</td><td align="left">0.25 ± 0.1</td></tr><tr valign="top"><td align="left"><b>2h</b></td><td align="left">3.2 ± 0.3<a class="ref internalNav" href="#tbl2-fn3" aria-label="c">c</a></td><td align="left">6.7 ± 0.1</td><td align="left">6.1 ± 2</td><td align="left">0.09 ± 0.01</td></tr><tr valign="top"><td align="left"><b>2i</b></td><td align="left">7.5 ± 1</td><td align="left">17.7 ± 0.6</td><td align="left"> </td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>3a</b></td><td align="left">13.3 ± 1</td><td align="left"> </td><td align="left"> </td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>3b</b></td><td align="left">34.4 ± 1.2</td><td align="left"> </td><td align="left"> </td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>3c</b></td><td align="left">18.4 ± 0.8</td><td align="left"> </td><td align="left"> </td><td align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Mean values ± SD from at least two independent experiments performed in duplicate are reported.</p></div><div class="footnote" id="tbl2-fn2"><sup>b</sup><p class="last">Stable reversion of transformed morphology of NIH3T3<sup>MEN2A</sup> cells exposed to 10 μM RPI-1.</p></div><div class="footnote" id="tbl2-fn3"><sup>c</sup><p class="last">Partial or transient reversion of transformed morphology of NIH3T3<sup>MEN2A</sup> cells observed during drug treatment.</p></div><div class="footnote" id="tbl2-fn4"><sup>d</sup><p class="last">Kinase assay using recombinant RET active protein and MBP as a substrate.</p></div></div></div><div class="NLM_p">Compounds with structure <b>1</b>, characterized by a seven-membered azepinone ring fused to an indole moiety, showed in general a lower antiproliferative activity than the reference compound against NIH3T3<sup>MEN2A</sup> cells and no revertant capacity. In contrast, compounds with structure <b>2</b>, in particular <b>2a</b>,<b>b</b> and <b>2f</b>−<b>h</b>, appeared to be comparable to the reference compound RPI-1 as for the activity on NIH3T3<sup>MEN2A</sup> cells. In addition, some of them (<b>2a</b> and <b>2b</b>) induced a partial or transient reversion of the transformed morphology of these cells. Similar to RPI-1, <b>2a</b> and <b>2b</b> showed a selective antiproliferative activity against NIH3T3 cells expressing the RET mutant. Moreover, the remarkable inhibitory activity in the RET kinase assay by both compounds suggested that the lack of <i>N</i>-methyl in the indole moiety did not abrogate the enzyme inhibitory activity. These findings were apparently (but see later) in contrast with the results previously obtained in a series of analogues of the indolin-2-one RPI-1<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> in which the presence of <i>N</i>-methyl in the indole moiety was found to abrogate the inhibitory activity.</div><div class="NLM_p">The low antiproliferative activity of compounds <b>2c</b>,<b>d</b> could be explained by the lack of one or both the methoxy groups on the indole moiety, a detrimental effect already observed in the indolinone series.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Despite the deletion of the phenolic OH, compound <b>2g</b> maintained the antiproliferative effect with only a slight reduction of the inhibitory activity on recombinant enzyme. At variance, deletion of the whole phenolic ring (<b>2f</b>) heavily impaired the enzyme inhibitory activity. Finally, compounds of structure <b>3</b>, intended to mimic the <i>Z</i>-isomer of RPI-1, were much less active.</div><div class="NLM_p last">The RET inhibitory activity of compound <b>2b</b>, identified as the best inhibitor in these series, was further confirmed on NIH3T3<sup>MEN2A</sup> intact cells. Accordingly to the relative activity in the Ret kinase assay, <b>2b</b> inhibited Ret tyrosine phosphorylation in a dose-dependent way showing a slightly higher potency, compared to RPI-1, upon 24 h of cell treatment. As previously reported for RPI-1,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> RET kinase inhibition in treated cells was associated with a reduction of Ret protein expression (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Molecular Modeling</h3><div class="NLM_p">Since the present results seemed in apparent contrast with previous studies, suggesting a preferential or exclusive role of the <i>Z</i> isomer of indolinone molecules for the tyrosine kinase inhibitory activity,<a onclick="showRef(event, 'ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21">(19-21)</a> we investigated the binding interactions between the new derivatives and the RET tyrosine kinase domain. An automated docking analysis of compounds reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> was performed into the crystallographic structure of RET kinase (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ivu">2ivu</a><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a>) using GOLD 3.2 software.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structures of Compounds <b>1</b>−<b>3</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/medium/jm-2008-007823_0003.gif" alt="" id="_i12" /></img><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle">R<sub>1</sub></th><th align="center" valign="middle">R<sub>2</sub></th><th align="center" valign="middle">R<sub>3</sub></th><th align="center" valign="middle">R<sub>4</sub></th><th align="center" valign="middle">R<sub>5</sub></th><th align="center" valign="middle">R<sub>6</sub></th></tr></thead><tbody><tr valign="top"><td align="left"><b>1a</b></td><td align="left">H</td><td align="left">H</td><td align="left">H</td><td align="left">4-OH-Ph</td><td align="left">OCH<sub>3</sub></td><td align="left">OCH<sub>3</sub></td></tr><tr valign="top"><td align="left"><b>1b</b></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">H</td><td align="left">4-OH-Ph</td><td align="left">OCH<sub>3</sub></td><td align="left">OCH<sub>3</sub></td></tr><tr valign="top"><td align="left"><b>1c</b></td><td align="left">CH<sub>3</sub></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">4-OH-Ph</td><td align="left">OCH<sub>3</sub></td><td align="left">OCH<sub>3</sub></td></tr><tr valign="top"><td align="left"><b>1d</b></td><td align="left">CH<sub>3</sub></td><td align="left">PMB<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></td><td align="left">H</td><td align="left">4-OH-Ph</td><td align="left">OCH<sub>3</sub></td><td align="left">OCH<sub>3</sub></td></tr><tr valign="top"><td align="left"><b>1e</b></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">H</td><td align="left">H</td><td align="left">OCH<sub>3</sub></td><td align="left">OCH<sub>3</sub></td></tr><tr valign="top"><td align="left"><b>1f</b></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">H</td><td align="left">CH<sub>3</sub></td><td align="left">OCH<sub>3</sub></td><td align="left">OCH<sub>3</sub></td></tr><tr valign="top"><td align="left"><b>1g</b></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">H</td><td align="left">4-OCH<sub>3</sub>-Ph</td><td align="left">OCH<sub>3</sub></td><td align="left">OCH<sub>3</sub></td></tr><tr valign="top"><td align="left"><b>2a</b></td><td align="left">H</td><td align="left">H</td><td align="left">H</td><td align="left">4-OH-Ph</td><td align="left">OCH<sub>3</sub></td><td align="left">OCH<sub>3</sub></td></tr><tr valign="top"><td align="left"><b>2b</b></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">H</td><td align="left">4-OH-Ph</td><td align="left">OCH<sub>3</sub></td><td align="left">OCH<sub>3</sub></td></tr><tr valign="top"><td align="left"><b>2c</b></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">H</td><td align="left">4-OH-Ph</td><td align="left">H</td><td align="left">H</td></tr><tr valign="top"><td align="left"><b>2d</b></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">H</td><td align="left">4-OH-Ph</td><td align="left">OCH<sub>3</sub></td><td align="left">H</td></tr><tr valign="top"><td align="left"><b>2e</b></td><td align="left">CH<sub>3</sub></td><td align="left">CH<sub>2</sub>-Ph</td><td align="left">H</td><td align="left">H</td><td align="left">OCH<sub>3</sub></td><td align="left">OCH<sub>3</sub></td></tr><tr valign="top"><td align="left"><b>2f</b></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">H</td><td align="left">CH<sub>3</sub></td><td align="left">OCH<sub>3</sub></td><td align="left">OCH<sub>3</sub></td></tr><tr valign="top"><td align="left"><b>2g</b></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">H</td><td align="left">Ph</td><td align="left">OCH<sub>3</sub></td><td align="left">OCH<sub>3</sub></td></tr><tr valign="top"><td align="left"><b>2h</b></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">H</td><td align="left">3-OH-Ph</td><td align="left">OCH<sub>3</sub></td><td align="left">OCH<sub>3</sub></td></tr><tr valign="top"><td align="left"><b>2i</b></td><td align="left">CH<sub>2</sub>-Ph</td><td align="left">H</td><td align="left">H</td><td align="left">4-OH-Ph</td><td align="left">OCH<sub>3</sub></td><td align="left">OCH<sub>3</sub></td></tr><tr valign="top"><td align="left"><b>3a</b></td><td align="left">H</td><td align="left">H</td><td align="left">Ph</td><td align="left">H</td><td align="left">OCH<sub>3</sub></td><td align="left">OCH<sub>3</sub></td></tr><tr valign="top"><td align="left"><b>3b</b></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">Ph</td><td align="left">H</td><td align="left">OCH<sub>3</sub></td><td align="left">OCH<sub>3</sub></td></tr><tr valign="top"><td align="left"><b>3c</b></td><td align="left">Naf-2-CH<sub>2</sub></td><td align="left">H</td><td align="left">Ph</td><td align="left">H</td><td align="left">H</td><td align="left">H</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">PMB = 4-methoxybenzyl.</p></div></div></div><div class="NLM_p">The parameters chosen in GOLD (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>) were tested for their ability to reproduce the crystallized binding geometry of the 4-anilinoquinazoline ZD6474. The docking software easily found the binding geometry corresponding to the crystallized complex among the solutions with the lowest energy, with a root-mean-square deviation (rmsd) between the docked and crystallized geometries in the limit of the crystallographic resolution (the rmsd was less than 1.4 Å, whereas the crystallographic resolution was greater than 2.5 Å).</div><div class="NLM_p">We have already reported the docking of the reference compound RPI-1, and our previous studies suggested that the active diastereoisomer has the <i>Z</i> configuration.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> shows a schematic representation of the main interactions of this ligand inside the RET ATP binding site, with the indolin-2-one central scaffold that formed two H-bonds with the backbone of Glu805 and Ala807, respectively. These two interactions were supported by the analysis of the X-ray complexes between different kinases and inhibitors interacting in the ATP binding site<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and by pharmacophoric studies.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Such studies confirmed in fact that the backbone portion of these two residues play a role in inhibitor binding, as they make H-bonds with N-1 and N-6 of the ATP adenine, as well as with most kinase inhibitors. With regard to the lipophilic interactions, the indolin-2-one group mainly interacted with Phe735, Val738, and Val804 whereas the phenolic substituent interacted with Leu730.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/medium/jm-2008-007823_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Schematic representation of the main interactions of <i>Z</i>-RPI-1 into the RET binding site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8007823&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/medium/jm-2008-007823_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Inhibition of RET autophosphorylation and expression in NIH3T3<sup>MEN2A</sup> cells treated with compound <b>2b</b> or RPI-1 as reference compound. Cells were exposed to vehicle (DMSO) or to the indicated concentrations of the compounds for 24 h. Whole cell lysates were analyzed by Western blotting with anti-p(Y1062)Ret and anti-Ret antibodies. A cell extract from untreated parental NIH3T3 cells was run in parallel. Anti-actin blot is shown as protein loading control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8007823&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A shows the docking of compound <b>2a</b>. Its interactions were indeed completely different from those hypothesized in the design step; the nitrogen and the oxygen of the pyridone ring formed H-bonds with the backbone of key residues Glu805 and Ala807, respectively. The planar 2H-pyrido[3,4-<i>b</i>]indol-1(9<i>H</i>)-one central scaffold mainly interacted with Leu730, Val738, Ala756, and Leu881, while the nitrogen of the indole moiety seemed devoid of important interactions. As for the 4-(<i>p</i>-hydroxyphenyl) substituent, it was inserted into a pocket delimited by Leu779, Ile788, Val804, and Ser891 and the hydroxy group formed an H-bond with Asp892 that constitutes an H-bond network with Lys758 and Glu775.</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/medium/jm-2008-007823_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0008.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Docking of compounds <b>2a</b> (A), <b>3a</b> (B), and <b>1a</b> (C) into the RET binding site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8007823&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The docking studies highlighted that the 3-substitution determined the weakening of the H-bond between the oxygen of the pyridone ring and Ala807 and the loss of the H-bond between the nitrogen of the pyridone ring and Glu805 (see docking of compound <b>3a</b> in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B). Finally the docking of compound <b>1a</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>C) revealed that the change of geometry due to the seven-membered structure of the azepine ring fused to the indole determined a completely different binding mode, with the formation of two H-bonds with D892 and the loss of the fundamental interactions with the key residues Glu805 and Ala807.</div><div class="NLM_p">As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A, the docking of compound <b>2b</b>, which differs from <b>2a</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A) only for the methyl substitution on the indole nitrogen, highlighted the same binding disposition and the same interactions described above. Furthermore, the <i>N</i>-methyl substituent showed lipophilic interactions with Leu730.</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/medium/jm-2008-007823_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0009.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Docking of compounds <b>2b</b> (A), <b>2h</b> (B), and <b>2d</b> (C) into the RET binding site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8007823&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B shows the docking of compound <b>2h</b> which differs from compound <b>2b</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A) for the 4-(<i>m</i>-hydroxyphenyl) substituent. In agreement with a profile of activity in the antiproliferative and biochemical tests very similar to that of <b>2b</b>, it showed all the main interactions of <b>2b</b>, in particular the H-bond between the phenolic OH group and Asp892.</div><div class="NLM_p">Finally, compounds <b>2c</b> and <b>2d</b> are both characterized by the absence of the 7-methoxy substituent, and their low activity seemed to suggest a role for this group. However, in all the already mentioned compounds, this substituent did not show any important interaction with the enzyme and was exposed to the solvent. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>C, compound <b>2d</b> showed the same interaction scheme; it possessed all the main interactions of the other compounds, and the 7-methoxy substituent was exposed to the solvent. Therefore, these data suggested that its lower affinity could be determined by different solvation effects.</div><div class="NLM_p">In order to investigate this hypothesis, compounds <b>2b</b> and <b>2d</b> were subjected to 1 ns of molecular dynamics (MD) simulation with explicit water, followed by a molecular mechanics generalized Born surface area (MM-GBSA) analysis.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> This approach has been shown to be able to estimate the ligand−receptor energy interaction.<a onclick="showRef(event, 'ref31 ref32 ref33 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33 ref34 ref35">(31-35)</a> It averages contributions of gas-phase energies and solvation free energies calculated for snapshots of the complex molecule as well as the unbound components, extracted from MD trajectories according to the procedure fully described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</div><div class="NLM_p">As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>A, after 200 ps of MD, both complex systems reached equilibrium, since the total energy for the remaining simulation time was constant. Analyzing the rmsd from the X-ray structure of all the heavy atoms of the complexes, we observed that, after an initial increase, the rmsd did not exceed the value of 1.4 Å (see Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>B), suggesting that our MD procedure was correct.</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/medium/jm-2008-007823_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0010.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Results of the MD simulation of compounds <b>2b</b> (black) and <b>2d</b> (red) complexed with RET: (A) total energy (kcal/mol) of the system plotted versus time (ps); (B) rmsd in angstroms (Å), between the protein and the starting X-ray structure for all the heavy atoms, versus time (ps).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8007823&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As regard the two ligands, during the whole MD simulation their relative position appeared to change only slightly, since the rmsd of the heavy atoms of the ligands between the starting and the final structures of the MD simulation was 1.2 Å for <b>2b</b> and 1.1 Å for <b>2d</b>.</div><div class="NLM_p">As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, the two ligands possessed a very similar binding interaction scheme: the nitrogen and the oxygen of the pyridone ring of both ligands maintained the H-bond with the backbone of Glu805 and Ala807, respectively, the 4-(<i>p</i>-hydroxyphenyl) substituent maintained an H-bond with the network constituted by Lys758 and Glu775 and Asp892, but instead of interacting with the carboxylic group of Asp892, it formed an H-bond with Glu775 and occasionally interacted with the backbone of Asp892.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Hydrogen Bonds Analysis of <b>2b</b> and <b>2d</b> with RET during the Simulation of Both Complexes</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/medium/jm-2008-007823_0004.gif" alt="" id="_i14" /></img><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="center">donor</th><th align="center">acceptor H</th><th align="center">acceptor</th><th align="center">distance (Å)</th><th align="center" char=".">% occupied</th></tr></thead><tbody><tr valign="top"><td colspan="5" align="center"><b>2b</b> (R = OCH<sub><b>3</b></sub>)</td></tr><tr valign="top"><td align="left"><a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="1d582a2a285d52582f">[email protected]</a></td><td align="left"><a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="a4e8ede3e4ec95">[email protected]</a></td><td align="left"><a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="bef2f7f9fef18f">[email protected]</a></td><td align="left">2.63 (0.11)</td><td align="char" char=".">97.0</td></tr><tr valign="top"><td align="left"><a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="da9fe2eaef9a95">[email protected]</a></td><td align="left"><a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="e6aaafa1a6a8d4">[email protected]</a></td><td align="left"><a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="410d0806010973">[email protected]</a></td><td align="left">2.70 (0.19)</td><td align="char" char=".">94.6</td></tr><tr valign="top"><td align="left"><a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="7a36333d3a3549">[email protected]</a></td><td align="left"><a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="bcfd848c8bfcf4">[email protected]</a></td><td align="left"><a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="e8a9d0d8dfa8a6">[email protected]</a></td><td align="left">2.83 (0.22)</td><td align="char" char=".">94.1</td></tr><tr valign="top"><td align="left"><a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="6925202e292658">[email protected]</a></td><td align="left"><a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="7d3945444f3d35">[email protected]</a></td><td align="left"><a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="5b1f6362691b15">[email protected]</a></td><td align="left">3.10 (0.16)</td><td align="char" char=".">54.4</td></tr><tr valign="top"><td colspan="5" align="center"><b>2d</b> (R = H)</td></tr><tr valign="top"><td align="left"><a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="5e1217191e116d">[email protected]</a></td><td align="left"><a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="3d7c050d0a7d75">[email protected]</a></td><td align="left"><a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="fabbc2cacdbab4">[email protected]</a></td><td align="left">2.79 (0.09)</td><td align="char" char=".">100</td></tr><tr valign="top"><td align="left"><a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="02473a3237424d">[email protected]</a></td><td align="left"><a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="511d1816111f63">[email protected]</a></td><td align="left"><a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="e6aaafa1a6aed4">[email protected]</a></td><td align="left">2.92 (0.12)</td><td align="char" char=".">99.8</td></tr><tr valign="top"><td align="left"><a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="c683f1f1f3868983f4">[email protected]</a></td><td align="left"><a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="2965606e696118">[email protected]</a></td><td align="left"><a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="105c5957505f21">[email protected]</a></td><td align="left">2.58 (0.10)</td><td align="char" char=".">98.0</td></tr><tr valign="top"><td align="left"><a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="8ec2c7c9cec1bf">[email protected]</a></td><td align="left"><a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="a1e5999893e1e9">[email protected]</a></td><td align="left"><a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="6c2854555e2c22">[email protected]</a></td><td align="left">3.11 (0.16)</td><td align="char" char=".">54.1</td></tr></tbody></table></div></div><div class="NLM_p">The two MD trajectories were then analyzed through the MM-GBSA method. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, the molecular mechanical energy (Δ<i>E</i><sub>MM</sub>) of the interaction of the ligands with RET (i.e., the sum of the electrostatic and van der Waals energies) was very similar for both compounds. However, the solvation free energy (ΔGB<sub>Sol</sub>), which includes the polar solvation free energy calculated with the generalized Born (GB) approximation model and the nonpolar part obtained by fitting solvent accessible surface area (SASA), was more favorable for compound <b>2b</b>. Therefore, even if the energy difference between the interaction of the two compounds was in the same order of magnitude of the standard deviation of error (see Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>), the effect of the 7-methoxy substituent on the activity could be explained in terms of solvation free energy, in agreement with our hypothesis.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. MM-GBSA Results for Compounds <b>2b</b> and <b>2d</b><a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th align="center" valign="middle"><b>2b</b> (STD)</th><th align="center" valign="middle"><b>2d</b> (STD)</th></tr></thead><tbody><tr valign="top"><td align="left">Ele</td><td align="left">−41.9 (4.1)</td><td align="left">−42.9 (3.8)</td></tr><tr valign="top"><td align="left">VdW</td><td align="left">−38.0 (3.4)</td><td align="left">−36.5 (3.6)</td></tr><tr valign="top"><td align="left"><i>E</i><sub>int</sub></td><td align="left">0.0 (0.0)</td><td align="left">0.0 (0.0)</td></tr><tr valign="top"><td align="left">Δ<i>E</i><sub>MM</sub></td><td align="left">−79.9 (3.9)</td><td align="left">−79.4 (4.3)</td></tr><tr valign="top"><td align="left">GB<sub>Sur</sub></td><td align="left">−5.8 (0.1)</td><td align="left">−5.3 (0.1)</td></tr><tr valign="top"><td align="left">GB</td><td align="left">41.1 (1.9)</td><td align="left">42.7 (2.3)</td></tr><tr valign="top"><td align="left">ΔGB<sub>Solv</sub></td><td align="left">35.3 (1.9)</td><td align="left">37.4 (2.3)</td></tr><tr valign="top"><td align="left">Δ<i>G</i><sub>GBSA</sub></td><td align="left">−44.6 (3.1)</td><td align="left">−42.0 (3.5)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">Δ<i>E</i><sub>MM</sub> is the sum of the electrostatic (Ele), van der Waals (VdW), and internal (<i>E</i><sub>int</sub>) energies. ΔGB<sub>Solv</sub> is the sum of the polar (GB) and nonpolar (GB<sub>Sur</sub>) solvation free energy. Finally Δ<i>G</i><sub>GBSA</sub> is the sum of the molecular mechanical and solvation free energy. STD means the standard deviation. Data are expressed as kcal/mol.</p></div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84523" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84523" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The results reported above indicate that compounds with structure <b>2</b> (e,g, <b>2a</b>, <b>2b</b>, and <b>2h</b>) exhibit a remarkable inhibitory activity against the RET protein kinase, which is correlated with an antiproliferative activity on NIH3T3<sup>MEN2A</sup> cells comparable to that of the reference compound RPI-1 which is correlated with a revertant activity on NIH3T3<sup>MEN2A</sup> cells. No precise correlations between inhibitory activity against RET kinase and antiproliferative activity could be detected for compounds of this series because it is likely that the cell growth inhibition reflects inhibitory effects on multiple targets. Nonetheless, compounds of series <b>2</b> showed a preferential antiproliferative activity on RET mutant-expressing cells. As for SAR, it appears that methylation of the indole nitrogen is not detrimental but seems to increase the activity (<b>2b</b> vs <b>2a</b>). The presence of the two methoxy groups in positions 6 and 7 of the indole moiety is important in maintaining the activity, and the presence of a 3- or 4-OH substituted phenyl ring in position 4 is also beneficial, compound <b>2b</b> being the most active, on both the enzyme and cells. All these results are well explained by the analysis of the docking of the compounds in the crystallographic model of the enzyme. The same analysis also explains the lack of activity of compounds with structure <b>3</b>, where the ring attached to position 3 seems devoid of favorable interactions. For these reasons, this latter group of compounds was not investigated further. The same could be possible for compounds of structure <b>1</b>, where most probably the change of geometry due to the seven-membered structure of the azepine ring fused to the indole moves the substituent in position 5 to another zone of unfavorable interactions.</div><div class="NLM_p">The compounds structurally most similar to the isomer <i>E</i> of RPI-1, i.e., <b>2a</b> and <b>2b</b>, are the most active of the series. At first glance, this finding could have appeared surprising, since on the basis of previous studies, the isomer <i>Z</i> is likely responsible of the inhibitory effects.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> However, considering the results of the present docking analysis, the strong H-bond interactions with Glu805 and Ala807 of the enzyme ATP binding site do not occur with the indole NH and the CO amide groups of <b>2</b>, as we hypothesized, but with the amide NH and CO groups of the pyridone ring. The consequence is that the compounds dock themselves in the binding site in a position flipped of roughly 180° with respect to RPI-1, and the phenolic OH in position 4 of <b>2a</b> and <b>2b</b> interacts with amino acids different from those interacting with RPI-1. The docking analysis also explains the slightly better inhibitory activity of <b>2b</b> vs <b>2a</b> in the kinase assay, on the basis of the absence of H-bond interactions with the indole NH and of the existence of lipophilic interactions with Leu730. Notably, in spite of the different binding mode to the RET kinase, compound <b>2b</b> maintained the ability to inhibit RET protein expression, in addition to tyrosine phosphorylation, as previously described for RPI-1.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><div class="NLM_p last">In conclusion, we have found a new series of inhibitors of RET protein kinase with an inhibitory and antiproliferative activity comparable to that of RPI-1, which may provide a new lead candidate. Since this series is characterized by lack of changes of configuration, the rigid structure could provide biochemical and pharmacological advantages over conventional indolinones.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22114" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22114" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> General Chemical Methods</h3><div class="NLM_p last">All reagents and solvents were reagent grade or were purified by standard methods before use. Melting points were determined in open capillaries on a Büchi melting point apparatus and are uncorrected. Column chromatography was carried out on flash silica gel (Merck 230−400 mesh). TLC analysis was conducted on silica gel plates (Merck 60F<sub>254</sub>). NMR spectra were recorded at 300 MHz with a Bruker instrument. Chemical shifts (δ values) and coupling constants (<i>J</i> values) are given in ppm and Hz, respectively. Compounds <b>2</b> and <b>3</b> were prepared as already described.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 3-[(5,6-Dimethoxy-1<i>H</i>-indole-2-carbonyl)amino]propionic Acid Ethyl Ester (<b>5a</b>)</h3><div class="NLM_p last">A solution of 5,6-dimethoxy-1<i>H</i>-indole-2-carboxylic acid (1.46 g, 6.6 mmol), EDC (1.52 g, 7.9 mmol), and HOBt (1.07 g, 7.9 mmol) in 36 mL of THF was stirred 8 h at room temperature. Then β-alanine ethyl ester hydrochloride (3.04 g, 19.8 mmol) and TEA (2.74 mL, 19.8 mmol) were added. The mixture was stirred overnight at room temperature. After partial evaporation of the solvent, water and HCl 10% (12 mL) were added. The precipitate was filtered to give 2.02 g of the title compound. Yield 96%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 9.15 (1H, NH), 7.00 (s, 1H, 1 Ar), 6.82 (s, 1H, 1 Ar), 6.65−6.75 (m, 2H, CH═ + NHCO), 4.20 (q, 2H, OCH<sub>2</sub>, <i>J</i> = 7.1 Hz), 3.98 (s, 3H OMe), 3.95 (s, 3H, OMe), 3.65−3.75 (m, 2H, CH<sub>2</sub>N), 2.65 (t, 2H, CH<sub>2</sub><i>J</i> = 6.9 Hz), 1.25 (t, 3H, CH<sub>3</sub>, <i>J</i> = 7.1 Hz). Anal. (C<sub>16</sub>H<sub>20</sub>N<sub>2</sub>O<sub>5</sub>) C, H, N.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 3-[(5,6-Dimethoxy-1-methyl-1<i>H</i>-indole-2-carbonyl)amino]propionic Acid Ethyl Ester (<b>5b</b>)</h3><div class="NLM_p last">To a solution of <b>5a</b> (500 mg, 1.56 mmol) in 25 mL of acetonitrile, K<sub>2</sub>CO<sub>3</sub> (970 mg, 7.02 mmol) and MeI (554 mg, 3.9 mmol) were added. The solution was refluxed for 30 h. Then the precipitate was filtered and the solvent evaporated. The residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> and washed with 40 mL of 1 N HCl. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated in vacuo. The crude residue was purified by column chromatography (eluent, hexane/ethyl acetate 35:65) to afford <b>5b</b>. Yield 72%, mp 135 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.00 (s, 1H, 1 Ar), 6.76 (s, 1H, 1 Ar), 6.73 (s, 1H, 1 Ar), 4.17 (q, 2H, OCH<sub>2</sub>, <i>J</i> = 7.1 Hz), 4.01 (s, 3H OMe), 3.96 (s, 3H, OMe), 3.90 (s, 3H, NMe), 3.64−3.70 (m, 2H, CH<sub>2</sub>), 2.60−2.68 (m. 2H, CH<sub>2</sub>), 1.27 (t, 3H, CH<sub>3</sub>, <i>J</i> = 7.1 Hz). Anal. (C<sub>17</sub>H<sub>22</sub>N<sub>2</sub>O<sub>5</sub>) C, H, N.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 3-[(5,6-Dimethoxy-1<i>H</i>-indole-2-carbonyl)amino]propionic Acid (<b>6a</b>)</h3><div class="NLM_p last">To a suspension of <b>5a</b> (1 g, 3.12 mmol) in 55 mL of EtOH was added LiOH·H<sub>2</sub>O (0.262 g, 6.24 mmol), and the mixture was stirred for 48 h at room temperature. After evaporation of the solvent, the residue was dissolved in water and cold concentrated HCl was dropped during 15 min under stirring. The precipitate was filtered to obtain 810 mg of the title compound. Yield 89%, mp 245 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 12.25 (br s, 1H, COOH), 11.26 (s, 1H, NH), 8.26 (t, 1H, NH, <i>J</i> = 5.2 Hz), 7.05 (s, 1H, 1Ar), 6.96 (s, 1H, 1 Ar), 6.87 (s, 1H, 1Ar), 3.76 (s, 3H, OMe), 3.75 (s, 3H, OMe), 3.4−3.5 (m, 2H, CH<sub>2</sub>), 2.45−2.55 (m, 2H, CH<sub>2</sub>). Anal. (C<sub>14</sub>H<sub>16</sub>N<sub>2</sub>O<sub>5</sub>) C, H, N.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 3-[(5,6-Dimethoxy-1-methyl-1<i>H</i>-indole-2-carbonyl)amino]propionic Acid (<b>6b</b>)</h3><div class="NLM_p last">To a suspension of of <b>5b</b> (378 mg, 1.13 mmol) in 20 mL of EtOH was added LiOH·H<sub>2</sub>O (96 mg, 2.26 mmol), and the mixture was stirred for 48 h at room temperature. After evaporation of the solvent, the residue was dissolved in water and cold 6 N HCl was dropped during 15 min under stirring. The white precipitate was filtered to obtain 324 mg of the title compound. Yield 94%, mp 200 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 12.23 (s, 1H, COOH), 8.34 (t, 1H, NH, <i>J</i> = 5.9 Hz), 7.07 (s, 1H, 1 Ar), 7.03 (s, 1H, 1Ar), 6.94 (s, 1H, 1Ar), 3.94 (s, 3H, OMe), 3.83 (s, 3H, OMe), 3.76 (s, 3H, NMe), 3.3−3.5 (m, 2H, CH<sub>2</sub>), 2.45−2.55 (m, 2H, CH<sub>2</sub>). Anal. (C<sub>15</sub>H<sub>18</sub>N<sub>2</sub>O<sub>5</sub>) C, H, N.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 7,8-Dimethoxy-3,4-dihydro-2<i>H</i>,10<i>H</i>-azepino[3,4-<i>b</i>]indole-1,5-dione (<b>7a</b>)</h3><div class="NLM_p last">A mixture of <b>6a</b>(0.76 g, 2.6 mmol) and PPA (58 g) was stirred at 95 °C for 6 h. After the mixture was cooled, iced water was added and the aqueous phase was continuously extracted with a solution CH<sub>2</sub>Cl<sub>2</sub>/MeOH 95:5. Purification by flash chromatography (eluent, CH<sub>2</sub>Cl<sub>2</sub>/MeOH 95:5) afforded the title compound in a 45% yield. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 12.20 (s, 1H, NH), 8.68 (t, 1H, CONH, <i>J</i> = 5.9 Hz), 7.75 (s, 1H, 1 Ar), 6.99 (s, 1H, 1Ar), 3.78 (s, 6H, 2OMe), 3.3−3.5 (m, 2H, CH<sub>2</sub>), 2,75−2.85 (m, 2H, CH<sub>2</sub>). Anal. (C<sub>14</sub>H<sub>14</sub>N<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 7,8-Dimethoxy-10-methyl-3,4-dihydro-2<i>H</i>,10<i>H</i>-azepino[3,4-<i>b</i>]indole-1,5-dione (<b>7b</b>)</h3><div class="NLM_p last">A mixture of <b>6b</b> (324 mg, 1.06 mmol) and PPA (13 g) was stirred at 90 °C for 90 min. After the mixture was cooled, an amount of 50 mL of iced water was added and the aqueous phase was extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated in vacuo to afford 208 mg of the title compound. Yield 68%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 8.65 (t, 1H, CONH, <i>J</i> = 5.9 Hz), 7.74 (s, 1H, 1Ar), 7.19 (s, 1H, 1Ar), 3.99 (s, 3H, 2OMe), 3.87 (s, 3H, OMe), 3.80 (s, 3H, NMe), 3.45−3.50 (m, 2H, CH<sub>2</sub>), 2,72−2.78 (m, 2H, CH<sub>2</sub>). Anal. (C<sub>15</sub>H<sub>16</sub>N<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 7,8-Dimethoxy-10-(4-methoxybenzyl)-3,4-dihydro-2<i>H</i>,10<i>H</i>-azepino[3,4-<i>b</i>]indole-1,5-dione (<b>7c</b>)</h3><div class="NLM_p last">A suspension of <b>7a</b> (0.843 g, 3.07 mmol) in DMF (15.2 mL) was cooled to 0 °C. Then NaH (60% in mineral oil, 0.843 g, 7.37mmol) was added. The solution was stirred for 1 h at room temperature. Then PMBCl (1.19 g, 7.37 mmol) was dropped and stirring was continued for further 3 h. The mixture was added to water and extracted twice with dichloromethane. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated in vacuo. Flash chromatography (eluent from ethyl acetate/hexane 85:15 to ethyl acetate) afforded <b>7c</b>. Yield 50%, mp 260 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 8.69 (t, 1H, CONH, <i>J</i> = 5.9 Hz), 7.73 (s, 1H, 1 Ar), 7.18 (s, 1H, 1 Ar), 7.11 (d, 2H, 2Ar, <i>J</i> = 8.6 Hz), 6.84 (d, 2H, 2Ar, <i>J</i> = 8.6 Hz), 5.82 (s, 2H, CH<sub>2</sub>Ph), 3.79 (s, 6H, 2OMe), 3.69 (s, 3H, OMe), 3.3−3.4 (m, 2H, CH<sub>2</sub>), 2,74−2.82 (m, 2H, CH<sub>2</sub>). Anal. (C<sub>22</sub>H<sub>22</sub>N<sub>2</sub>O<sub>5</sub>) C, H, N.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 7,8-Dimethoxy-2,10-dimethyl-3,4-dihydro-2<i>H</i>,10<i>H</i>-azepino[3,4-<i>b</i>]indole-1,5-dione (<b>8b</b>)</h3><div class="NLM_p last">To a suspension of <b>7a</b> (314 mg, 1.14 mmol) in DMF (4.35 mL), NaH (60% in mineral oil, 65 mg, 2.69 mmol) was added. The solution was stirred for 1 h at room temperature, and then MeI (389 mg, 2.74 mmol) was dropped and stirring was continued for 1 h. The mixture was added to water and extracted twice with dichloromethane. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated in vacuo. Flash chromatography (eluent, CH<sub>2</sub>Cl<sub>2</sub>/MeOH 98:2) afforded <b>8b</b>. Yield 40%, mp 182 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.82 (s, 1H, 1Ar), 6.82 (s, 1H, 1Ar), 4.02, 3.95, 3.95, (2s, 9H, 2OMe and NMe), 3.7−3.8 (m, 2H, CH<sub>2</sub>), 3.25 (s, 3H, NMe), 2.8−2.9 (m, 2H, CH<sub>2</sub>). Anal. (C<sub>16</sub>H<sub>18</sub>N<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 7,8-Dimethoxy-2-(4-methoxybenzyl)-10-methyl-3,4-dihydro-2<i>H</i>,10<i>H</i>-azepino[3,4-<i>b</i>]indole-1,5-dione (<b>8c</b>)</h3><div class="NLM_p last">A suspension of <b>7b</b> (205 mg, 0.71 mmol) in DMF (3.7 mL) was cooled to 0 °C, and then NaH (60% in mineral oil, 20.5 mg, 0.85 mmol) was added. The solution was stirred for 1 h at room temperature, and then PMBCl (138 mg, 0.85 mmol) was dropped and stirring was continued overnight. The mixture was added to water (6 mL) and extracted twice with ethyl acetate. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated in vacuo. Flash chromatography (eluent, hexane/ethyl acetate 45:55) afforded the title compound as a white solid. Yield 33%, mp 167 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.80 (s, 1H, 1Ar), 7.30 (d, 2H, 2Ar, <i>J</i> = 8.5 Hz), 6.88 (d, 2H, 2Ar, <i>J</i> = 8.5 Hz), 6.79 (s, 1H, 1Ar), 4.77 (s, 2H, CH<sub>2</sub>Ph), 4.09 (s, 3H, OMe), 3.99 (s, 3H, OMe), 3.95 (s, 3H, OMe), 3.76 (s, 3H, NMe), 3.65−3.75 (m, 2H, CH<sub>2</sub>), 2.65−2.75 (m, 2H, CH<sub>2</sub>). Anal. (C<sub>23</sub>H<sub>24</sub>N<sub>2</sub>O<sub>5</sub>) C, H, N.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Trifluoromethanesulfonic Acid 7,8-Dimethoxy-1-oxo-1,2,3,10-tetrahydroazepino[3,4-<i>b</i>]indol-5-yl Ester (<b>9a</b>)</h3><div class="NLM_p last">To a suspension of compound <b>7c</b> (290 mg, 0.735 mmol) and Na<sub>2</sub>CO<sub>3</sub> (109 mg, 1.03 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (7.5 mL) was added trifluoromethanesulfonic anhydride (317 mg, 1.10 mmol). The mixture was stirred for 3 h at room temperature. Then water was added and the aqueous phase was extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated in vacuo. Flash chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH 99.5:0.5) afforded <b>9a</b> (26%), mp >250 °C (dec). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 12.87 (s, 1H, NH), 7.21 (s, 1H, 1Ar), 6.98 (s, 1H, 1Ar), 6.56 (t, 1H, CH═, <i>J</i> = 7.1 Hz), 4.5−4.6 (m, 2H, CH<sub>2</sub>), 3.82 (s, 3H, OMe), 3.78 (s, 3H, OMe). Anal. (C<sub>15</sub>H<sub>13</sub>F<sub>3</sub>N<sub>2</sub>O<sub>6</sub>S) C, H, N.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Trifluoromethanesulfonic Acid 7,8-Dimethoxy-2,10-dimethyl-1-oxo-1,2,3,10-tetrahydroazepino[3,4-<i>b</i>]indol-5-yl Ester (<b>9b</b>)</h3><div class="NLM_p last">To a suspension of compound <b>8b</b> (127 mg, 0.42 mmol) and Na<sub>2</sub>CO<sub>3</sub> (63.7 mg, 0.60 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (1.6 mL) was dropped a solution of trifluoromethanesulfonic anhydride (176 mg, 0.613 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2.6 mL). The mixture was stirred at room temperature overnight. Then water was added and the aqueous phase was extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated in vacuo. Flash chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH 99:1) afforded <b>9b</b> (75%), mp 96 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.31 (s, 1H, 1Ar), 6.80 (s, 1H, 1Ar), 6.09 (t, 1H, CH═, <i>J</i> = 7.1 Hz), 4.04 (s, 3H, OMe), 3.99 (s, 3H, OMe), 3.93 (s, 3H, NMe), 3.83 (d, 2H, CH<sub>2</sub>N, <i>J</i> = 7.1 Hz), 3.28 (s, 3H, NMe). Anal. (C<sub>17</sub>H<sub>17</sub>F<sub>3</sub>N<sub>2</sub>O<sub>6</sub>S) C, H, N.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Trifluoromethanesulfonic Acid 7,8-Dimethoxy-2-(4-methoxybenzyl)-10-methyl-1-oxo-1,2,3,10-tetrahydroazepino[3,4-<i>b</i>]indol-5-yl Ester (<b>9c</b>)</h3><div class="NLM_p last">To a suspension of compound <b>8c</b> (80 mg, 0.136 mmol) and Na<sub>2</sub>CO<sub>3</sub> (29.1 mg, 0.274 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (1 mL) was dropped trifluoromethanesulfonic anhydride (84.6 mg, 0.294 mmol). The mixture was stirred at room temperature overnight, and then water was added and the aqueous phase was extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated in vacuo. Flash chromatography (eluent, hexane/ethyl acetate 55:45) afforded <b>9c</b> (28%), mp 190 °C. <sup>1</sup>H NMR (acetone-<i>d</i><sub>6</sub>) δ: 7.32 (d, 2H, 2Ar, <i>J</i> = 8.6 Hz), 7.29 (s, 1H, 1Ar), 7.18 (s, 1H, 1Ar), 6.89 (d, 2H, 2Ar, <i>J</i> = 8.6 Hz), 5.99 (t, 1H, CH═, <i>J</i> = 7.5 Hz), 4.76 (s, 2H, CH<sub>2</sub>Ph), 4.06 (s, 3H, OMe), 3.94 (s, 3H, OMe), 3.89 (d, 2H, CH<sub>2</sub>N, <i>J</i> = 7.5 Hz), 3.84 (s, 3H, NMe), 3.78 (s, 3H, NMe). Anal. (C<sub>24</sub>H<sub>23</sub>F<sub>3</sub>N<sub>2</sub>O<sub>7</sub>S) C, H, N.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 5-(4-Hydroxyphenyl)-7,8-dimethoxy-3,10-dihydro-2<i>H</i>-azepino[3,4-<i>b</i>]indol-1-one (<b>1a</b>)</h3><div class="NLM_p last">A solution of <b>9a</b> (375 mg, 0.222 mmol) and palladium tetrakis (15 mg) in 5 mL of toluene was stirred at room temperature for 3 h. Then a solution of 4-hydroxybenzeneboronic acid (46 mg, 0.33 mmol) in EtOH (2 mL) and a saturated solution of Na<sub>2</sub>CO<sub>3</sub> (2 mL) were added. After the mixture was stirred for 90 min at 80 °C, brine was added and the mixture was extracted with ethyl acetate. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated in vacuo. Flash chromatography (eluent, hexane/ethyl acetate 60:40) afforded <b>1a</b> (12%), mp 159 °C. <sup>1</sup>H NMR (acetone-<i>d</i><sub>6</sub>) δ: 11.25 (s, 1H, NH), 8.65 (s, 1H, CONH), 7.25 (d, 2H, 2Ar, <i>J</i> = 8.4 Hz), 7.08 (s, 1H, 1Ar), 6.91 (d, 2H, 2Ar, <i>J</i> = 8.4 Hz), 6.30 (t, 1H, CH═, <i>J</i> = 6.9 Hz), 6.01 (s, 1H, 1Ar), 4.45−4.55 (m, 2H, CH<sub>2</sub>), 3.89 (s, 3H, OMe), 3.42 (s, 3H, OMe). Anal. (C<sub>20</sub>H<sub>18</sub>N<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 5-(4-Hydroxyphenyl)-7,8-dimethoxy-10-methyl-3,10-dihydro-2<i>H</i>-azepino[3,4-<i>b</i>]indol-1-one (<b>1b</b>)</h3><div class="NLM_p last">A solution of <b>1d</b> (130 mg, 0.27 mmol) in 10 mL of TFA was refluxed for 5 h. After evaporation of the solvent, a saturated solution of NaHCO<sub>3</sub> was added. The precipitate was filtered to obtain a crude that was purified by flash chromatography (eluent, CH<sub>2</sub>Cl<sub>2</sub>/MeOH 96:4). Yield 49%, mp >270 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 9.50 (s, 1H, OH), 8.18 (t, 1H, NHCO, <i>J</i> = 5.9 Hz), 7.10 (d, 2H, 2Ar, <i>J</i> = 8.4 Hz), 7.09 (s, 1H, 1Ar), 6.75 (d, 2H, 2Ar, <i>J</i> = 8.4 Hz), 6.01 (t, 1H, CH═, <i>J</i> = 6.9 Hz), 5.95 (s, 1H, 1Ar), 3.99 (s, 3H, OMe), 3.81 (s, 3H OMe), 3.45 (m, 2H, CH<sub>2</sub>), 3.30 (s, 3H, NMe). Anal. (C<sub>21</sub>H<sub>20</sub>N<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 5-(4-Hydroxyphenyl)-7,8-dimethoxy-2,10-dimethyl-3,10-dihydro-2<i>H</i>-azepino[3,4-<i>b</i>]indol-1-one (<b>1c</b>)</h3><div class="NLM_p last">A solution of <b>9b</b> (133 mg, 0.31 mmol) and palladium tetrakis (21 mg) in 7 mL of toluene was stirred at room temperature for 30 min. Then a solution of 4-hydroxybenzeneboronic acid (63 mg, 0.46 mmol) in EtOH (2.8 mL) and a saturated solution of Na<sub>2</sub>CO<sub>3</sub> (2.8 mL) were added. After the mixture was stirred for 60 min at 80 °C, brine was added and the mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated in vacuo. Flash chromatography (eluent, hexane/ethyl acetate 35:65) afforded <b>1c</b> (49%), mp 228 °C. <sup>1</sup>H NMR (acetone-<i>d</i><sub>6</sub>) δ: 7.20 (d, 2H, 2Ar, <i>J</i> = 8.4 Hz), 7.08 (s, 1H, 1Ar), 7.85 (d, 2H, 2Ar, <i>J</i> = 8.4 Hz), 6.17 (t, 1H, CH═, <i>J</i> = 6.7 Hz), 6.11 (s, 1H 1 Ar), 4.01 (s, 3H, OMe), 3.89 (s, 3H, OMe), 3.84 (d, 2H, CH<sub>2</sub>N, <i>J</i> = 6.7 Hz), 3.40 (s, 3H, NMe), 3.15 (s, 3H, NMe). Anal. (C<sub>22</sub>H<sub>22</sub>N<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 5-(4-Hydroxyphenyl)-7,8-dimethoxy-2-(4-methoxybenzyl)-10-methyl-3,10-dihydro-2<i>H</i>-azepino[3,4-<i>b</i>]indol-1-one (<b>1d</b>)</h3><div class="NLM_p last">A solution of <b>9c</b> (30 mg, 0.055 mmol) and palladium tetrakis (5 mg) in 1.26 mL of toluene was stirred at room temperature for 30 min. Then a solution of 4-hydroxybenzeneboronic acid (11.5 mg, 0.083 mmol) in EtOH (0.5 mL) and a saturated solution of Na<sub>2</sub>CO<sub>3</sub> (0.5 mL) were added sequentially. After the mixture was stirred for 60 min at 80 °C, brine was added and the mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated in vacuo. Flash chromatography (eluent, hexane/ethyl acetate 50:50) afforded <b>1d</b> (78%), mp 193 °C. <sup>1</sup>H NMR (acetone-<i>d</i><sub>6</sub>) δ: 7.39 (d, 2H, 2 Ar, <i>J</i> = 8.4 Hz), 7.18 (d, 2H, 2Ar, <i>J</i> = 8.4 Hz), 7.08 (s, 1H, 1Ar), 6.80−6.90 (m, 4H, 4Ar), 6.09 (s, 1H, 1Ar), 5.95 (t, 1H, CH═, <i>J</i> = 6.9 Hz), 4.71 (s, 2H, CH<sub>2</sub>Ph), 4.06 (s, 3H, OMe), 3.90 (s, 3H, OMe), 3.75 (s, 6H, NMe and OMe), 3.38 (s, 3H, NMe). Anal. (C<sub>29</sub>H<sub>28</sub>N<sub>2</sub>O<sub>5</sub>) C, H, N.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 5,6-Dimethoxy-1-methyl-1<i>H</i>-indole-2-carboxylic Acid (<b>4b</b>)</h3><div class="NLM_p">To a solution of 5,6-dimethoxy-1<i>H</i>-indole-2-carboxylic acid ethyl ester (500 mg, 2 mmol) in CH<sub>3</sub>CN (32 mL) were added K<sub>2</sub>CO<sub>3</sub> (1.24 g, 9 mmol) and iodomethane (0.31 mL, 5 mmol), and the mixture was stirred at reflux for 13 h. The mixture was cooled to room temperature and filtered and the filtrate evaporated in vacuo. The solid was then washed with 1 N HCl and extracted with CH<sub>2</sub>Cl<sub>2</sub>, and the combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated to give 480 mg (93%) of 5,6-dimethoxy-1-methyl-1<i>H</i>-indole-2-carboxylic acid ethyl ester, mp 148 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.17 (s, 1H), 7.00 (s, 1H), 6.75 (s, 1H), 4.53 (q, <i>J</i> = 7.5 Hz, 2H), 4.04 (s, 3H), 3.97 (s, 3H), 3.90 (s, 3H), 1.20 (q, <i>J</i> = 7.5 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ: 162.1, 149.8, 146.0, 134.9, 126.3, 118.6, 109.9, 102.4, 92.1, 60.2, 56.1, 56.0, 31.8, 14.4.</div><div class="NLM_p last">The above ester (0.48 mg, 1.8 mmol) was added to a solution of NaOH (2.90 g, 72.4 mmol) in ethanol (31.8 mL), and the mixture was refluxed for 2 h. Ethanol was evaporated to dryness in vacuo, the residue was dissolved in water, and the solution was acidified to pH 3 with 12 N HCl to form a yellow solid. The mixture was allowed to stand at 0 °C for 15 min, and the product was isolated by filtration (330 mg, 85%), mp 221 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 12.6 (br s, 1H), 7.10 (s, 1H), 7.08 (s, 1H), 7.05 (s, 1H), 4.00 (s, 3H), 3.87 (s, 3H), 3.78 (s, 3H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 163.2, 149.9, 146.1, 135.1, 126.8, 118.4, 110.0, 103.0, 93.7, 56.1 (2C), 32.1. Anal. (C<sub>12</sub>H<sub>13</sub>NO<sub>4</sub>) C, H, N.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 5,6-Dimethoxy-1-methyl-1<i>H</i>-indole-2-carboxylic Acid (3-Hydroxypropyl)amide (<b>11e</b>)</h3><div class="NLM_p last">3-Amino-1-propanol (121 μL, 1.59 mmol) was dissolved in dry THF (5.8 mL), and then EDC (311 mg, 1.59 mmol), HOBt (220 mg, 1.59 mmol), and <b>4b</b> (250 mg, 1.06 mmol) were added sequentially at room temperature. After the resulting mixture was stirred overnight, the solvent was removed and the crude product was poured into saturated aqueous NaHCO<sub>3</sub> and extracted with ethyl acetate. The combined organic layers were washed with 1 N HCl, saturated aqueous NaHCO<sub>3</sub>, brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to give 210 mg (64%) of <b>11a</b>, mp 154 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 8.28 (t, <i>J</i> = 5.58 Hz, 1H), 7.07 (s, 1H), 7.03 (s, 1H), 6.92 (s, 1H), 4.57−4.45 (m, 1H), 3.95 (s, 3H), 3.84 (s, 3H), 3.76 (s, 3H), 3.55−3.44 (m, 2H), 3.29 (q, <i>J</i> = 6.70 Hz, 2H),1.78 (q, <i>J</i> = 6.70 Hz, 2H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 162.4, 148.8, 145.8, 133.9, 130.8, 118.5, 104.5, 103.0, 93.8, 59.1, 56.2, 56.1, 36.5, 32.9, 32.0. Anal. (C<sub>15</sub>H<sub>20</sub>N<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 5,6-Dimethoxy-1-methyl-1<i>H</i>-indole-2-carboxylic Acid (3-Hydroxybutyl)amide (<b>11f</b>)</h3><div class="NLM_p last">4-Amino-2-butanol (206 μL, 2.12 mmol) was dissolved in dry THF (5.77 mL), and then EDC (415 mg, 2.12 mmol), HOBt (365 mg, 2.12 mmol), and <b>4b</b> (250 mg, 1.06 mmol) were added sequentially at room temperature. After the resulting mixture was stirred for 3 h under nitrogen, the solvent was removed and the crude product was poured into saturated aqueous NaHCO<sub>3</sub> and extracted with ethyl acetate. The combined organic layers were washed with 1 N HCl, saturated NaHCO<sub>3,</sub> brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to give 321 mg (99%) of <b>11b</b>, mp 162 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 8.26 (t, 5.95 Hz, 1H), 7.07 (s, 1H), 7.03 (s, 1H), 6.92 (s, 1H), 4.54 (d, <i>J</i> = 4.8 Hz, 1H), 3.94 (s, 1H), 3.83 (s, 1H), 3.76 (s, 1H), 3.74−3−62 (m, 1H), 3.30 (q, <i>J</i> = 5.9 Hz, 2H), 1.66−1.50 (m, 2H), 1.09 (d, <i>J</i> = 6.3 Hz, 3H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 162.3, 148.8, 145.8, 133.9, 130.8, 118.5 104.5, 103.0, 93.8, 64.5, 56.2 (2C), 40.7, 36.5, 31.9, 24.1. Anal. (C<sub>16</sub>H<sub>22</sub>N<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 5,6-Dimethoxy-1-methyl-1<i>H</i>-indole-2-carboxylic Acid (3-Formylpropyl)amide (<b>12e</b>)</h3><div class="NLM_p last">To a solution of IBX (371 mg, 1.37 mmol) in DMSO (1.85 mL) was added <b>11e</b> (200 mg, 0.684 mmol), and the solution was stirred for 2 h at room temperature under nitrogen. The solution was diluted with water and extracted with ethyl acetate. The combined organic layers were washed with saturated aqueous NaHCO<sub>3</sub>, water, dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated. The crude product was crystallized from ethyl acetate to give 120 mg (61%) of <b>12e</b>, mp 102 °C. <sup>1</sup>H NMR (acetone-<i>d</i><sub>6</sub>) δ: 9.81(t, <i>J</i> = 1.5 Hz, 1H), 7.77−7.60 (br s, 1H), 7.05 (s, 1H), 7.02 (s, 1H), 6.91 (s, 1H), 4.03 (s, 3H), 3.91 (s, 3H), 3.80 (s, 3H), 3.70 (q, <i>J</i> = 6.7 Hz, 2H), 2.77 (td, <i>J</i> = 6.7 Hz, <i>J</i> = 1.5 Hz, 2H). <sup>13</sup>C NMR (75 MHz, acetone-<i>d</i><sub>6</sub>) δ: 201.1, 162.3, 153.8, 149.4, 146.2, 134.2, 118.8, 103.9, 102.9, 93.1, 55.5, 53.3, 43.7, 33.0, 31.0. Anal. (C<sub>15</sub>H<sub>18</sub>N<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 5,6-Dimethoxy-1-methyl-1<i>H</i>-indole-2-carboxylic Acid (3-Oxobutyl)amide (<b>12f</b>)</h3><div class="NLM_p last">Compound <b>11f</b> (178 mg, 0.58 mmol) was suspended in ethyl acetate (19.7 mL), and IBX (473 mg, 1.74 mmol) was added. The resulting mixture was refluxed for 3 h, and then the reaction was cooled to room temperature and filtered. The solid was washed with ethyl acetate and the combined filtrates were concentrated to yield 150 mg (85%) of <b>12f</b>, mp 135−136 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 8.27 (t, <i>J</i> = 5.9 Hz, 1H), 7.07 (s, 1H), 7.03 (s, 1H), 6.92 (s, 1H), 3.93 (s, 3H), 3.83 (s, 3H), 3.76 (s, 3H), 3.46−3−38 (m, 2H), 2.72 (t, <i>J</i> = 7.1 Hz, 2H), 2.13 (s, 3H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 207.9, 162.3, 146.9, 145.8, 134.9, 133.9, 131.5, 130.5, 118.5, 104.7, 103.0, 93.8, 56.2, 56.1, 43.1, 34.6, 32.0, 30.3. Anal. (C<sub>16</sub>H<sub>20</sub>N<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 5,6-Dimethoxy-1-methyl-1<i>H</i>-indole-2-carboxylic Acid [3-(4-Methoxyphenyl)-3-oxopropyl]amide (<b>12g</b>)</h3><div class="NLM_p last">To a suspension of <b>4b</b> (47.5 mg, 0.20 mmol) in dry THF (1.09 mL) were added EDC (59.3 mg, 0.30 mmol) and HOBt (40.9 mg, 0.30 mmol). The mixture was stirred at room temperature, under nitrogen, for 3 h. 3-Amino-1-(4-methoxyphenyl)propan-1-one trifluoromethanesulfonate (133 mg, 0.404 mmol) was added followed by <i>N</i>-ethyldiisopropylamine (69 μL, 0.4 mmol). After the mixture was stirred for 1 h at room temperature, the solvent was evaporated and the crude product was poured into saturated NaHCO<sub>3</sub> and extracted with ethyl acetate. The combined extracts were then washed with 1 N HCl, saturated aqueous NaHCO<sub>3</sub>, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude product was purified by flash chromatography (ethyl acetate/hexane 60:40) to give 45 mg (56%) of <b>12g</b>, mp 136 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 8.35 (t, <i>J</i> = 5.6 Hz, 1H), 7.98 (d, <i>J</i> = 8.9 Hz, 2H), 7.07 (s, 1H), 7.05 (d, <i>J</i> = 8.9 Hz, 2H), 7.02 (s, 1H), 6.92 (s, 1H), 3.93 (s, 3H), 3.83 (s, 6H), 3.75 (s, 3H), 3.55 (dt, <i>J</i> = 7.07 Hz, <i>J</i> = 5.6 Hz, 2H), 3.26 (t, <i>J</i> = 7.1 Hz, 2H). Anal. (C<sub>22</sub>H<sub>24</sub>N<sub>2</sub>O<sub>5</sub>) C, H, N.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 7,8-Dimethoxy-10-methyl-3,10-dihydro-2<i>H</i>-azepino[3,4-<i>b</i>]indol-1-one (<b>1e</b>)</h3><div class="NLM_p last">(A) Trifluoroacetic acid (19.7 μL, 0.26 mmol) was added to a solution of <b>12e</b> (50 mg, 0.172 mmol) in CH<sub>3</sub>CN (3.16 mL), and the mixture was refluxed for 1 h. The solvent was evaporated and the crude product was purified by preparative layer chromatography (ethyl acetate/hexane 95:5) to give 22 mg (47%) of <b>1e</b>, mp 208 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 7.80 (t, <i>J</i> = 5.6 Hz, 1H), 7.26 (s, 1H), 7.14 (d, <i>J</i> = 9.7 Hz, 1H), 7.07 (s, 1H), 6.13−6.00 (m, 1H), 3.97 (s, 3H), 3.88 (s, 3H), 3.80 (s, 3H), 3.5−3.4 (m, 2H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 163.4, 149.3, 146.1, 133.7, 129.7, 125.7, 117.5, 117.2, 101.7, 101.5, 93.4, 56.4 (2C), 39.9 (one peak missing due to overlapping with solvent signal), 32.8. Anal. (C<sub>15</sub>H<sub>16</sub>N<sub>2</sub>O<sub>3</sub>) C, H, N. (B) InCl<sub>3</sub> (15 mg, 0.068 mmol) was added to <b>12e</b> (40 mg, 0.14 mmol) in CH<sub>3</sub>CN (2.4 mL), and the mixture was refluxed for 2 h. Evaporation and PLC (ethyl acetate/hexane 95:5) gave 12 mg (32%) of <b>1e</b>.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 7,8-Dimethoxy-5,10-dimethyl-3,10-dihydro-2<i>H</i>-azepino[3,4-<i>b</i>]indol-1-one (<b>1f</b>)</h3><div class="NLM_p last">Trifluoroacetic acid (121 μL, 1.57 mmol) was added to a solution of <b>12f</b> (60 mg, 0.197 mmol) in CH<sub>3</sub>CN (3.62 mL), and the mixture was refluxed for 18 h. The solvent was removed, and the crude product was poured into saturated aqueous NaHCO<sub>3</sub> and extracted with ethyl acetate. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub> and filtered and the solvent was evaporated to give 27 mg (47%) of <b>1f</b> after crystallization from acetone, mp 238 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 8.06 (t, <i>J</i> = 5.6 Hz, 1H), 7.26 (s, 1H), 7.10 (s, 1H), 5.80 (t, <i>J</i> = 6.7 Hz, 1H), 3.94 (s, 3H), 3.89 (s, 3H), 3.81 (s, 3H), 3.35−3.20 (m, 2H), 2.37 (s, 3H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 168.1, 154.1, 150.3, 140.3, 138.6, 135.1, 127.4, 123.6, 121.6, 108.8, 96.5, 61.1, 60.9, 42.7, 37.1, 25.9. Anal. (C<sub>16</sub>H<sub>18</sub>N<sub>2</sub>O<sub>3</sub>) C, H, N.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 7,8-Dimethoxy-5-(4-methoxyphenyl)-10-methyl-3,10-dihydro-2<i>H</i>-azepino[3,4-<i>b</i>]indol-1-one (<b>1g</b>)</h3><div class="NLM_p last">Trifluoroacetic acid (80 μL, 1.04 mmol) was added to a suspension of <b>12g</b> (42 mg, 0.106 mmol) in CH<sub>3</sub>CN (1 mL), and the mixture was refluxed for 18 h. The solvent was evaporated, and the residue was poured into saturated aqueous NaHCO<sub>3</sub> and extracted with ethyl acetate. The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub> and filtered, and the solvent was evaporated in vacuo. The crude product was purified by PLC (dichloromethane/methanol 97:3) to give 18 mg (43%) of <b>1g</b>, mp 198 °C. <sup>1</sup>H NMR (acetone-<i>d</i><sub>6</sub>) δ: 7.26 (t, <i>J</i> = 6.5 Hz, 1H), 7.25 (d, <i>J</i> = 8.7 Hz, 1H), 7.05 (s, 1H), 6.92 (d, <i>J</i> = 8.7 Hz, 2H), 6.10 (t, <i>J</i> = 6.5 Hz, 1H), 6.02 (s, 1H), 4.03 (s, 3H), 3.90 (s, 3H), 3.83 (s, 3H), 3.60 (t, <i>J</i> = 6.51 Hz, 2H), 3.35 (s, 3H). <sup>13</sup>C NMR (75 MHz, acetone-<i>d</i><sub><i>6</i></sub>) δ: 163.4, 159.6, 149.6, 145.3, 140.8, 133.8, 133.3, 131.0, 129.6 (2C), 121.9, 117.3, 117.0, 113.5 (2C), 104.4, 92.9, 55.3, 54.7, 38.1, 31.3.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Cell Culture and Antibodies</h3><div class="NLM_p last">Cells were maintained in Dulbecco’s modified Eagle medium supplemented with 5% serum for NIH3T3<sup>MEN2A</sup> or 10% calf serum (Colorado Serum Company, Denver, CO) for NIH3T3 and NIH3T3<sup>H-Ras</sup> and incubated at 37 °C in a 10% CO<sub>2</sub> atmosphere. Antiproliferative activity was evaluated by cell counting after 72 h of treatment with compounds dissolved in DMSO or solvent (0.5% final concentration). IC<sub>50</sub> values were calculated from dose−response curves. The effect of selected compounds on tyrosine phosphorylation and expression of the RET oncoprotein was assessed by Western blot analysis of NIH3T3<sup>MEN2A</sup> cells after 24 h of treatment as previously described.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> The following antibodies were used: monoclonal anti-pTyr antibody clone 4610 (Upstate Biotechnology, Lake Placid, NY), rabbit polyclonal anti-Ret H300 and antiphospho Ret (Y1062) (Santa Cruz Biotechnology, SantaCruz, CA), and anti-actin (Sigma Chemical Company, St. Louis, MO).</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Kinase Assay</h3><div class="NLM_p last">A nonradioactive kinase assay was performed using recombinant Ret active protein (Upstate, Lake Placid, NY) and myelin basic protein (MBP) (Sigma) as kinase substrate, as previously described.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Briefly, the kinase activity was assayed in the presence of Ret (30 ng), 2 μM MBP, solvent, or inhibitor (DMSO 4% final concentration), and 5 μM ATP. After 10 min of incubation at 30 °C, the enzyme-catalyzed reaction was terminated by addition of 3-fold concentrated Laemmli buffer. Samples were subjected to SDS−PAGE and immunoblotted with antiphosphotyrosine antibody. Phosphorylated MBP was revealed by enhanced chemioluminescence reaction (GE Healthcare, Little Chalf-ont, U.K.). Signal intensity was detected by ChemiDoc XRS system, PC, and analyzed with the interfaced software Quantity One 4.6.3 (Biorad, Hercules, CA).</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Docking Methods</h3><div class="NLM_p">The crystal structure of RET (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ivu">2ivu</a><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a>) was taken from the Protein Data Bank.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> After addition of hydrogen atoms and correction of the wrong residues, the protein complexed with its reference inhibitor (i.e., ZD6474) was minimized using AMBER 9 software<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> and the parm03 force field at 300 K. The complex was placed in a rectangular parallelepiped water box, an explicit solvent model for water, TIP3P, was used, and the complex was solvated with a 8 Å water cap. Chlorine ions were added as counterions to neutralize the system. Two steps of minimization were then carried out. In the first stage, we kept the complex fixed with a position restraint of 500 (kcal/mol)/Å<sup>2</sup> and we solely minimized the positions of the water molecules. In the second stage, we minimized the entire system through 5000 steps of steepest descent followed by conjugate gradient (CG) until a convergence of 0.05 kcal/(Å·mol) was attained.</div><div class="NLM_p">The ligands were built by means of Maestro<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and were then minimized in a water environment (using the generalized Born/surface-area model) by means of Macromodel.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> They were minimized using the CG method until a convergence value of 0.05 kcal/(Å·mol) was attained, using the MMFFs force field and a distance-dependent dielectric constant of 1.0.</div><div class="NLM_p last">The ligands minimized in this manner were docked into the RET binding site by means of GOLD 3.2.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The region of interest used by GOLD was defined to contain the atoms that stayed within 10 Å of ZD6474 in the minimized receptor model. The “allow early termination” command was deactivated. All the other parameters were used as GOLD default values, and the ligands were submitted to 30 genetic algorithm runs. The docking analysis was carried out using the ChemScore kinase fitness scoring function, and the best docked conformation was then analyzed.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> MD Simulations</h3><div class="NLM_p">All simulations were performed using AMBER 9.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> MD simulations were carried out using the parm03 force field at 300 K. The complex was placed in a rectangular parallelepiped water box, an explicit solvent model for water, TIP3P, was used, and the complex was solvated with a 8 Å water cap. Chlorine ions were added as counterions to neutralize the system. Prior to MD simulations, two steps of minimization were carried out. In the first stage, we kept the protein fixed with a position restraint of 500 (kcal/mol)/Å<sup>2</sup>, and we solely minimized the positions of the water molecules. In the second stage, we minimized the entire system by applying a constraint of 20 kcal/mol on the α carbon. The two minimization stages consisted of 5000 steps of steepest descent followed by CG until a convergence of 0.05 kcal/(Å·mol) was attained.</div><div class="NLM_p">MD was done on a 1 CPU/node, 4 node, 1024 MB RAM/node cluster Intel Core 2 Duo E6600, 2.4 GHz, and the average wall clock time for a 1 ns simulation was about 33 h.</div><div class="NLM_p">Particle mesh Ewald (PME)<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> electrostatics and periodic boundary conditions were used in the simulation. The MD trajectory was run using the minimized structure as the starting conformation. The time step of the simulations was 2.0 fs with a cutoff of 10 Å for the nonbonded interaction, and SHAKE was employed to keep all bonds involving hydrogen atoms rigid. Constant-volume periodic boundary MD was carried out for 80 ps, during which the temperature was raised from 0 to 300 K. Then 1 ns of constant-pressure periodic boundary MD was carried out at 300 K using the Langevin thermostat to maintain constant the temperature of our system.</div><div class="NLM_p last">The α carbons of the receptor were blocked with a harmonic force constant of 20 (kcal/mol)/Å<sup>2</sup> during the simulation. General Amber force field (GAFF) parameters were assigned to the ligands, while partial charges were calculated using the AM1-BCC method as implemented in the Antechamber suite of AMBER 9.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Energy Evaluation</h3><div class="NLM_p">We extracted from the last 800 ps of MD of the <b>2b</b>− and <b>2a</b>−RET complexes 400 snapshots (at time intervals of 2 ps) for each species (complex, receptor, and ligand). In general, the binding free energy of a protein−ligand complex (Δ<i>G</i><sub>bind</sub>) is defined as <span class="NLM_disp-formula"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/jm-2008-007823_m001.gif" alt="" /></img></span> where <i>G</i><sub>complex</sub>, <i>G</i><sub>protein</sub>, and <i>G</i><sub>ligand</sub> are the free energies of the complex, protein, and the ligand respectively.</div><div class="NLM_p last">For each system the free energy can be estimated as <span class="NLM_disp-formula"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/jm-2008-007823_m002.gif" alt="" /></img></span> Electrostatic, van der Waals energies, and internal energies (<i>E</i><sub>MM</sub>) were obtained using the SANDER module in AMBER 9.0.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The solvation free energy (<i>G</i><sub>sol</sub>) was obtained from the sum of the polar solvation and nonpolar solvation free energy. The polar energy was obtained using the Sander module, applying dielectric constants of 1 and 80 for the solute and the solvent, respectively. Nonpolar energies were determined using the MOLSURF program applying the LCPO method.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i50"><a href="/doi/suppl/10.1021/jm8007823">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63152" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63152" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Elemental analysis of analysis data of the compounds. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm8007823/suppl_file/jm8007823_si_001.pdf">jm8007823_si_001.pdf (46.99 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm8007823" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00823" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00823" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sabrina Dallavalle</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Scienze Molecolari Agroalimentari, Università di Milano, Via Celoria 2, 20133 Milano, Italy, Unità di Chemioterapia e Farmacologia Antitumorale Preclinica, Dipartimento di Oncologia Sperimentale e Laboratori, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milano, Italy, Dipartimento Farmaco Chimico Tecnologico, Università degli Studi di Siena, Via De Gasperi 2, 53100 Siena, Italy, and Dipartimento di Scienze Farmaceutiche, Università di Pisa, Via Bonanno 6, 56126 Pisa, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2053414252494e410e44414c4c4156414c4c4560554e494d490e49540043494e5a49410e4c414e5a4960495354495455544f54554d4f52490e4d490e495400424f54544160554e4953490e4954"><span class="__cf_email__" data-cfemail="cbb8aaa9b9a2a5aae5afaaa7a7aabdaaa7a7ae8bbea5a2a6a2e5a2bf">[email protected]</span> <span class="__cf_email__" data-cfemail="54373d3a2e3d357a38353a2e3d143d27203d2021203b2021393b263d7a393d7a3d20">[email protected]</span> <span class="__cf_email__" data-cfemail="b8dad7ccccd9f8cdd6d1cbd196d1cc">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cinzia Lanzi</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Scienze Molecolari Agroalimentari, Università di Milano, Via Celoria 2, 20133 Milano, Italy, Unità di Chemioterapia e Farmacologia Antitumorale Preclinica, Dipartimento di Oncologia Sperimentale e Laboratori, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milano, Italy, Dipartimento Farmaco Chimico Tecnologico, Università degli Studi di Siena, Via De Gasperi 2, 53100 Siena, Italy, and Dipartimento di Scienze Farmaceutiche, Università di Pisa, Via Bonanno 6, 56126 Pisa, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c7b4a6a5b5aea9a6e9a3a6ababa6b1a6ababa287b2a9aeaaaee9aeb3e7a4aea9bdaea6e9aba6a9bdae87aeb4b3aeb3b2b3a8b3b2aaa8b5aee9aaaee9aeb3e7a5a8b3b3a687b2a9aeb4aee9aeb3"><span class="__cf_email__" data-cfemail="c4b7a5a6b6adaaa5eaa0a5a8a8a5b2a5a8a8a184b1aaada9adeaadb0">[email protected]</span> <span class="__cf_email__" data-cfemail="27444e495d4e46094b46495d4e674e54534e5352534853524a48554e094a4e094e53">[email protected]</span> <span class="__cf_email__" data-cfemail="e4868b909085a4918a8d978dca8d90">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maurizio Botta</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Scienze Molecolari Agroalimentari, Università di Milano, Via Celoria 2, 20133 Milano, Italy, Unità di Chemioterapia e Farmacologia Antitumorale Preclinica, Dipartimento di Oncologia Sperimentale e Laboratori, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milano, Italy, Dipartimento Farmaco Chimico Tecnologico, Università degli Studi di Siena, Via De Gasperi 2, 53100 Siena, Italy, and Dipartimento di Scienze Farmaceutiche, Università di Pisa, Via Bonanno 6, 56126 Pisa, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#681b090a1a010609460c090404091e0904040d281d0601050146011c480b010612010946040906120128011b1c011c1d1c071c1d05071a0146050146011c480a071c1c09281d06011b0146011c"><span class="__cf_email__" data-cfemail="e5968487978c8b84cb81848989849384898980a5908b8c888ccb8c91">[email protected]</span> <span class="__cf_email__" data-cfemail="beddd7d0c4d7df90d2dfd0c4d7fed7cdcad7cacbcad1cacbd3d1ccd790d3d790d7ca">[email protected]</span> <span class="__cf_email__" data-cfemail="4e2c213a3a2f0e3b20273d2760273a">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Raffaella Cincinelli</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Scienze Molecolari Agroalimentari, Università di Milano, Via Celoria 2, 20133 Milano, Italy, Unità di Chemioterapia e Farmacologia Antitumorale Preclinica, Dipartimento di Oncologia Sperimentale e Laboratori, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milano, Italy, Dipartimento Farmaco Chimico Tecnologico, Università degli Studi di Siena, Via De Gasperi 2, 53100 Siena, Italy, and Dipartimento di Scienze Farmaceutiche, Università di Pisa, Via Bonanno 6, 56126 Pisa, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giuliana Cassinelli</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Scienze Molecolari Agroalimentari, Università di Milano, Via Celoria 2, 20133 Milano, Italy, Unità di Chemioterapia e Farmacologia Antitumorale Preclinica, Dipartimento di Oncologia Sperimentale e Laboratori, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milano, Italy, Dipartimento Farmaco Chimico Tecnologico, Università degli Studi di Siena, Via De Gasperi 2, 53100 Siena, Italy, and Dipartimento di Scienze Farmaceutiche, Università di Pisa, Via Bonanno 6, 56126 Pisa, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lucio Merlini</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Scienze Molecolari Agroalimentari, Università di Milano, Via Celoria 2, 20133 Milano, Italy, Unità di Chemioterapia e Farmacologia Antitumorale Preclinica, Dipartimento di Oncologia Sperimentale e Laboratori, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milano, Italy, Dipartimento Farmaco Chimico Tecnologico, Università degli Studi di Siena, Via De Gasperi 2, 53100 Siena, Italy, and Dipartimento di Scienze Farmaceutiche, Università di Pisa, Via Bonanno 6, 56126 Pisa, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tiziano Tuccinardi</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Scienze Molecolari Agroalimentari, Università di Milano, Via Celoria 2, 20133 Milano, Italy, Unità di Chemioterapia e Farmacologia Antitumorale Preclinica, Dipartimento di Oncologia Sperimentale e Laboratori, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milano, Italy, Dipartimento Farmaco Chimico Tecnologico, Università degli Studi di Siena, Via De Gasperi 2, 53100 Siena, Italy, and Dipartimento di Scienze Farmaceutiche, Università di Pisa, Via Bonanno 6, 56126 Pisa, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adriano Martinelli</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Scienze Molecolari Agroalimentari, Università di Milano, Via Celoria 2, 20133 Milano, Italy, Unità di Chemioterapia e Farmacologia Antitumorale Preclinica, Dipartimento di Oncologia Sperimentale e Laboratori, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milano, Italy, Dipartimento Farmaco Chimico Tecnologico, Università degli Studi di Siena, Via De Gasperi 2, 53100 Siena, Italy, and Dipartimento di Scienze Farmaceutiche, Università di Pisa, Via Bonanno 6, 56126 Pisa, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sergio Penco</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Scienze Molecolari Agroalimentari, Università di Milano, Via Celoria 2, 20133 Milano, Italy, Unità di Chemioterapia e Farmacologia Antitumorale Preclinica, Dipartimento di Oncologia Sperimentale e Laboratori, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milano, Italy, Dipartimento Farmaco Chimico Tecnologico, Università degli Studi di Siena, Via De Gasperi 2, 53100 Siena, Italy, and Dipartimento di Scienze Farmaceutiche, Università di Pisa, Via Bonanno 6, 56126 Pisa, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Franco Zunino</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Scienze Molecolari Agroalimentari, Università di Milano, Via Celoria 2, 20133 Milano, Italy, Unità di Chemioterapia e Farmacologia Antitumorale Preclinica, Dipartimento di Oncologia Sperimentale e Laboratori, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milano, Italy, Dipartimento Farmaco Chimico Tecnologico, Università degli Studi di Siena, Via De Gasperi 2, 53100 Siena, Italy, and Dipartimento di Scienze Farmaceutiche, Università di Pisa, Via Bonanno 6, 56126 Pisa, Italy</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i49">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71165" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71165" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are indebted to Cell Therapeutics, Bresso, Italy, for a generous gift of 5,6-dimethoxyindolin-2-one and RPI-1 and to Laura Zanesi for aid in editing the manuscript. This work was partially supported by Associazione Italiana per la Ricerca sul Cancro, Milan, Italy, by Alleanza Contro il Cancro, Italy, and by University of Milano (FIRST funds). Molecular graphics images were produced using the UCSF Chimera package from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIH Grant P41 RR-01081).</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i51">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16676" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16676" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 37 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Arighi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borrello, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sariola, H.</span><span> </span><span class="NLM_article-title">RET tyrosine kinase signaling in development and cancer</span> <span class="citation_source-journal">Cytokine Growth Factor Rev.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">16</span> <span class="NLM_fpage">441</span> <span class="NLM_lpage">467</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm8007823&amp;key=10.1016%2Fj.cytogfr.2005.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm8007823&amp;key=15982921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvVCnu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=441-467&author=E.+Arighiauthor=M.+G.+Borrelloauthor=H.+Sariola&title=RET+tyrosine+kinase+signaling+in+development+and+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">RET tyrosine kinase signaling in development and cancer</span></div><div class="casAuthors">Arighi, Elena; Borrello, Maria Grazia; Sariola, Hannu</div><div class="citationInfo"><span class="NLM_cas:title">Cytokine & Growth Factor Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4-5</span>),
    <span class="NLM_cas:pages">441-467</span>CODEN:
                <span class="NLM_cas:coden">CGFRFB</span>;
        ISSN:<span class="NLM_cas:issn">1359-6101</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The variety of diseases caused by mutations in RET receptor tyrosine kinase provides a classic example of phenotypic heterogeneity.  Gain-of-function mutations of RET are assocd. with human cancer.  Gene rearrangements juxtaposing the tyrosine kinase domain to heterologous gene partners have been found in sporadic papillary carcinomas of the thyroid (PTC).  These rearrangements generate chimeric RET/PTC oncogenes.  In the germline, point mutations of RET are responsible for multiple endocrine neoplasia type 2 (MEN 2A and 2B) and familial medullary thyroid carcinoma (FMTC).  Both MEN 2 mutations and PTC gene rearrangements potentiate the intrinsic tyrosine kinase activity of RET and, ultimately, activate the RET downstream targets.  Loss-of-function mutations of RET cause Hirschsprung's disease (HSCR) or colonic aganglionosis.  A deeper understanding of the mol. signaling of normal vs. abnormal RET activity in cancer will enable the development of potential new treatments for patients with sporadic and inherited thyroid cancer or MEN 2 syndrome.  We now review the role and mechanisms of RET signaling in development and carcinogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozw_crTv66LbVg90H21EOLACvtfcHk0lg4TybXtDPJww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvVCnu7s%253D&md5=8f664352542b6034d0ca001b9c1c4f16</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.cytogfr.2005.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cytogfr.2005.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DArighi%26aufirst%3DE.%26aulast%3DBorrello%26aufirst%3DM.%2BG.%26aulast%3DSariola%26aufirst%3DH.%26atitle%3DRET%2520tyrosine%2520kinase%2520signaling%2520in%2520development%2520and%2520cancer%26jtitle%3DCytokine%2520Growth%2520Factor%2520Rev.%26date%3D2005%26volume%3D16%26spage%3D441%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Asai, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jijiwa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enomoto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichiahara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakumo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, M.</span><span> </span><span class="NLM_article-title">RET receptor signaling: dysfunction in thyroid cancer and Hirschsprung’s disease</span> <span class="citation_source-journal">Pathol. Int.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">56</span> <span class="NLM_fpage">164</span> <span class="NLM_lpage">172</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm8007823&amp;key=10.1111%2Fj.1440-1827.2006.01942.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm8007823&amp;key=16634961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADC%252BD28XnsFGjtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2006&pages=164-172&author=N.+Asaiauthor=M.+Jijiwaauthor=A.+Enomotoauthor=K.+Hawaiauthor=K.+Maedaauthor=M.+Ichiaharaauthor=Y.+Murakumoauthor=M.+Takahashi&title=RET+receptor+signaling%3A+dysfunction+in+thyroid+cancer+and+Hirschsprung%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">RET receptor signaling: dysfunction in thyroid cancer and Hirschsprung's disease</span></div><div class="casAuthors">Asai, Naoya; Jijiwa, Mayumi; Enomoto, Atsushi; Kawai, Kumi; Maeda, Kengo; Ichiahara, Masatoshi; Murakumo, Yoshiki; Takahashi, Masahide</div><div class="citationInfo"><span class="NLM_cas:title">Pathology International</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">164-172</span>CODEN:
                <span class="NLM_cas:coden">PITEES</span>;
        ISSN:<span class="NLM_cas:issn">1320-5463</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">A review.  Gain-of-function mutations within the receptor tyrosine kinase gene RET cause inherited and non-inherited thyroid cancer.  Somatic gene rearrangements of RET have been found in papillary thyroid carcinoma and germline point mutations in multiple endocrine neoplasia (MEN) types 2A and 2B and familial medullary thyroid carcinoma (FMTC).  Conversely, loss-of-function mutations are responsible for the development of Hirschsprung's disease, a congenital malformation of the enteric nervous system.  Comparison between normal RET signaling activated by the RET ligand glial cell line-derived neurotrophic factor (GDNF) and abnormal RET signaling caused by various mutations has led to a deeper understanding of disease mechanisms.  The focus of the present review is on recent progress in the study of RET signaling dysfunction in human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSGspNKvmRNLVg90H21EOLACvtfcHk0lg4TybXtDPJww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnsFGjtL0%253D&md5=752bfaa58e6836866e45d5ef72051eff</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1111%2Fj.1440-1827.2006.01942.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1440-1827.2006.01942.x%26sid%3Dliteratum%253Aachs%26aulast%3DAsai%26aufirst%3DN.%26aulast%3DJijiwa%26aufirst%3DM.%26aulast%3DEnomoto%26aufirst%3DA.%26aulast%3DHawai%26aufirst%3DK.%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DIchiahara%26aufirst%3DM.%26aulast%3DMurakumo%26aufirst%3DY.%26aulast%3DTakahashi%26aufirst%3DM.%26atitle%3DRET%2520receptor%2520signaling%253A%2520dysfunction%2520in%2520thyroid%2520cancer%2520and%2520Hirschsprung%25E2%2580%2599s%2520disease%26jtitle%3DPathol.%2520Int.%26date%3D2006%26volume%3D56%26spage%3D164%26epage%3D172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Murakumo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jijiwa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asai, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichihara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, M.</span><span> </span><span class="NLM_article-title">RET and neuroendocrine tumors</span> <span class="citation_source-journal">Pituitary</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">9</span> <span class="NLM_fpage">179</span> <span class="NLM_lpage">192</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=179-192&author=Y.+Murakumoauthor=M.+Jijiwaauthor=N.+Asaiauthor=M.+Ichiharaauthor=M.+Takahashi&title=RET+and+neuroendocrine+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurakumo%26aufirst%3DY.%26aulast%3DJijiwa%26aufirst%3DM.%26aulast%3DAsai%26aufirst%3DN.%26aulast%3DIchihara%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DM.%26atitle%3DRET%2520and%2520neuroendocrine%2520tumors%26jtitle%3DPituitary%26date%3D2006%26volume%3D9%26spage%3D179%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Rosa, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ismael, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dal Lago, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awada, A.</span><span> </span><span class="NLM_article-title">Molecular-targeted therapies: lessons from years of clinical development</span> <span class="citation_source-journal">Cancer Treat. Rev.</span><span class="NLM_year" style="font-weight: bold;">2008</span> <span class="NLM_volume">34</span> <span class="NLM_fpage">61</span> <span class="NLM_lpage">80</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm8007823&amp;key=10.1016%2Fj.ctrv.2007.07.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm8007823&amp;key=17826917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVKhtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2008&pages=61-80&author=D.+D.+Rosaauthor=G.+Ismaelauthor=L.+Dal+Lagoauthor=A.+Awada&title=Molecular-targeted+therapies%3A+lessons+from+years+of+clinical+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular-targeted therapies: Lessons from years of clinical development</span></div><div class="casAuthors">Rosa, Daniela D.; Ismael, Gustavo; Dal Lago, Lissandra; Awada, Ahmad</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-80</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Summary: Over the past decade, mol.-targeted therapies have been added to cytotoxic and anti-endocrine drugs in the treatment of cancer, with the aim to target the mol. pathways that underlie the carcinogenic process and maintain the cancer phenotype.  Success with some of these agents has suggested that identification and validation of the drug target is the starting point for the route of development of active, safe and effective drugs.  Main mol. targets used to the development of anticancer drugs are cell surface receptors, signal transduction pathways, gene transcription targets, ubiquitin-proteasome/heat shock proteins and tumor microenvironment components (esp. antiangiogenic agents).  Here, we review the development of the main mol. targeted non-cytotoxic agents studied in cancer, highlighting lessons derived from the development of these novel drugs and proposing new horizons for the clin. development of mol.-targeted therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvnza4h4gL1bVg90H21EOLACvtfcHk0lg4TybXtDPJww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVKhtL4%253D&md5=548e8f0a529befa67f7e7382cdaf02ec</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2007.07.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2007.07.019%26sid%3Dliteratum%253Aachs%26aulast%3DRosa%26aufirst%3DD.%2BD.%26aulast%3DIsmael%26aufirst%3DG.%26aulast%3DDal%2BLago%26aufirst%3DL.%26aulast%3DAwada%26aufirst%3DA.%26atitle%3DMolecular-targeted%2520therapies%253A%2520lessons%2520from%2520years%2520of%2520clinical%2520development%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2008%26volume%3D34%26spage%3D61%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Drosten, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pützer, B. M.</span><span> </span><span class="NLM_article-title">Mechanisms of disease: cancer targeting and the impact of oncogenic RET for medullary thyroid carcinoma therapy</span> <span class="citation_source-journal">Nat. Clin. Pract.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">3</span> <span class="NLM_fpage">564</span> <span class="NLM_lpage">574</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm8007823&amp;key=10.1038%2Fncponc0610" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm8007823&amp;key=17019434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFKqtb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=564-574&author=M.+Drostenauthor=B.+M.+P%C3%BCtzer&title=Mechanisms+of+disease%3A+cancer+targeting+and+the+impact+of+oncogenic+RET+for+medullary+thyroid+carcinoma+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of disease: cancer targeting and the impact of oncogenic RET for medullary thyroid carcinoma therapy</span></div><div class="casAuthors">Drosten, Matthias; Puetzer, Brigitte M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Clinical Practice Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">564-574</span>CODEN:
                <span class="NLM_cas:coden">NCPOB5</span>;
        ISSN:<span class="NLM_cas:issn">1743-4254</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Growing evidence supports the concept of oncogene dependence for cancer development; inhibition of the initiating oncogene can result in reversion of the neoplastic phenotype.  The outstanding role of the RET proto-oncogene in the development of medullary thyroid carcinoma (MTC) is well established.  With the emerging knowledge concerning the signal transduction pathways leading to subsequent neoplastic transformation, oncogenic activated RET becomes a highly attractive target for selective cancer therapy.  A variety of novel approaches that target RET directly or indirectly have recently emerged and an increasing no. are currently being assessed in clin. trials.  In view of these findings, it becomes strikingly obvious that inhibition of RET oncogene function can be a viable option for the treatment of MTC.  We summarize the current evidence for RET involvement in the etiol. of MTC, and the therapeutic targeting of this process in preclin. and clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1uD4yBa4RELVg90H21EOLACvtfcHk0lhdIVAqFRvCjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFKqtb3O&md5=dccd7e93162fa5750f7b2b3666f60b0f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fncponc0610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncponc0610%26sid%3Dliteratum%253Aachs%26aulast%3DDrosten%26aufirst%3DM.%26aulast%3DP%25C3%25BCtzer%26aufirst%3DB.%2BM.%26atitle%3DMechanisms%2520of%2520disease%253A%2520cancer%2520targeting%2520and%2520the%2520impact%2520of%2520oncogenic%2520RET%2520for%2520medullary%2520thyroid%2520carcinoma%2520therapy%26jtitle%3DNat.%2520Clin.%2520Pract.%26date%3D2006%26volume%3D3%26spage%3D564%26epage%3D574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">De Groot, J. W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Links, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plukker, J. T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lips, C. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofstra, R. M. W.</span><span> </span><span class="NLM_article-title">RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">27</span> <span class="NLM_fpage">535</span> <span class="NLM_lpage">560</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm8007823&amp;key=10.1210%2Fer.2006-0017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm8007823&amp;key=16849421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVelurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=535-560&author=J.+W.+B.+De+Grootauthor=T.+P.+Linksauthor=J.+T.+M.+Plukkerauthor=C.+J.+M.+Lipsauthor=R.+M.+W.+Hofstra&title=RET+as+a+diagnostic+and+therapeutic+target+in+sporadic+and+hereditary+endocrine+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors</span></div><div class="casAuthors">de Groot, Jan Willem B.; Links, Thera P.; Plukker, John T. M.; Lips, Cornelis J. M.; Hofstra, Robert M. W.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">535-560</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  The RET gene encodes a receptor tyrosine kinase that is expressed in neural crest-derived cell lineages.  The RET receptor plays a crucial role in regulating cell proliferation, migration, differentiation, and survival through embryogenesis.  Activating mutations in RET lead to the development of several inherited and noninherited diseases.  Germline point mutations are found in the cancer syndromes multiple endocrine neoplasia (MEN) type 2, including MEN 2A and 2B, and familial medullary thyroid carcinoma.  These syndromes are autosomal dominantly inherited.  The identification of mutations assocd. with these syndromes has led to genetic testing to identify patients at risk for MEN 2 and familial medullary thyroid carcinoma and subsequent implementation of prophylactic thyroidectomy in mutation carriers.  In addn., more than 10 somatic rearrangements of RET have been identified from papillary thyroid carcinomas.  These mutations, as those found in MEN 2, induce oncogenic activation of the RET tyrosine kinase domain via different mechanisms, making RET an excellent candidate for the design of mol. targeted therapy.  Recently, various kinds of therapeutic approaches, such as tyrosine kinase inhibition, gene therapy with dominant neg. RET mutants, monoclonal antibodies against oncogene products, and nuclease-resistant aptamers that recognize and inhibit RET have been developed.  The use of these strategies in preclin. models has provided evidence that RET is indeed a potential target for selective cancer therapy.  However, a clin. useful therapeutic option for treating patients with RET-assocd. cancer is still not available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1ULqQfojz0rVg90H21EOLACvtfcHk0lhdIVAqFRvCjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvVelurc%253D&md5=69053deda18ea7daf973f11828663cc7</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1210%2Fer.2006-0017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2006-0017%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BGroot%26aufirst%3DJ.%2BW.%2BB.%26aulast%3DLinks%26aufirst%3DT.%2BP.%26aulast%3DPlukker%26aufirst%3DJ.%2BT.%2BM.%26aulast%3DLips%26aufirst%3DC.%2BJ.%2BM.%26aulast%3DHofstra%26aufirst%3DR.%2BM.%2BW.%26atitle%3DRET%2520as%2520a%2520diagnostic%2520and%2520therapeutic%2520target%2520in%2520sporadic%2520and%2520hereditary%2520endocrine%2520tumors%26jtitle%3DEndocr.%2520Rev.%26date%3D2006%26volume%3D27%26spage%3D535%26epage%3D560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Cuccuru, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassinelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratesi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortoreto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrangolini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seregni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laccabue, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanchi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunino, F.</span><span> </span><span class="NLM_article-title">Cellular effects and antitumor activity of RET inhibitor RPI-1 on MEN2A-associated medullary thyroid carcinoma</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">96</span> <span class="NLM_fpage">1006</span> <span class="NLM_lpage">1014</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm8007823&amp;key=10.1093%2Fjnci%2Fdjh184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm8007823&amp;key=15240784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsFyisrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2004&pages=1006-1014&author=G.+Cuccuruauthor=C.+Lanziauthor=G.+Cassinelliauthor=G.+Pratesiauthor=M.+Tortoretoauthor=G.+Petrangoliniauthor=E.+Seregniauthor=A.+Martinettiauthor=D.+Laccabueauthor=C.+Zanchiauthor=F.+Zunino&title=Cellular+effects+and+antitumor+activity+of+RET+inhibitor+RPI-1+on+MEN2A-associated+medullary+thyroid+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular Effects and Antitumor Activity of RET Inhibitor RPI-1 on MEN2A-Associated Medullary Thyroid Carcinoma</span></div><div class="casAuthors">Cuccuru, Giuditta; Lanzi, Cinzia; Cassinelli, Giuliana; Pratesi, Graziella; Tortoreto, Monica; Petrangolini, Giovanna; Seregni, Ettore; Martinetti, Antonia; Laccabue, Diletta; Zanchi, Chiara; Zunino, Franco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1006-1014</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: The RET proto-oncogene encodes a receptor tyrosine kinase.  RET oncogenes arise through sporadic and inherited gene mutations and are involved in the etiopathogenesis of medullary thyroid carcinoma, a cancer that responds poorly to conventional chemotherapy.  Medullary thyroid carcinoma is a component of multiple endocrine neoplasia type 2 or MEN2 syndromes.  Methods: We investigated the cellular effects of RPI-1, a novel 2-indolinone Ret tyrosine kinase inhibitor on cells that express RET C634 oncogenic mutants common in the MEN2A syndrome: NIH3T3 fibroblasts transfected with RETC634R and human medullary thyroid carcinoma TT cells that express endogenous RETC634W.  RPI-1 antiproliferative activity was detd. by cell proliferation and anchorage-independent growth assays.  Expression and phosphorylation of Ret and of proteins involved in downstream signaling pathways were examd. by immunoblotting.  Antitumor activity of oral RPI-1 treatment was tested by using two dosing levels in nude mice bearing s.c. TT xenograft tumors.  All statistical tests were two-sided.  Results: The RPI-1 IC50 value for cell proliferation was 3.6 μM (95% confidence interval [CI] = 1.8 to 5.4 μM) in NIH3T3 cells expressing the Ret mutant compared with 16 μM (95% CI = 12.3 to 19.7 μM) in non-transfected NIH3T3 cells, and that for colony formation in soft agar was 2.4 μM (95% CI = 0.8 to 4.0 μM) and 26 μM (95% CI = 17 to 35 μM) in RET mutant-transfected and H-RAS-transfected NIH3T3 cells, resp.  In NIH3T3 cells expressing the Ret mutant, Ret protein and tyrosine phosphorylation were undetectable after 24 h of RPI-1 treatment.  In TT cells, RPI-1 inhibited proliferation, Ret tyrosine phosphorylation, Ret protein expression, and the activation of PLCγ, ERKs and AKT.  In mice, oral daily RPI-1 treatment inhibited the tumor growth of TT xenografts by 81% (P<.001 vs. control mice) and reduced the plasma levels of the specific biomarker calcitonin (P = .01 vs. control mice).  Twenty-five percent of RPI-1-treated mice were tumor-free.  Conclusions: Ret oncoproteins represent exploitable targets for therapeutic intervention in MEN2A-assocd. medullary thyroid carcinoma.  The antitumor efficacy and oral bioavailability of RPI-1 support its therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPDUJ-ksbk9LVg90H21EOLACvtfcHk0lhdIVAqFRvCjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsFyisrk%253D&md5=66cb92214834e20a39e974d0e1009020</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjh184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjh184%26sid%3Dliteratum%253Aachs%26aulast%3DCuccuru%26aufirst%3DG.%26aulast%3DLanzi%26aufirst%3DC.%26aulast%3DCassinelli%26aufirst%3DG.%26aulast%3DPratesi%26aufirst%3DG.%26aulast%3DTortoreto%26aufirst%3DM.%26aulast%3DPetrangolini%26aufirst%3DG.%26aulast%3DSeregni%26aufirst%3DE.%26aulast%3DMartinetti%26aufirst%3DA.%26aulast%3DLaccabue%26aufirst%3DD.%26aulast%3DZanchi%26aufirst%3DC.%26aulast%3DZunino%26aufirst%3DF.%26atitle%3DCellular%2520effects%2520and%2520antitumor%2520activity%2520of%2520RET%2520inhibitor%2520RPI-1%2520on%2520MEN2A-associated%2520medullary%2520thyroid%2520carcinoma%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2004%26volume%3D96%26spage%3D1006%26epage%3D1014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Drosten, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilken, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Böckmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rödicker, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mise, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cranston, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahmen, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponder, B. A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pützer, B. M.</span><span> </span><span class="NLM_article-title">Role of MEN2A-derived RET in maintenance and proliferation of medullary thyroid carcinoma</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">96</span> <span class="NLM_fpage">1231</span> <span class="NLM_lpage">1239</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm8007823&amp;key=15316058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntFamtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2004&pages=1231-1239&author=M.+Drostenauthor=G.+Hilkenauthor=M.+B%C3%B6ckmannauthor=F.+R%C3%B6dickerauthor=N.+Miseauthor=A.+N.+Cranstonauthor=U.+Dahmenauthor=B.+A.+J.+Ponderauthor=B.+M.+P%C3%BCtzer&title=Role+of+MEN2A-derived+RET+in+maintenance+and+proliferation+of+medullary+thyroid+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Role of MEN2A-derived RET in maintenance and proliferation of medullary thyroid carcinoma</span></div><div class="casAuthors">Drosten, Matthias; Hilken, Gero; Boeckmann, Miriam; Roedicker, Florian; Mise, Nikica; Cranston, Aaron N.; Dahmen, Uta; Ponder, Bruce A. J.; Puetzer, Brigitte M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1231-1239</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Dominant-activating mutations in the RET protooncogene, a receptor tyrosine kinase, have been identified as a cause of medullary thyroid carcinoma.  Such oncogenic RET mutations induce its ligand-independent constitutive trans-autophosphorylation.  We investigated the role of endogenous oncogenic RET autophosphorylation in maintaining the neoplastic phenotype in medullary thyroid carcinoma cells and orthotopic medullary thyroid carcinomas in RET transgenic mice.  We constructed adenoviral vectors expressing a dominant-neg. truncated form of RET, termed RETΔTK, and analyzed its effect on cell viability, apoptosis, and proliferation of TT medullary thyroid carcinoma cells.  We investigated the effect of RETΔTK on downstream signaling by assessing alterations in phosphorylation or in gene expression.  The effect of RETΔTK in primary medullary thyroid carcinomas in transgenic mice was assessed by monitoring tumor growth.  All statistical tests were two-sided.  Cell viability was reduced.  Phosphorylation of Akt and extracellular signal-regulated kinase (ERK), components of downstream signal transduction pathways, was abolished, and cell cycle progression was reduced.  Expression of cell cycle regulator cyclin D1 was decreased, and expression of cell cyle regulators p21CIP1/WAF1 and p27KIP1 was increased.  Apoptosis was stimulated and concurrently the expression of BCL-2 was decreased.  All in vitro expts. compared TT cells expressing RETΔTK with untreated control cells or control vector-treated cells.  Furthermore, 2 wk after injecting adenovirus-carrying RETΔTK into thyroid glands of transgenic mice with orthotopic medullary thyroid carcinoma, tumors were statistically significantly smaller than their initial size in mice treated with RETΔTK (43.6%, 95% confidence interval [CI] = 30.7% to 56.5%; P = .010; two-sided unpaired Student's t test), whereas tumors in mice treated with a control vector were larger than their initial size (139.8%, 95% CI = 120.3% to 159.3%; P<.001).  Selective disruption of oncogenic RET signaling in medullary thyroid carcinoma in vitro and in vivo is assocd. with loss of the neoplastic phenotype of medullary thyroid carcinoma and should be investigated further as the basis for new therapeutic approaches for this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAgWjjNIpa6LVg90H21EOLACvtfcHk0lhNiokKK9bWWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntFamtrc%253D&md5=e3fd5d63197d694180b13d2bbec88a3c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDrosten%26aufirst%3DM.%26aulast%3DHilken%26aufirst%3DG.%26aulast%3DB%25C3%25B6ckmann%26aufirst%3DM.%26aulast%3DR%25C3%25B6dicker%26aufirst%3DF.%26aulast%3DMise%26aufirst%3DN.%26aulast%3DCranston%26aufirst%3DA.%2BN.%26aulast%3DDahmen%26aufirst%3DU.%26aulast%3DPonder%26aufirst%3DB.%2BA.%2BJ.%26aulast%3DP%25C3%25BCtzer%26aufirst%3DB.%2BM.%26atitle%3DRole%2520of%2520MEN2A-derived%2520RET%2520in%2520maintenance%2520and%2520proliferation%2520of%2520medullary%2520thyroid%2520carcinoma%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2004%26volume%3D96%26spage%3D1231%26epage%3D1239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Petrangolini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuccuru, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortoreto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratesi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassinelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunino, F.</span><span> </span><span class="NLM_article-title">Apoptotic cell death induction and angiogenesis inhibition in large established medullary thyroid carcinoma xenografts by Ret inhibitor RPI-1</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">72</span> <span class="NLM_fpage">405</span> <span class="NLM_lpage">414</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2006&pages=405-414&author=G.+Petrangoliniauthor=G.+Cuccuruauthor=C.+Lanziauthor=M.+Tortoretoauthor=S.+Bellucoauthor=G.+Pratesiauthor=G.+Cassinelliauthor=F.+Zunino&title=Apoptotic+cell+death+induction+and+angiogenesis+inhibition+in+large+established+medullary+thyroid+carcinoma+xenografts+by+Ret+inhibitor+RPI-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPetrangolini%26aufirst%3DG.%26aulast%3DCuccuru%26aufirst%3DG.%26aulast%3DLanzi%26aufirst%3DC.%26aulast%3DTortoreto%26aufirst%3DM.%26aulast%3DBelluco%26aufirst%3DS.%26aulast%3DPratesi%26aufirst%3DG.%26aulast%3DCassinelli%26aufirst%3DG.%26aulast%3DZunino%26aufirst%3DF.%26atitle%3DApoptotic%2520cell%2520death%2520induction%2520and%2520angiogenesis%2520inhibition%2520in%2520large%2520established%2520medullary%2520thyroid%2520carcinoma%2520xenografts%2520by%2520Ret%2520inhibitor%2520RPI-1%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2006%26volume%3D72%26spage%3D405%26epage%3D414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Sharma, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Settleman, J.</span><span> </span><span class="NLM_article-title">Oncogene addiction: setting the stage for molecularly targeted cancer therapy</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">21</span> <span class="NLM_fpage">3214</span> <span class="NLM_lpage">3231</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm8007823&amp;key=10.1101%2Fgad.1609907" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm8007823&amp;key=18079171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVOrsb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=3214-3231&author=S.+V.+Sharmaauthor=J.+Settleman&title=Oncogene+addiction%3A+setting+the+stage+for+molecularly+targeted+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogene addiction: setting the stage for molecularly targeted cancer therapy</span></div><div class="casAuthors">Sharma, Sreenath V.; Settleman, Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">3214-3231</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review.  In pugilistic parlance, the one-two punch is a devastating combination of blows, with the first punch setting the stage and the second delivering the knock-out.  This analogy can be extended to molecularly targeted cancer therapies, with oncogene addiction serving to set the stage for tumor cell killing by a targeted therapeutic agent.  While in vitro and in vivo examples abound documenting the existence of this phenomenon, the mechanistic underpinnings that govern oncogene addiction are just beginning to emerge.  Our current inability to fully exploit this weakness of cancer cells stems from an incomplete understanding of oncogene addiction, which nonetheless represents one of the rare chinks in the formidable armor of cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk4ia5nlRCDbVg90H21EOLACvtfcHk0lhNiokKK9bWWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVOrsb7J&md5=e367eb201f849ecac6c29ce7f80138fa</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1101%2Fgad.1609907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.1609907%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DS.%2BV.%26aulast%3DSettleman%26aufirst%3DJ.%26atitle%3DOncogene%2520addiction%253A%2520setting%2520the%2520stage%2520for%2520molecularly%2520targeted%2520cancer%2520therapy%26jtitle%3DGenes%2520Dev.%26date%3D2007%26volume%3D21%26spage%3D3214%26epage%3D3231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Cassinelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pensa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambetta, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuccuru, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassinis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratesi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polizzi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortoreto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunino, F.</span><span> </span><span class="NLM_article-title">Clavilactones, a novel class of tyrosine kinase inhibitors of fungal origin</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">59</span> <span class="NLM_fpage">1539</span> <span class="NLM_lpage">1547</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2000&pages=1539-1547&author=G.+Cassinelliauthor=C.+Lanziauthor=T.+Pensaauthor=R.+A.+Gambettaauthor=G.+Nasiniauthor=G.+Cuccuruauthor=M.+Cassinisauthor=G.+Pratesiauthor=D.+Polizziauthor=M.+Tortoretoauthor=F.+Zunino&title=Clavilactones%2C+a+novel+class+of+tyrosine+kinase+inhibitors+of+fungal+origin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCassinelli%26aufirst%3DG.%26aulast%3DLanzi%26aufirst%3DC.%26aulast%3DPensa%26aufirst%3DT.%26aulast%3DGambetta%26aufirst%3DR.%2BA.%26aulast%3DNasini%26aufirst%3DG.%26aulast%3DCuccuru%26aufirst%3DG.%26aulast%3DCassinis%26aufirst%3DM.%26aulast%3DPratesi%26aufirst%3DG.%26aulast%3DPolizzi%26aufirst%3DD.%26aulast%3DTortoreto%26aufirst%3DM.%26aulast%3DZunino%26aufirst%3DF.%26atitle%3DClavilactones%252C%2520a%2520novel%2520class%2520of%2520tyrosine%2520kinase%2520inhibitors%2520of%2520fungal%2520origin%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2000%26volume%3D59%26spage%3D1539%26epage%3D1547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Kundra, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burman, K. D.</span><span> </span><span class="NLM_article-title">Thyroid cancer molecular signaling pathways and use of targeted therapy</span> <span class="citation_source-journal">Endocrinol. Metab. Clin. N. Am.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">36</span> <span class="NLM_fpage">839</span> <span class="NLM_lpage">853</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm8007823&amp;key=10.1016%2Fj.ecl.2007.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm8007823&amp;key=17673131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFCgsrjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2007&pages=839-853&author=P.+Kundraauthor=K.+D.+Burman&title=Thyroid+cancer+molecular+signaling+pathways+and+use+of+targeted+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Thyroid cancer molecular signaling pathways and use of targeted therapy</span></div><div class="casAuthors">Kundra, Priya; Burman, Kenneth D.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology and Metabolism Clinics of North America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">839-853</span>CODEN:
                <span class="NLM_cas:coden">ECNAER</span>;
        ISSN:<span class="NLM_cas:issn">0889-8529</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review on agents targeted to inhibit crit. pathways in thyroid tumorigenesis or progression, including agents with different but often overlapping mechanisms of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8mlbwWPKI97Vg90H21EOLACvtfcHk0ljZB3o-9yAPLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFCgsrjI&md5=ea1c97b89043ce83614fdde1cff4dbd0</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.ecl.2007.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ecl.2007.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DKundra%26aufirst%3DP.%26aulast%3DBurman%26aufirst%3DK.%2BD.%26atitle%3DThyroid%2520cancer%2520molecular%2520signaling%2520pathways%2520and%2520use%2520of%2520targeted%2520therapy%26jtitle%3DEndocrinol.%2520Metab.%2520Clin.%2520N.%2520Am.%26date%3D2007%26volume%3D36%26spage%3D839%26epage%3D853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Deshpande, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gettinger, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sosa, J. A.</span><span> </span><span class="NLM_article-title">Novel chemotherapy options for advanced thyroid tumors: small molecules offer great hope</span> <span class="citation_source-journal">Curr. Opin. Oncol.</span><span class="NLM_year" style="font-weight: bold;">2008</span> <span class="NLM_volume">20</span> <span class="NLM_fpage">19</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm8007823&amp;key=18043252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGns7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2008&pages=19-24&author=H.+A.+Deshpandeauthor=S.+N.+Gettingerauthor=J.+A.+Sosa&title=Novel+chemotherapy+options+for+advanced+thyroid+tumors%3A+small+molecules+offer+great+hope"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Novel chemotherapy options for advanced thyroid tumors: small molecules offer great hope</span></div><div class="casAuthors">Deshpande, Hari A.; Gettinger, Scott N.; Sosa, Julie Ann</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Oncology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-24</span>CODEN:
                <span class="NLM_cas:coden">CUOOE8</span>;
        ISSN:<span class="NLM_cas:issn">1040-8746</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: Endocrine tumors are often overlooked in medical oncol. discussions, as many of them are effectively cured by surgery alone or surgery plus an ablative radiation therapy.  For the rare aggressive endocrine cancers that are widely metastatic or rapidly progressive, however, the role of the medical oncologist becomes more important.  To date, conventional chemotherapy has not had a significant impact on the natural history of these malignancies.  This has led to the evaluation of novel compds.; some of which have already entered into randomized clin. trials.  This review will focus on the advances made in the treatment of advanced thyroid cancer, the commonest of endocrine malignancies.  Recent findings: A growing understanding of mol. oncol. has allowed the development of targeted agents in different types of thyroid cancer.  Some agents presently being evaluated in clin. trials include inhibitors of angiogenesis (sorafenib, CA4P, axitinib and vandetanib), the epidermal growth factor receptor (gefitinib, vandetanib) and RET protein (vandetanib).  Preliminary results from these studies will be reviewed in this paper.  Summary: The recent explosion of targeted agents available for study has generated enthusiasm for oncologists treating thyroid cancer.  Antiangiogenesis strategies in particular appear promising.  RET inhibition in medullary thyroid cancer is also being explored.  Further clin. trials will det. which of these will enter the clinic in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8ujCfb0WIgrVg90H21EOLACvtfcHk0ljZB3o-9yAPLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGns7zP&md5=02dfdd36fea65d8c74a8407254f6313a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeshpande%26aufirst%3DH.%2BA.%26aulast%3DGettinger%26aufirst%3DS.%2BN.%26aulast%3DSosa%26aufirst%3DJ.%2BA.%26atitle%3DNovel%2520chemotherapy%2520options%2520for%2520advanced%2520thyroid%2520tumors%253A%2520small%2520molecules%2520offer%2520great%2520hope%26jtitle%3DCurr.%2520Opin.%2520Oncol.%26date%3D2008%26volume%3D20%26spage%3D19%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Schlumberger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlomagno, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baudin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bidart, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santoro, M.</span><span> </span><span class="NLM_article-title">New therapeutic approaches to treat medullary thyroid carcinoma</span> <span class="citation_source-journal">Nat. Clin. Pract.</span><span class="NLM_year" style="font-weight: bold;">2008</span> <span class="NLM_volume">4</span> <span class="NLM_fpage">22</span> <span class="NLM_lpage">32</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm8007823&amp;key=10.1038%2Fncpendmet0717" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVegtbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=22-32&author=M.+Schlumbergerauthor=F.+Carlomagnoauthor=E.+Baudinauthor=J.+M.+Bidartauthor=M.+Santoro&title=New+therapeutic+approaches+to+treat+medullary+thyroid+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">New therapeutic approaches to treat medullary thyroid carcinoma</span></div><div class="casAuthors">Schlumberger, Martin; Carlomagno, Francesca; Baudin, Eric; Bidart, Jean Michel; Santoro, Massimo</div><div class="citationInfo"><span class="NLM_cas:title">Nature Clinical Practice Endocrinology & Metabolism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-32</span>CODEN:
                <span class="NLM_cas:coden">NCPEDB</span>;
        ISSN:<span class="NLM_cas:issn">1745-8366</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Medullary thyroid carcinoma (MTC) accounts for up to 8% of all thyroid cancers.  Although primary surgery is curative in the vast majority of patients treated at an early stage, disease can persist or recur with deleterious effects on quality of life.  Local and distant metastases can occur and are the major causes of mortality.  Reoperation, embolization, and perhaps radiotherapy can improve the outcome for some patients who are not cured by primary surgery, but there is a need for novel treatments.  No comprehensive clin. trial data are available on conventional cytotoxic agents for the treatment of MTC.  Patients with distant metastases, in particular, might benefit from several novel compds. directed against angiogenesis and mol. targets in tumor cells, such as products of the proto-oncogene RET and mutants of it, and other signaling components.  Well-conducted clin. trials are needed to assess and optimize these treatment strategies, and this article outlines how such trials should be conducted.  Although RET mutations are common in hereditary MTC and can occur in some cases of sporadic MTC, knowledge of other mol. defects assocd. with the development of MTC should reveal new targets for therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjZeeRyLjygbVg90H21EOLACvtfcHk0ljZB3o-9yAPLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVegtbfL&md5=11806d18927f568bd963791a65d9e662</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fncpendmet0717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncpendmet0717%26sid%3Dliteratum%253Aachs%26aulast%3DSchlumberger%26aufirst%3DM.%26aulast%3DCarlomagno%26aufirst%3DF.%26aulast%3DBaudin%26aufirst%3DE.%26aulast%3DBidart%26aufirst%3DJ.%2BM.%26aulast%3DSantoro%26aufirst%3DM.%26atitle%3DNew%2520therapeutic%2520approaches%2520to%2520treat%2520medullary%2520thyroid%2520carcinoma%26jtitle%3DNat.%2520Clin.%2520Pract.%26date%3D2008%26volume%3D4%26spage%3D22%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">App, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">1998</span> <span class="NLM_volume">41</span> <span class="NLM_fpage">2588</span> <span class="NLM_lpage">2603</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980123i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADyaK1cXkt12jtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=2588-2603&author=L.+Sunauthor=N.+Tranauthor=F.+Tangauthor=H.+Appauthor=P.+Hirthauthor=G.+McMahonauthor=C.+Tang&title=Synthesis+and+biological+evaluations+of+3-substituted+indolin-2-ones%3A+a+novel+class+of+tyrosine+kinase+inhibitors+that+exhibit+selectivity+toward+particular+receptor+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluations of 3-Substituted Indolin-2-ones: A Novel Class of Tyrosine Kinase Inhibitors That Exhibit Selectivity toward Particular Receptor Tyrosine Kinases</span></div><div class="casAuthors">Sun, Li; Tran, Ngoc; Tang, Flora; App, Harald; Hirth, Peter; McMahon, Gerald; Tang, Cho</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2588-2603</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">3-Substituted indolin-2-ones have been designed and synthesized as a novel class of tyrosine kinase inhibitors which exhibit selectivity toward different receptor tyrosine kinases (RTKs).  These compds. have been evaluated for their relative inhibitory properties against a panel of RTKs in intact cells.  By modifying the 3-substituted indolin-2-ones, we have identified compds. which showed selective inhibition of the ligand-dependent autophosphorylation of various RTKs at submicromolar levels in cells.  Structure-activity anal. for these compds. and their relative potency and selectivity to inhibit particular RTKs has detd. that (1) 3-[(five-membered heteroaryl ring)methylidenyl]indolin-2-ones are highly specific against the VEGF (Flk-1) RTK activity, (2) 3-(substituted benzylidenyl)indolin-2-ones contg. bulky group(s) in the Ph ring at the C-3 position of indolin-2-ones showed high selectivity toward the EGF and Her-2 RTKs, and (3) the compd. contg. an extended side chain at the C-3 position of the indolin-2-one exhibited high potency and selectivity when tested against the PDGF and VEGF (Flk-1) RTKs.  Recent published crystallog. data for two of these 3-substituted indolin-2-ones provides a rationale to suggest that these compds. may bind in the ATP binding pocket of RTKs.  The structure-activity anal. supports the use of subsets of these compds. as specific chem. leads for the development of RTK-specific drugs with broad application for the treatment of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJoPixq8Am5rVg90H21EOLACvtfcHk0ljZB3o-9yAPLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkt12jtrw%253D&md5=536302b717170a630008dac14832204c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm980123i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980123i%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26aulast%3DTran%26aufirst%3DN.%26aulast%3DTang%26aufirst%3DF.%26aulast%3DApp%26aufirst%3DH.%26aulast%3DHirth%26aufirst%3DP.%26aulast%3DMcMahon%26aufirst%3DG.%26aulast%3DTang%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520biological%2520evaluations%2520of%25203-substituted%2520indolin-2-ones%253A%2520a%2520novel%2520class%2520of%2520tyrosine%2520kinase%2520inhibitors%2520that%2520exhibit%2520selectivity%2520toward%2520particular%2520receptor%2520tyrosine%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D2588%26epage%3D2603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Lanzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassinelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuccuru, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaffaroni, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supino, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vignati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanchi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunino, F.</span><span> </span><span class="NLM_article-title">Inactivation of Ret/Ptc1 oncoprotein and inhibition of papillary thyroid carcinoma cell proliferation by indolinone RPI-1</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">60</span> <span class="NLM_fpage">1449</span> <span class="NLM_lpage">1459</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm8007823&amp;key=10.1007%2Fs00018-003-2381-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm8007823&amp;key=12943231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1Witrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2003&pages=1449-1459&author=C.+Lanziauthor=G.+Cassinelliauthor=G.+Cuccuruauthor=N.+Zaffaroniauthor=R.+Supinoauthor=S.+Vignatiauthor=C.+Zanchiauthor=M.+Yamamotoauthor=F.+Zunino&title=Inactivation+of+Ret%2FPtc1+oncoprotein+and+inhibition+of+papillary+thyroid+carcinoma+cell+proliferation+by+indolinone+RPI-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Inactivation of Ret/Ptc1 oncoprotein and inhibition of papillary thyroid carcinoma cell proliferation by indolinone RPI-1</span></div><div class="casAuthors">Lanzi, C.; Cassinelli, G.; Cuccuru, G.; Zaffaroni, N.; Supino, R.; Vignati, S.; Zanchi, C.; Yamamoto, M.; Zunino, F.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1449-1459</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">Genetic alterations causing oncogenic activation of the RET gene are recognized as pathogenic events in papillary and medullary thyroid carcinomas.  Inhibition of Ret oncoprotein functions could thereby represent a specific therapeutic approach.  We previously described the inhibitory activity of the 2-indolinone deriv. RPI-1 (formerly Cpd1) on the tyrosine kinase activity and transforming ability of the products of the RET/PTC1 oncogene exogenously expressed in murine cells.  In the present study, we investigated the effects of RPI-1 in the human papillary thyroid carcinoma cell line TPC-1 spontaneously harboring the RET/PTC1 rearrangement.  Treatment with RPI-1 inhibited cell proliferation and induced accumulation of cells at the G2 cell cycle phase.  In treated cells, Ret/Ptc1 tyrosine phosphorylation was abolished along with its binding to She and phospholipase Cγ, thereby indicating abrogation of constitutive signaling mediated by the oncoprotein.  Activation of JNK2 and AKT was abolished, thus supporting the drug inhibitory efficacy on downstream pathways.  In addn., cell growth inhibition was assocd. with a redn. in telomerase activity by nearly 85%.  These findings in a cellular context relevant to the pathol. function of RET oncogenes support the role of Ret oncoproteins as useful targets for therapeutic intervention, and suggest RPI-1 as a promising candidate for preclin. development in the treatment of thyroid tumors expressing RET oncogenes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8QuJL5hq3jrVg90H21EOLACvtfcHk0lh1zPCb_MbDlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1Witrg%253D&md5=91e9670ba82a723adb005d7ac1a72e9f</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1007%2Fs00018-003-2381-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-003-2381-8%26sid%3Dliteratum%253Aachs%26aulast%3DLanzi%26aufirst%3DC.%26aulast%3DCassinelli%26aufirst%3DG.%26aulast%3DCuccuru%26aufirst%3DG.%26aulast%3DZaffaroni%26aufirst%3DN.%26aulast%3DSupino%26aufirst%3DR.%26aulast%3DVignati%26aufirst%3DS.%26aulast%3DZanchi%26aufirst%3DC.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DZunino%26aufirst%3DF.%26atitle%3DInactivation%2520of%2520Ret%252FPtc1%2520oncoprotein%2520and%2520inhibition%2520of%2520papillary%2520thyroid%2520carcinoma%2520cell%2520proliferation%2520by%2520indolinone%2520RPI-1%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2003%26volume%3D60%26spage%3D1449%26epage%3D1459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Lanzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassinelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pensa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassinis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambetta, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borrello, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menta, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierotti, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunino, F.</span><span> </span><span class="NLM_article-title">Inhibition of transforming activity of the ret/ptc1 oncoprotein by a 2-indolinone derivative</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">85</span> <span class="NLM_fpage">384</span> <span class="NLM_lpage">390</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm8007823&amp;key=10.1002%2F%28SICI%291097-0215%2820000201%2985%3A3%3C384%3A%3AAID-IJC15%3E3.0.CO%3B2-Y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm8007823&amp;key=10652431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsVCgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2000&pages=384-390&author=C.+Lanziauthor=G.+Cassinelliauthor=T.+Pensaauthor=M.+Cassinisauthor=R.+A.+Gambettaauthor=M.+G.+Borrelloauthor=E.+Mentaauthor=M.+A.+Pierottiauthor=F.+Zunino&title=Inhibition+of+transforming+activity+of+the+ret%2Fptc1+oncoprotein+by+a+2-indolinone+derivative"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of transforming activity of the ret/ptc1 oncoprotein by a 2-indolinone derivative</span></div><div class="casAuthors">Lanzi, Cinzia; Cassinelli, Giuliana; Pensa, Tiziana; Cassinis, Marco; Gambetta, Romolo A.; Borrello, Maria G.; Menta, Ernesto; Pierotti, Marco A.; Zunino, Franco</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">384-390</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Ret-derived oncogenes are frequently and specifically expressed in thyroid tumors.  In contrast to the ret receptor, ret oncoproteins are characterized by ligand-independent tyrosine-kinase activity and tyrosine phosphorylation.  In this study, novel synthetic arylidene 2-indolinone compds. were evaluated as inhibitors of the ret/ptc1 tyrosine kinase.  Four compds. inhibited ret/ptc1 activity in immunokinase assay (IC50 27-42 μM) including one (1,3-dihydro-5,6-dimethoxy-3-[(4-hydroxyphenyl) methylene]-2H-indol-2-one) (Cpd I) that selectively inhibited the anchorage-independent growth of NIH3T3 transformants expressing the ret/ptc1 gene (NIH3T3ptc1 cells).  Following exposure to Cpd I, the transformed phenotype of NIH3T3ptc1 cells was reverted, within 24 h, to a normal fibroblast-like morphol. in adherent-cell culture.  In these cells, the constitutive tyrosine phosphorylation of ret/ptc1, of the transducing adaptor protein shc and of a series of co-immunopptd. peptides became much reduced, as demonstrated by immunopptn./Western-blot analyses.  Data presented provide addnl. evidence that ret/ptc1 is directly implicated in malignant transformation, and demonstrate the ability of Cpd I to interfere in the signal transduction pathway constitutively activated by the ret/ptc1 oncoprotein.  These results confirm the interest of the arylidene 2-indolinone class of tyrosine-kinase inhibitors as tools for the study of ret signaling and the control of cell proliferation in ret- and ret/ptcs-assocd. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf0GmslFY4ZbVg90H21EOLACvtfcHk0lh1zPCb_MbDlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsVCgtA%253D%253D&md5=f549ad7108c6d55d0d6473f25656d3fd</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0215%2820000201%2985%3A3%3C384%3A%3AAID-IJC15%3E3.0.CO%3B2-Y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0215%252820000201%252985%253A3%253C384%253A%253AAID-IJC15%253E3.0.CO%253B2-Y%26sid%3Dliteratum%253Aachs%26aulast%3DLanzi%26aufirst%3DC.%26aulast%3DCassinelli%26aufirst%3DG.%26aulast%3DPensa%26aufirst%3DT.%26aulast%3DCassinis%26aufirst%3DM.%26aulast%3DGambetta%26aufirst%3DR.%2BA.%26aulast%3DBorrello%26aufirst%3DM.%2BG.%26aulast%3DMenta%26aufirst%3DE.%26aulast%3DPierotti%26aufirst%3DM.%2BA.%26aulast%3DZunino%26aufirst%3DF.%26atitle%3DInhibition%2520of%2520transforming%2520activity%2520of%2520the%2520ret%252Fptc1%2520oncoprotein%2520by%2520a%25202-indolinone%2520derivative%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2000%26volume%3D85%26spage%3D384%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Cassinelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrangolini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortoreto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratesi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuccuru, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laccabue, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supino, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poletti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunino, F.</span><span> </span><span class="NLM_article-title">Inhibition of c-Met and prevention of spontaneous metastatic spreading by the 2-indolinine RPI-1</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">5</span> <span class="NLM_fpage">2388</span> <span class="NLM_lpage">2397</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm8007823&amp;key=10.1158%2F1535-7163.MCT-06-0245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm8007823&amp;key=16985073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1ynsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=2388-2397&author=C.+Cassinelliauthor=C.+Lanziauthor=G.+Petrangoliniauthor=M.+Tortoretoauthor=G.+Pratesiauthor=G.+Cuccuruauthor=D.+Laccabueauthor=R.+Supinoauthor=S.+Bellucoauthor=E.+Faviniauthor=A.+Polettiauthor=F.+Zunino&title=Inhibition+of+c-Met+and+prevention+of+spontaneous+metastatic+spreading+by+the+2-indolinine+RPI-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of c-Met and prevention of spontaneous metastatic spreading by the 2-indolinone RPI-1</span></div><div class="casAuthors">Cassinelli, Giuliana; Lanzi, Cinzia; Petrangolini, Giovanna; Tortoreto, Monica; Pratesi, Graziella; Cuccuru, Giuditta; Laccabue, Diletta; Supino, Rosanna; Belluco, Sara; Favini, Enrica; Poletti, Anna; Zunino, Franco</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2388-2397</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Hepatocyte growth factor (HGF) and its tyrosine kinase receptor Met play a pivotal role in the tumor metastatic phenotype and represent attractive therapeutic targets.  We investigated the biochem. and biol. effects of the tyrosine kinase inhibitor RPI-1 on the human lung cancer cell lines H460 and N592, which express constitutively active Met.  RPI-1-treated cells showed down-regulation of Met activation and expression, inhibition of HGF/Met-dependent downstream signaling involving AKT, signal transducers and activators of transcription 3 and paxillin, as well as a reduced expression of the proangiogenic factors vascular endothelial growth factor and basic fibroblast growth factor.  Cell growth in soft agar of H460 cells was strongly reduced in the presence of the drug.  Furthermore, RPI-1 inhibited both spontaneous and HGF-induced motility/invasiveness of both H460 and human endothelial cells.  Targeting of Met signaling by alternative methods (Met small interfering RNA and anti-phosphorylated Met antibody intracellular transfer) produced comparable biochem. and biol. effects.  Using the spontaneously metastasizing lung carcinoma xenograft H460, daily oral treatment with well-tolerated doses of RPI-1 produced a significant redn. of spontaneous lung metastases (-75%; P < 0.001, compared with control mice).  In addn., a significant inhibition of angiogenesis in primary s.c. tumors of treated mice was obsd., possibly contributing to limit the development of metastases.  The results provide preclin. evidence in support of Met targeting pharmacol. approach as a new option for the control of tumor metastatic dissemination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphBviSKcvNcLVg90H21EOLACvtfcHk0lgsszssm3IJyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1ynsbs%253D&md5=cdaf5e8491e31a4e72e52bedc4a16f6d</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0245%26sid%3Dliteratum%253Aachs%26aulast%3DCassinelli%26aufirst%3DC.%26aulast%3DLanzi%26aufirst%3DC.%26aulast%3DPetrangolini%26aufirst%3DG.%26aulast%3DTortoreto%26aufirst%3DM.%26aulast%3DPratesi%26aufirst%3DG.%26aulast%3DCuccuru%26aufirst%3DG.%26aulast%3DLaccabue%26aufirst%3DD.%26aulast%3DSupino%26aufirst%3DR.%26aulast%3DBelluco%26aufirst%3DS.%26aulast%3DFavini%26aufirst%3DE.%26aulast%3DPoletti%26aufirst%3DA.%26aulast%3DZunino%26aufirst%3DF.%26atitle%3DInhibition%2520of%2520c-Met%2520and%2520prevention%2520of%2520spontaneous%2520metastatic%2520spreading%2520by%2520the%25202-indolinine%2520RPI-1%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D2388%26epage%3D2397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">App, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">1998</span> <span class="NLM_volume">41</span> <span class="NLM_fpage">2588</span> <span class="NLM_lpage">2603</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980123i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADyaK1cXkt12jtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=2588-2603&author=L.+Sunauthor=N.+Tranauthor=F.+Tangauthor=H.+Appauthor=P.+Hirthauthor=G.+McMahonauthor=C.+Tang&title=Synthesis+and+biological+evaluations+of+3-substituted+indolin-2-ones%3A+a+novel+class+of+tyrosine+kinase+inhibitors+that+exhibit+selectivity+toward+particular+receptor+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluations of 3-Substituted Indolin-2-ones: A Novel Class of Tyrosine Kinase Inhibitors That Exhibit Selectivity toward Particular Receptor Tyrosine Kinases</span></div><div class="casAuthors">Sun, Li; Tran, Ngoc; Tang, Flora; App, Harald; Hirth, Peter; McMahon, Gerald; Tang, Cho</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2588-2603</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">3-Substituted indolin-2-ones have been designed and synthesized as a novel class of tyrosine kinase inhibitors which exhibit selectivity toward different receptor tyrosine kinases (RTKs).  These compds. have been evaluated for their relative inhibitory properties against a panel of RTKs in intact cells.  By modifying the 3-substituted indolin-2-ones, we have identified compds. which showed selective inhibition of the ligand-dependent autophosphorylation of various RTKs at submicromolar levels in cells.  Structure-activity anal. for these compds. and their relative potency and selectivity to inhibit particular RTKs has detd. that (1) 3-[(five-membered heteroaryl ring)methylidenyl]indolin-2-ones are highly specific against the VEGF (Flk-1) RTK activity, (2) 3-(substituted benzylidenyl)indolin-2-ones contg. bulky group(s) in the Ph ring at the C-3 position of indolin-2-ones showed high selectivity toward the EGF and Her-2 RTKs, and (3) the compd. contg. an extended side chain at the C-3 position of the indolin-2-one exhibited high potency and selectivity when tested against the PDGF and VEGF (Flk-1) RTKs.  Recent published crystallog. data for two of these 3-substituted indolin-2-ones provides a rationale to suggest that these compds. may bind in the ATP binding pocket of RTKs.  The structure-activity anal. supports the use of subsets of these compds. as specific chem. leads for the development of RTK-specific drugs with broad application for the treatment of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJoPixq8Am5rVg90H21EOLACvtfcHk0lgsszssm3IJyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkt12jtrw%253D&md5=536302b717170a630008dac14832204c</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm980123i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980123i%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26aulast%3DTran%26aufirst%3DN.%26aulast%3DTang%26aufirst%3DF.%26aulast%3DApp%26aufirst%3DH.%26aulast%3DHirth%26aufirst%3DP.%26aulast%3DMcMahon%26aufirst%3DG.%26aulast%3DTang%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520biological%2520evaluations%2520of%25203-substituted%2520indolin-2-ones%253A%2520a%2520novel%2520class%2520of%2520tyrosine%2520kinase%2520inhibitors%2520that%2520exhibit%2520selectivity%2520toward%2520particular%2520receptor%2520tyrosine%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D2588%26epage%3D2603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Tuccinardi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botta, M.</span><span> </span><span class="NLM_article-title">Construction and validation of a RET TK catalytic domain by homology modeling</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">47</span> <span class="NLM_fpage">644</span> <span class="NLM_lpage">655</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci6004383" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsFOlu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=644-655&author=T.+Tuccinardiauthor=F.+Manettiauthor=S.+Schenoneauthor=A.+Martinelliauthor=M.+Botta&title=Construction+and+validation+of+a+RET+TK+catalytic+domain+by+homology+modeling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Construction and Validation of a RET TK Catalytic Domain by Homology Modeling</span></div><div class="casAuthors">Tuccinardi, Tiziano; Manetti, Fabrizio; Schenone, Silvia; Martinelli, Adriano; Botta, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">644-655</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">RET tyrosine kinase (TK) oncoproteins are potential targets for anticancer therapy.  However, the search for novel RET inhibitors has been hampered by the lack of a 3D structure of the receptor.  In this study, the "open" and the "closed" structure of the RET TK catalytic domain have been built by homol. modeling techniques.  The structures were validated by extensive docking studies with practically all the inhibitors reported in the literature and through mol. dynamics simulations of the resulting complexes.  All the expected major interactions between the active domain amino acids and the inhibitors have been reproduced in their details.  Furthermore, the proposed 3D models are in agreement with the results of available mutation studies.  Therefore, these models could be profitably used to filter off from large libraries new potential hit compds. able to target this enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpajtbODoG4DrVg90H21EOLACvtfcHk0lgsszssm3IJyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsFOlu78%253D&md5=3d0e569c592ec6f060f3416ef739b0d6</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fci6004383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci6004383%26sid%3Dliteratum%253Aachs%26aulast%3DTuccinardi%26aufirst%3DT.%26aulast%3DManetti%26aufirst%3DF.%26aulast%3DSchenone%26aufirst%3DS.%26aulast%3DMartinelli%26aufirst%3DA.%26aulast%3DBotta%26aufirst%3DM.%26atitle%3DConstruction%2520and%2520validation%2520of%2520a%2520RET%2520TK%2520catalytic%2520domain%2520by%2520homology%2520modeling%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2007%26volume%3D47%26spage%3D644%26epage%3D655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Mohammadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span> </span><span class="NLM_article-title">Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors</span> <span class="citation_source-journal">Science</span><span class="NLM_year" style="font-weight: bold;">1997</span> <span class="NLM_volume">276</span> <span class="NLM_fpage">955</span> <span class="NLM_lpage">960</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm8007823&amp;key=10.1126%2Fscience.276.5314.955" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm8007823&amp;key=9139660" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADyaK2sXjt1ans7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=1997&pages=955-960&author=M.+Mohammadiauthor=G.+McMahonauthor=L.+Sunauthor=C.+Tangauthor=P.+Hirthauthor=B.+K.+Yehauthor=S.+R.+Hubbardauthor=J.+Schlessinger&title=Structures+of+the+tyrosine+kinase+domain+of+fibroblast+growth+factor+receptor+in+complex+with+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors</span></div><div class="casAuthors">Mohammadi, Moosa; McMahon, Gerald; Sun, Li; Tang, Cho; Hirth, Peter; Yeh, Brian K.; Hubbard, Stevan R.; Schlessinger, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">5314</span>),
    <span class="NLM_cas:pages">955-960</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A new class of protein tyrosine kinase inhibitors was identified that is based on an oxindole core (indolinones).  Two compds. from this class inhibited the kinase activity of fibroblast growth factor receptor 1 (FGFR1) and showed differential specificity toward others receptor tyrosine kinases.  Crystal structures of the tyrosine kinase domain of FGFR1 in complex with the two compds. were detd.  The oxindole occupies the sites in which the adenine of ATP binds, whereas the moieties that extend from the oxindole contact residues in the hinge region between the two kinase lobes.  The more specific inhibitor of FGFR1 induces a conformational change in the nucleotide-binding loop.  This structural information will facilitate the design of new inhibitors for use in the treatment of cancer and other diseases in which cell signaling by tyrosine kinases plays a crucial role in disease pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDwP7A-FMgDLVg90H21EOLACvtfcHk0lgsszssm3IJyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjt1ans7w%253D&md5=fdbedba79850d11771677e6d25f3842f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1126%2Fscience.276.5314.955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.276.5314.955%26sid%3Dliteratum%253Aachs%26aulast%3DMohammadi%26aufirst%3DM.%26aulast%3DMcMahon%26aufirst%3DG.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DHirth%26aufirst%3DP.%26aulast%3DYeh%26aufirst%3DB.%2BK.%26aulast%3DHubbard%26aufirst%3DS.%2BR.%26aulast%3DSchlessinger%26aufirst%3DJ.%26atitle%3DStructures%2520of%2520the%2520tyrosine%2520kinase%2520domain%2520of%2520fibroblast%2520growth%2520factor%2520receptor%2520in%2520complex%2520with%2520inhibitors%26jtitle%3DScience%26date%3D1997%26volume%3D276%26spage%3D955%26epage%3D960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span> </span><span class="NLM_article-title">3-Aryl beta-carbolin-1-ones as a new class of potent inhibitors of tumor cell proliferation: synthesis and biological evaluation</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">3</span> <span class="NLM_fpage">911</span> <span class="NLM_lpage">916</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2005&pages=911-916&author=S.+Wangauthor=Y.+Dongauthor=X.+Wangauthor=X.+Huauthor=J.+O.+Liuauthor=Y.+Hu&title=3-Aryl+beta-carbolin-1-ones+as+a+new+class+of+potent+inhibitors+of+tumor+cell+proliferation%3A+synthesis+and+biological+evaluation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DJ.%2BO.%26aulast%3DHu%26aufirst%3DY.%26atitle%3D3-Aryl%2520beta-carbolin-1-ones%2520as%2520a%2520new%2520class%2520of%2520potent%2520inhibitors%2520of%2520tumor%2520cell%2520proliferation%253A%2520synthesis%2520and%2520biological%2520evaluation%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2005%26volume%3D3%26spage%3D911%26epage%3D916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Chacun-Lefèvre, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mérour, J.-Y.</span><span> </span><span class="NLM_article-title">Synthesis and reactivity of azepino[3,4-<i>b</i>]indol-5-yl trifluoromethanesulfonate</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">56</span> <span class="NLM_fpage">4491</span> <span class="NLM_lpage">4499</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2000&pages=4491-4499&author=B.+Chacun-Lef%C3%A8vreauthor=B.+Josephauthor=J.-Y.+M%C3%A9rour&title=Synthesis+and+reactivity+of+azepino%5B3%2C4-b%5Dindol-5-yl+trifluoromethanesulfonate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChacun-Lef%25C3%25A8vre%26aufirst%3DB.%26aulast%3DJoseph%26aufirst%3DB.%26aulast%3DM%25C3%25A9rour%26aufirst%3DJ.-Y.%26atitle%3DSynthesis%2520and%2520reactivity%2520of%2520azepino%255B3%252C4-b%255Dindol-5-yl%2520trifluoromethanesulfonate%26jtitle%3DTetrahedron%26date%3D2000%26volume%3D56%26spage%3D4491%26epage%3D4499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Cincinelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dallavalle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlini, L.</span><span> </span><span class="NLM_article-title">Intramolecular Friedel−Crafts reaction of indoles with carbonyl groups: a simple synthesis of 3- and 4-substituted β-carbolin-1-ones</span> <span class="citation_source-journal">Synlett</span><span class="NLM_year" style="font-weight: bold;">2008</span> <span class="NLM_fpage">1309</span> <span class="NLM_lpage">1312</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=1309-1312&author=R.+Cincinelliauthor=S.+Dallavalleauthor=L.+Merlini&title=Intramolecular+Friedel%E2%88%92Crafts+reaction+of+indoles+with+carbonyl+groups%3A+a+simple+synthesis+of+3-+and+4-substituted+%CE%B2-carbolin-1-ones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCincinelli%26aufirst%3DR.%26aulast%3DDallavalle%26aufirst%3DS.%26aulast%3DMerlini%26aufirst%3DL.%26atitle%3DIntramolecular%2520Friedel%25E2%2588%2592Crafts%2520reaction%2520of%2520indoles%2520with%2520carbonyl%2520groups%253A%2520a%2520simple%2520synthesis%2520of%25203-%2520and%25204-substituted%2520%25CE%25B2-carbolin-1-ones%26jtitle%3DSynlett%26date%3D2008%26spage%3D1309%26epage%3D1312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Rizzi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassinelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dallavalle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cincinelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nannei, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuccuru, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunino, F.</span><span> </span><span class="NLM_article-title">Synthesis and RET protein kinase inhibitory activity of 3-arylureidobenzylidene-indolin-2-ones</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">17</span> <span class="NLM_fpage">3962</span> <span class="NLM_lpage">3968</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3962-3968&author=E.+Rizziauthor=G.+Cassinelliauthor=S.+Dallavalleauthor=C.+Lanziauthor=R.+Cincinelliauthor=R.+Nanneiauthor=G.+Cuccuruauthor=F.+Zunino&title=Synthesis+and+RET+protein+kinase+inhibitory+activity+of+3-arylureidobenzylidene-indolin-2-ones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRizzi%26aufirst%3DE.%26aulast%3DCassinelli%26aufirst%3DG.%26aulast%3DDallavalle%26aufirst%3DS.%26aulast%3DLanzi%26aufirst%3DC.%26aulast%3DCincinelli%26aufirst%3DR.%26aulast%3DNannei%26aufirst%3DR.%26aulast%3DCuccuru%26aufirst%3DG.%26aulast%3DZunino%26aufirst%3DF.%26atitle%3DSynthesis%2520and%2520RET%2520protein%2520kinase%2520inhibitory%2520activity%2520of%25203-arylureidobenzylidene-indolin-2-ones%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3962%26epage%3D3968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Knowles, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray-Rust, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kjaer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanrahan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santoro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibáñez, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, N. Q.</span><span> </span><span class="NLM_article-title">Structure and chemical inhibition of the RET tyrosine kinase domain</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">281</span> <span class="NLM_fpage">33577</span> <span class="NLM_lpage">33587</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm8007823&amp;key=10.1074%2Fjbc.M605604200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm8007823&amp;key=16928683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFegsb3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=33577-33587&author=P.+P.+Knowlesauthor=J.+Murray-Rustauthor=S.+Kjaerauthor=R.+P.+Scottauthor=S.+Hanrahanauthor=M.+Santoroauthor=C.+F.+Ib%C3%A1%C3%B1ezauthor=N.+Q.+McDonald&title=Structure+and+chemical+inhibition+of+the+RET+tyrosine+kinase+domain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and Chemical Inhibition of the RET Tyrosine Kinase Domain</span></div><div class="casAuthors">Knowles, Phillip P.; Murray-Rust, Judith; Kjaer, Svend; Scott, Rizaldy P.; Hanrahan, Sarah; Santoro, Massimo; Ibanez, Carlos F.; McDonald, Neil Q.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">33577-33587</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The RET proto-oncogene encodes a receptor tyrosine kinase for the glial cell line-derived neurotrophic factor family of ligands.  Loss-of-function mutations in RET are implicated in Hirschsprung disease, whereas activating mutations in RET are found in human cancers, including familial medullar thyroid carcinoma and multiple endocrine neoplasias 2A and 2B.  We report here the biochem. characterization of the human RET tyrosine kinase domain and the structure detn. of the non-phosphorylated and phosphorylated forms.  Both structures adopt the same active kinase conformation competent to bind ATP and substrate and have a pre-organized activation loop conformation that is independent of phosphorylation status.  In agreement with the structural data, enzyme kinetic data show that autophosphorylation produces only a modest increase in activity.  Longer forms of RET contg. the juxtamembrane domain and C-terminal tail exhibited similar kinetic behavior, implying that there is no cis-inhibitory mechanism within the RET intracellular domain.  Our results suggest the existence of alternative inhibitory mechanisms, possibly in trans, for the autoregulation of RET kinase activity.  We also present the structures of the RET tyrosine kinase domain bound to two inhibitors, the pyrazolopyrimidine PP1 and the clin. relevant 4-anilinoquinazoline ZD6474.  These structures explain why certain multiple endocrine neoplasia 2-assocd. RET mutants found in patients are resistant to inhibition and form the basis for design of more effective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2p2bSJFNWxbVg90H21EOLACvtfcHk0ljkq0nfUC-Jgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFegsb3K&md5=005ddc426f2c1a0a48bf7dc6c6083c88</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M605604200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M605604200%26sid%3Dliteratum%253Aachs%26aulast%3DKnowles%26aufirst%3DP.%2BP.%26aulast%3DMurray-Rust%26aufirst%3DJ.%26aulast%3DKjaer%26aufirst%3DS.%26aulast%3DScott%26aufirst%3DR.%2BP.%26aulast%3DHanrahan%26aufirst%3DS.%26aulast%3DSantoro%26aufirst%3DM.%26aulast%3DIb%25C3%25A1%25C3%25B1ez%26aufirst%3DC.%2BF.%26aulast%3DMcDonald%26aufirst%3DN.%2BQ.%26atitle%3DStructure%2520and%2520chemical%2520inhibition%2520of%2520the%2520RET%2520tyrosine%2520kinase%2520domain%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D33577%26epage%3D33587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R.</span><span> </span><span class="NLM_article-title">Development and validation of a genetic algorithm for flexible docking</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_year" style="font-weight: bold;">1997</span> <span class="NLM_volume">267</span> <span class="NLM_fpage">727</span> <span class="NLM_lpage">748</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm8007823&amp;key=10.1006%2Fjmbi.1996.0897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm8007823&amp;key=9126849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1997&pages=727-748&author=G.+Jonesauthor=P.+Willettauthor=R.+C.+Glenauthor=A.+R.+Leachauthor=R.+Taylor&title=Development+and+validation+of+a+genetic+algorithm+for+flexible+docking"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a genetic algorithm for flexible docking</span></div><div class="casAuthors">Jones, Gareth; Willett, Peter; Glen, Robert C.; Leach, Andrew R.; Taylor, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">727-748</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Prediction of small mol. binding modes to macromols. of known three-dimensional structure is a problem of paramount importance in rational drug design (the "docking" problem).  We report the development and validation of the program GOLD (Genetic Optimization for Ligand Docking).  GOLD is an automated ligand docking program that uses a genetic algorithm to explore the full range of ligand conformational flexibility with partial flexibility of the protein and satisfies the fundamental requirement that the ligand must displace loosely bound water on binding.  Numerous enhancements and modifications have been applied to the original technique resulting in a substantial increase in the reliability and the applicability of the algorithm.  The advanced algorithm has been tested on a dataset of 100 complexes extd. from the Brookhaven Protein Data Bank.  When used to dock the ligand back into the binding site, GOLD achieved a 71% success rate in identifying the exptl. binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP3I60Rl2uorVg90H21EOLACvtfcHk0lidGHZUfTXTWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D&md5=476a2b1d8f80f3ba418052fe29d735ca</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1996.0897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1996.0897%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DTaylor%26aufirst%3DR.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%2520genetic%2520algorithm%2520for%2520flexible%2520docking%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D267%26spage%3D727%26epage%3D748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Toledo, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lydon, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elbaum, D.</span><span> </span><span class="NLM_article-title">The structure-based design of ATP-site directed protein kinase inhibitors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">6</span> <span class="NLM_fpage">775</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm8007823&amp;key=10495352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADyaK1MXlvFWqtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=775&author=L.+M.+Toledoauthor=N.+B.+Lydonauthor=D.+Elbaum&title=The+structure-based+design+of+ATP-site+directed+protein+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The structure-based design of ATP-site directed protein kinase inhibitors</span></div><div class="casAuthors">Toledo, Leticia M.; Lydon, Nicholas B.; Elbaum, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">775-805</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review with 158 refs.  The protein kinase family represents both a huge opportunity and a challenge for drug development.  The conservation of structural features within the ATP binding cleft initially led to the belief that specificity would be difficult to achieve.  This dogma has now been clearly dispelled with the discovery and clin. testing of a group of first generation compds., which are characterized by a high degree of selectivity towards a variety of oncol. targets.  The structural basis for selectivity and potency has now been clarified with the crystn. of a no. of such targets in complex with inhibitors.  The protein kinase inhibitor field is now ripe for the structure based exploitation of addnl. highly validated targets from a variety of therapeutic areas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJg9ofbUmOprVg90H21EOLACvtfcHk0lidGHZUfTXTWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvFWqtL0%253D&md5=9a916ac8f6ca8c28162c0c85b693cbed</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DToledo%26aufirst%3DL.%2BM.%26aulast%3DLydon%26aufirst%3DN.%2BB.%26aulast%3DElbaum%26aufirst%3DD.%26atitle%3DThe%2520structure-based%2520design%2520of%2520ATP-site%2520directed%2520protein%2520kinase%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D1999%26volume%3D6%26spage%3D775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Traxler, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mett, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sequin, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span> </span><span class="NLM_article-title">Use of a pharmacophore model for the design of EGFR tyrosine kinase inhibitors: isoflavones and 3-phenyl-4(1<i>H</i>)-quinolones</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">42</span> <span class="NLM_fpage">1018</span> <span class="NLM_lpage">1026</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980551o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=1018-1026&author=P.+Traxlerauthor=J.+Greenauthor=H.+Mettauthor=U.+Sequinauthor=P.+Furet&title=Use+of+a+pharmacophore+model+for+the+design+of+EGFR+tyrosine+kinase+inhibitors%3A+isoflavones+and+3-phenyl-4%281H%29-quinolones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm980551o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980551o%26sid%3Dliteratum%253Aachs%26aulast%3DTraxler%26aufirst%3DP.%26aulast%3DGreen%26aufirst%3DJ.%26aulast%3DMett%26aufirst%3DH.%26aulast%3DSequin%26aufirst%3DU.%26aulast%3DFuret%26aufirst%3DP.%26atitle%3DUse%2520of%2520a%2520pharmacophore%2520model%2520for%2520the%2520design%2520of%2520EGFR%2520tyrosine%2520kinase%2520inhibitors%253A%2520isoflavones%2520and%25203-phenyl-4%25281H%2529-quinolones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D1018%26epage%3D1026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Massova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollman, P. A.</span><span> </span><span class="NLM_article-title">Combined molecular mechanical and continuum solvent approach (MM-PBSA/GBSA) to predict ligand binding</span> <span class="citation_source-journal">Perspect. Drug Discovery Des.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">18</span> <span class="NLM_fpage">113</span> <span class="NLM_lpage">135</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm8007823&amp;key=10.1023%2FA%3A1008763014207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADC%252BD3cXis12ju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2000&pages=113-135&author=I.+Massovaauthor=P.+A.+Kollman&title=Combined+molecular+mechanical+and+continuum+solvent+approach+%28MM-PBSA%2FGBSA%29+to+predict+ligand+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Combined molecular mechanical and continuum solvent approach (MM-PBSA/GBSA) to predict ligand binding</span></div><div class="casAuthors">Massova, Irina; Kollman, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">Perspectives in Drug Discovery and Design</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">Hydrophobicity and Solvation in Drug Design, Pt. II</span>),
    <span class="NLM_cas:pages">113-135</span>CODEN:
                <span class="NLM_cas:coden">PDDDEC</span>;
        ISSN:<span class="NLM_cas:issn">0928-2866</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">Significant progress has been achieved in computational methods to treat solvent effects in recent years.  Among various techniques, the continuum solvent approach appears to be practically promising because it can be used to calc. reliable interaction and solvation energies in complex systems.  A computational scanning mutagenesis method, one of such new approaches, has been recently developed.  It combines the mol. mech. and continuum solvent approaches and allows one to identify the "hot spots" in binding interfaces from a single trajectory of a wild type complex.  Such techniques can be also used as a tool to optimize the interacting species for the binding, or as a ranking procedure in high throughput screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4IQPgMmXRBbVg90H21EOLACvtfcHk0lidGHZUfTXTWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXis12ju7Y%253D&md5=520df05a7c7ed02fdf76d3e1e6f377f9</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1023%2FA%3A1008763014207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1008763014207%26sid%3Dliteratum%253Aachs%26aulast%3DMassova%26aufirst%3DI.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26atitle%3DCombined%2520molecular%2520mechanical%2520and%2520continuum%2520solvent%2520approach%2520%2528MM-PBSA%252FGBSA%2529%2520to%2520predict%2520ligand%2520binding%26jtitle%3DPerspect.%2520Drug%2520Discovery%2520Des.%26date%3D2000%26volume%3D18%26spage%3D113%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Rizzo, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toba, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuntz, I. D.</span><span> </span><span class="NLM_article-title">A molecular basis for the selectivity of thiadiazole urea inhibitors with stromelysin-1 and gelatinase-A from generalized Born molecular dynamics simulations</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">47</span> <span class="NLM_fpage">3065</span> <span class="NLM_lpage">3074</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030570k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=3065-3074&author=R.+C.+Rizzoauthor=S.+Tobaauthor=I.+D.+Kuntz&title=A+molecular+basis+for+the+selectivity+of+thiadiazole+urea+inhibitors+with+stromelysin-1+and+gelatinase-A+from+generalized+Born+molecular+dynamics+simulations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm030570k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030570k%26sid%3Dliteratum%253Aachs%26aulast%3DRizzo%26aufirst%3DR.%2BC.%26aulast%3DToba%26aufirst%3DS.%26aulast%3DKuntz%26aufirst%3DI.%2BD.%26atitle%3DA%2520molecular%2520basis%2520for%2520the%2520selectivity%2520of%2520thiadiazole%2520urea%2520inhibitors%2520with%2520stromelysin-1%2520and%2520gelatinase-A%2520from%2520generalized%2520Born%2520molecular%2520dynamics%2520simulations%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D3065%26epage%3D3074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><a href="http://www.pdb.org/" class="extLink">http://www.pdb.org/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.pdb.org%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Case, D. A.; Darden, T. A.; Cheatham, T. E.,  III; Simmerling, C. L.; Wang, J.; Duke, R. E.; Luo, R.; Merz, K. M.; Pearlman, D. A.; Crowley, M.; Walker, R. C.; Zhang, W.; Wang, B.; Hayik, S.; Roitberg, A.; Seabra, G.; Wong, K. F.; Paesani, F.; Wu, X.; Brozell, S.; Tsui, V.; Gohlke, H.; Yang, L.; Tan, C.; Mongan, J.; Hornak, V.; Cui, G.; Beroza, P.; Mathews, D. H.; Schafmeister, C.; Ross, W. S.; Kollman, P. A.</span> <span class="citation_source-book">AMBER 9</span>; <span class="NLM_publisher-name">University of California</span>: <span class="NLM_publisher-loc">San Francisco, CA</span>, <span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=D.+A.+Case&author=T.+A.+Darden&author=T.+E.+Cheatham&author=C.+L.+Simmerling&author=J.+Wang&author=R.+E.+Duke&author=R.+Luo&author=K.+M.+Merz&author=D.+A.+Pearlman&author=M.+Crowley&author=R.+C.+Walker&author=W.+Zhang&author=B.+Wang&author=S.+Hayik&author=A.+Roitberg&author=G.+Seabra&author=K.+F.+Wong&author=F.+Paesani&author=X.+Wu&author=S.+Brozell&author=V.+Tsui&author=H.+Gohlke&author=L.+Yang&author=C.+Tan&author=J.+Mongan&author=V.+Hornak&author=G.+Cui&author=P.+Beroza&author=D.+H.+Mathews&author=C.+Schafmeister&author=W.+S.+Ross&author=P.+A.+Kollman&title=AMBER+9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCase%26aufirst%3DD.%2BA.%26btitle%3DAMBER%25209%26pub%3DUniversity%2520of%2520California%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span> <span class="citation_source-book">Maestro</span>, version 7.5; <span class="NLM_publisher-name">Schrödinger, Inc.</span>: <span class="NLM_publisher-loc">Portland, OR</span>, <span class="NLM_year">1999</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Maestro%2C+version+7.5%3B+Schr%C3%B6dinger%2C+Inc.%3A+Portland%2C+OR%2C+1999."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMaestro%26pub%3DSchr%25C3%25B6dinger%252C%2520Inc%26date%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span> <span class="citation_source-book">Macromodel</span>, version 8.5; <span class="NLM_publisher-name">Schrödinger, Inc.</span>: <span class="NLM_publisher-loc">Portland, OR</span>, <span class="NLM_year">1999</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Macromodel%2C+version+8.5%3B+Schr%C3%B6dinger%2C+Inc.%3A+Portland%2C+OR%2C+1999."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMacromodel%26pub%3DSchr%25C3%25B6dinger%252C%2520Inc%26date%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Essman, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perela, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berkowitz, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darden, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, L. G.</span><span> </span><span class="NLM_article-title">A smooth particle mesh Ewald method</span> <span class="citation_source-journal">J. Chem. Phys.</span><span class="NLM_year" style="font-weight: bold;">1995</span> <span class="NLM_volume">103</span> <span class="NLM_fpage">8577</span> <span class="NLM_lpage">8592</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm8007823&amp;key=10.1063%2F1.470117" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=1995&pages=8577-8592&author=U.+Essmanauthor=L.+Perelaauthor=M.+L.+Berkowitzauthor=T.+Dardenauthor=H.+Leeauthor=L.+G.+Pedersen&title=A+smooth+particle+mesh+Ewald+method"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1063%2F1.470117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.470117%26sid%3Dliteratum%253Aachs%26aulast%3DEssman%26aufirst%3DU.%26aulast%3DPerela%26aufirst%3DL.%26aulast%3DBerkowitz%26aufirst%3DM.%2BL.%26aulast%3DDarden%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DPedersen%26aufirst%3DL.%2BG.%26atitle%3DA%2520smooth%2520particle%2520mesh%2520Ewald%2520method%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1995%26volume%3D103%26spage%3D8577%26epage%3D8592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Weiser, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenkin, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Still, W. C.</span><span> </span><span class="NLM_article-title">Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO)</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">20</span> <span class="NLM_fpage">217</span> <span class="NLM_lpage">230</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm8007823&amp;key=10.1002%2F%28SICI%291096-987X%2819990130%2920%3A2%3C217%3A%3AAID-JCC4%3E3.0.CO%3B2-A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADyaK1MXltVCltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1999&pages=217-230&author=J.+Weiserauthor=P.+S.+Shenkinauthor=W.+C.+Still&title=Approximate+atomic+surfaces+from+linear+combinations+of+pairwise+overlaps+%28LCPO%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO)</span></div><div class="casAuthors">Weiser, Jorg; Shenkin, Peter S.; Still, W. Clark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">217-230</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A fast anal. formula was derived for the calcn. of approx. at. and mol. van der Waals (vdWSA), and solvent-accessible surface areas (SASAs), as well as the first and second derivs. of these quantities with respect to at. coordinates.  This method makes use of linear combinations of terms composed from pairwise overlaps of hard spheres; therefore, we term this the LCPO method for linear combination of pairwise overlaps.  For higher performance, neighbor-list redn. (NLR) was applied as a preprocessing step.  Eighteen compds. of different sizes (8-2366 atoms) and classes (org., proteins, DNA, and various complexes) were chosen as representative test cases.  LCPO/NLR computed the SASA and first derivs. of penicillopepsin, a protein with 2366 atoms, in 0.87 s (0.22 s for the creation of the neighbor list, 0.35 s for NLR, and 0.30 s for SASA and first derivs.) on an SGI R10000/194 Mhz processor.  This appears comparable to or better than timings reported previously for other algorithms.  The vdWSAs were in good agreement with the numerical results: relative errors for total mol. surface areas ranged from 0.1 to 2.0% and av. abs. at. surface area deviations from 0.3 to 0.7 Å2.  For SASAs without NLR, the LCPO method exhibited relative errors in the range of 0.4-9.2% for total mol. surface areas and av. abs. at. surface area deviations of 2.0-2.7 Å2; with NLR the relative mol. errors ranged from 0.1 to 7.8% and the av. abs. at. surface area deviation from 1.6 to 3.0 Å2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmPQhEyS_vfLVg90H21EOLACvtfcHk0lgDqVZ2XWftIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltVCltQ%253D%253D&md5=1c6cf923fe089cf61a1952fdcf55f788</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291096-987X%2819990130%2920%3A2%3C217%3A%3AAID-JCC4%3E3.0.CO%3B2-A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291096-987X%252819990130%252920%253A2%253C217%253A%253AAID-JCC4%253E3.0.CO%253B2-A%26sid%3Dliteratum%253Aachs%26aulast%3DWeiser%26aufirst%3DJ.%26aulast%3DShenkin%26aufirst%3DP.%2BS.%26aulast%3DStill%26aufirst%3DW.%2BC.%26atitle%3DApproximate%2520atomic%2520surfaces%2520from%2520linear%2520combinations%2520of%2520pairwise%2520overlaps%2520%2528LCPO%2529%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1999%26volume%3D20%26spage%3D217%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 28 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Martin Schröder, Alex N. Bullock, Oleg Fedorov, Franz Bracher, Apirat Chaikuad, <span class="NLM_string-name hlFld-ContribAuthor">Stefan Knapp</span>. </span><span class="cited-content_cbyCitation_article-title">DFG-1 Residue Controls Inhibitor Binding Mode and Affinity, Providing a Basis for Rational Design of Kinase Inhibitor Selectivity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (18)
                                     , 10224-10234. <a href="https://doi.org/10.1021/acs.jmedchem.0c00898" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00898</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00898%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDFG-1%252BResidue%252BControls%252BInhibitor%252BBinding%252BMode%252Band%252BAffinity%25252C%252BProviding%252Ba%252BBasis%252Bfor%252BRational%252BDesign%252Bof%252BKinase%252BInhibitor%252BSelectivity%26aulast%3DSchr%25C3%25B6der%26aufirst%3DMartin%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D27052020%26date%3D27082020%26date%3D12082020%26volume%3D63%26issue%3D18%26spage%3D10224%26epage%3D10234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Shaun M. Fillery, Clare L. Gregson, <span class="NLM_string-name hlFld-ContribAuthor">Carine M. Guérot</span>. </span><span class="cited-content_cbyCitation_article-title">Expeditious Access to Functionalized Tricyclic Pyrrolo-Pyridones via Tandem or Sequential C–N/C–C Bond Formations. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (22)
                                     , 9128-9132. <a href="https://doi.org/10.1021/acs.orglett.9b03514" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b03514</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b03514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b03514%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DExpeditious%252BAccess%252Bto%252BFunctionalized%252BTricyclic%252BPyrrolo-Pyridones%252Bvia%252BTandem%252Bor%252BSequential%252BC%2525E2%252580%252593N%25252FC%2525E2%252580%252593C%252BBond%252BFormations%26aulast%3DFillery%26aufirst%3DShaun%2BM.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D04102019%26date%3D07112019%26volume%3D21%26issue%3D22%26spage%3D9128%26epage%3D9132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter  Dinér</span>, <span class="hlFld-ContribAuthor ">John P.  Alao</span>, <span class="hlFld-ContribAuthor ">Johan  Söderlund</span>, <span class="hlFld-ContribAuthor ">Per  Sunnerhagen</span>, and <span class="hlFld-ContribAuthor ">Morten  Grøtli</span>  . </span><span class="cited-content_cbyCitation_article-title">Preparation of 3-Substituted-1-Isopropyl-1H-pyrazolo[3,4-d]pyrimidin-4-amines as RET Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (10)
                                     , 4872-4876. <a href="https://doi.org/10.1021/jm3003944" title="DOI URL">https://doi.org/10.1021/jm3003944</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3003944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3003944%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPreparation%252Bof%252B3-Substituted-1-Isopropyl-1H-pyrazolo%25255B3%25252C4-d%25255Dpyrimidin-4-amines%252Bas%252BRET%252BKinase%252BInhibitors%26aulast%3DDin%25C3%25A9r%26aufirst%3DPeter%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D02022012%26date%3D16052012%26date%3D24052012%26date%3D07052012%26volume%3D55%26issue%3D10%26spage%3D4872%26epage%3D4876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Longbin  Liu</span>, <span class="hlFld-ContribAuthor ">Mark H.  Norman</span>, <span class="hlFld-ContribAuthor ">Matthew  Lee</span>, <span class="hlFld-ContribAuthor ">Ning  Xi</span>, <span class="hlFld-ContribAuthor ">Aaron  Siegmund</span>, <span class="hlFld-ContribAuthor ">Alessandro A.  Boezio</span>, <span class="hlFld-ContribAuthor ">Shon  Booker</span>, <span class="hlFld-ContribAuthor ">Debbie  Choquette</span>, <span class="hlFld-ContribAuthor ">Noel D.  D’Angelo</span>, <span class="hlFld-ContribAuthor ">Julie  Germain</span>, <span class="hlFld-ContribAuthor ">Kevin  Yang</span>, <span class="hlFld-ContribAuthor ">Yajing  Yang</span>, <span class="hlFld-ContribAuthor ">Yihong  Zhang</span>, <span class="hlFld-ContribAuthor ">Steven F.  Bellon</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">Jean-Christophe  Harmange</span>, <span class="hlFld-ContribAuthor ">Celia  Dominguez</span>, <span class="hlFld-ContribAuthor ">Tae-Seong  Kim</span>, and <span class="hlFld-ContribAuthor ">Isabelle  Dussault</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of Novel Class II c-Met Inhibitors: 2. SAR and Kinase Selectivity Profiles of the Pyrazolone Series. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (5)
                                     , 1868-1897. <a href="https://doi.org/10.1021/jm201331s" title="DOI URL">https://doi.org/10.1021/jm201331s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201331s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201331s%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Bof%252BNovel%252BClass%252BII%252Bc-Met%252BInhibitors%25253A%252B2.%252BSAR%252Band%252BKinase%252BSelectivity%252BProfiles%252Bof%252Bthe%252BPyrazolone%252BSeries%26aulast%3DLiu%26aufirst%3DLongbin%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D06102011%26date%3D24022012%26date%3D08032012%26date%3D09022012%26volume%3D55%26issue%3D5%26spage%3D1868%26epage%3D1897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kilian  Huber</span>, <span class="hlFld-ContribAuthor ">Laurent  Brault</span>, <span class="hlFld-ContribAuthor ">Oleg  Fedorov</span>, <span class="hlFld-ContribAuthor ">Christelle  Gasser</span>, <span class="hlFld-ContribAuthor ">Panagis  Filippakopoulos</span>, <span class="hlFld-ContribAuthor ">Alex N.  Bullock</span>, <span class="hlFld-ContribAuthor ">Doriano  Fabbro</span>, <span class="hlFld-ContribAuthor ">Jörg  Trappe</span>, <span class="hlFld-ContribAuthor ">Jürg  Schwaller</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>, and <span class="hlFld-ContribAuthor ">Franz  Bracher</span>  . </span><span class="cited-content_cbyCitation_article-title">7,8-Dichloro-1-oxo-β-carbolines as a Versatile Scaffold for the Development of Potent and Selective Kinase Inhibitors with Unusual Binding Modes. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (1)
                                     , 403-413. <a href="https://doi.org/10.1021/jm201286z" title="DOI URL">https://doi.org/10.1021/jm201286z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201286z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201286z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D7%25252C8-Dichloro-1-oxo-%2525CE%2525B2-carbolines%252Bas%252Ba%252BVersatile%252BScaffold%252Bfor%252Bthe%252BDevelopment%252Bof%252BPotent%252Band%252BSelective%252BKinase%252BInhibitors%252Bwith%252BUnusual%252BBinding%252BModes%26aulast%3DHuber%26aufirst%3DKilian%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D27092011%26date%3D03012012%26date%3D12012012%26date%3D05122011%26volume%3D55%26issue%3D1%26spage%3D403%26epage%3D413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manasa  Kadagathur</span>, <span class="hlFld-ContribAuthor ">Sandip  Patra</span>, <span class="hlFld-ContribAuthor ">Dilep Kumar  Sigalapalli</span>, <span class="hlFld-ContribAuthor ">Nagula  Shankaraiah</span>, <span class="hlFld-ContribAuthor ">Neelima D.  Tangellamudi</span>. </span><span class="cited-content_cbyCitation_article-title">Syntheses and medicinal chemistry of azepinoindolones: a look back to leap forward. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2021,</strong> <em>19 </em>
                                    (4)
                                     , 738-764. <a href="https://doi.org/10.1039/D0OB02181D" title="DOI URL">https://doi.org/10.1039/D0OB02181D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB02181D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB02181D%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSyntheses%252Band%252Bmedicinal%252Bchemistry%252Bof%252Bazepinoindolones%25253A%252Ba%252Blook%252Bback%252Bto%252Bleap%252Bforward%26aulast%3DKadagathur%26aufirst%3DManasa%26date%3D2021%26date%3D2021%26volume%3D19%26issue%3D4%26spage%3D738%26epage%3D764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesco  Balestri</span>, <span class="hlFld-ContribAuthor ">Vito  Barracco</span>, <span class="hlFld-ContribAuthor ">Giovanni  Renzone</span>, <span class="hlFld-ContribAuthor ">Tiziano  Tuccinardi</span>, <span class="hlFld-ContribAuthor ">Christian Silvio  Pomelli</span>, <span class="hlFld-ContribAuthor ">Mario  Cappiello</span>, <span class="hlFld-ContribAuthor ">Marco  Lessi</span>, <span class="hlFld-ContribAuthor ">Rossella  Rotondo</span>, <span class="hlFld-ContribAuthor ">Fabio  Bellina</span>, <span class="hlFld-ContribAuthor ">Andrea  Scaloni</span>, <span class="hlFld-ContribAuthor ">Umberto  Mura</span>, <span class="hlFld-ContribAuthor ">Antonella  Del Corso</span>, <span class="hlFld-ContribAuthor ">Roberta  Moschini</span>. </span><span class="cited-content_cbyCitation_article-title">Stereoselectivity of Aldose Reductase in the Reduction of Glutathionyl-Hydroxynonanal Adduct. </span><span class="cited-content_cbyCitation_journal-name">Antioxidants</span><span> <strong>2019,</strong> <em>8 </em>
                                    (10)
                                     , 502. <a href="https://doi.org/10.3390/antiox8100502" title="DOI URL">https://doi.org/10.3390/antiox8100502</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/antiox8100502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fantiox8100502%26sid%3Dliteratum%253Aachs%26jtitle%3DAntioxidants%26atitle%3DStereoselectivity%252Bof%252BAldose%252BReductase%252Bin%252Bthe%252BReduction%252Bof%252BGlutathionyl-Hydroxynonanal%252BAdduct%26aulast%3DBalestri%26aufirst%3DFrancesco%26date%3D2019%26date%3D2019%26volume%3D8%26issue%3D10%26spage%3D502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tao  Shen</span>, <span class="hlFld-ContribAuthor ">Bencong  Zhu</span>, <span class="hlFld-ContribAuthor ">Fengguirong  Lin</span>, <span class="hlFld-ContribAuthor ">Jun  Pan</span>, <span class="hlFld-ContribAuthor ">Jialiang  Wei</span>, <span class="hlFld-ContribAuthor ">Xiao  Luo</span>, <span class="hlFld-ContribAuthor ">Jianzhong  Liu</span>, <span class="hlFld-ContribAuthor ">Ning  Jiao</span>. </span><span class="cited-content_cbyCitation_article-title">Direct Synthesis of Structurally Divergent Indole Alkaloids from Simple Chemicals. </span><span class="cited-content_cbyCitation_journal-name">Chinese Journal of Chemistry</span><span> <strong>2018,</strong> <em>36 </em>
                                    (9)
                                     , 815-818. <a href="https://doi.org/10.1002/cjoc.201800258" title="DOI URL">https://doi.org/10.1002/cjoc.201800258</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cjoc.201800258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcjoc.201800258%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Journal%2520of%2520Chemistry%26atitle%3DDirect%252BSynthesis%252Bof%252BStructurally%252BDivergent%252BIndole%252BAlkaloids%252Bfrom%252BSimple%252BChemicals%26aulast%3DShen%26aufirst%3DTao%26date%3D2018%26date%3D2018%26volume%3D36%26issue%3D9%26spage%3D815%26epage%3D818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rudrakshula  Madhavachary</span>, <span class="hlFld-ContribAuthor ">Naganaboina  Naveen</span>, <span class="hlFld-ContribAuthor ">Yuanze  Wang</span>, <span class="hlFld-ContribAuthor ">Qian  Wang</span>, <span class="hlFld-ContribAuthor ">Markella  Konstantinidou</span>, <span class="hlFld-ContribAuthor ">Alexander  Dömling</span>. </span><span class="cited-content_cbyCitation_article-title">β-Carbolinone Analogues from the Ugi Silver Mine. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>2018 </em>
                                    (24)
                                     , 3139-3143. <a href="https://doi.org/10.1002/ejoc.201800557" title="DOI URL">https://doi.org/10.1002/ejoc.201800557</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201800557&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201800557%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3D%2525CE%2525B2-Carbolinone%252BAnalogues%252Bfrom%252Bthe%252BUgi%252BSilver%252BMine%26aulast%3DMadhavachary%26aufirst%3DRudrakshula%26date%3D2018%26date%3D2018%26volume%3D2018%26issue%3D24%26spage%3D3139%26epage%3D3143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sara  Carpi</span>, <span class="hlFld-ContribAuthor ">Beatrice  Polini</span>, <span class="hlFld-ContribAuthor ">Giulio  Poli</span>, <span class="hlFld-ContribAuthor ">Gabriela  Alcantara Barata</span>, <span class="hlFld-ContribAuthor ">Stefano  Fogli</span>, <span class="hlFld-ContribAuthor ">Antonella  Romanini</span>, <span class="hlFld-ContribAuthor ">Tiziano  Tuccinardi</span>, <span class="hlFld-ContribAuthor ">Graziano  Guella</span>, <span class="hlFld-ContribAuthor ">Francesco  Frontini</span>, <span class="hlFld-ContribAuthor ">Paola  Nieri</span>, <span class="hlFld-ContribAuthor ">Graziano  Di Giuseppe</span>. </span><span class="cited-content_cbyCitation_article-title">Anticancer Activity of Euplotin C, Isolated from the Marine Ciliate Euplotes crassus, Against Human Melanoma Cells. </span><span class="cited-content_cbyCitation_journal-name">Marine Drugs</span><span> <strong>2018,</strong> <em>16 </em>
                                    (5)
                                     , 166. <a href="https://doi.org/10.3390/md16050166" title="DOI URL">https://doi.org/10.3390/md16050166</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/md16050166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmd16050166%26sid%3Dliteratum%253Aachs%26jtitle%3DMarine%2520Drugs%26atitle%3DAnticancer%252BActivity%252Bof%252BEuplotin%252BC%25252C%252BIsolated%252Bfrom%252Bthe%252BMarine%252BCiliate%252BEuplotes%252Bcrassus%25252C%252BAgainst%252BHuman%252BMelanoma%252BCells%26aulast%3DCarpi%26aufirst%3DSara%26date%3D2018%26date%3D2018%26volume%3D16%26issue%3D5%26spage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giulio  Poli</span>, <span class="hlFld-ContribAuthor ">Margherita  Lapillo</span>, <span class="hlFld-ContribAuthor ">Carlotta  Granchi</span>, <span class="hlFld-ContribAuthor ">Jessica  Caciolla</span>, <span class="hlFld-ContribAuthor ">Nayla  Mouawad</span>, <span class="hlFld-ContribAuthor ">Isabella  Caligiuri</span>, <span class="hlFld-ContribAuthor ">Flavio  Rizzolio</span>, <span class="hlFld-ContribAuthor ">Thierry  Langer</span>, <span class="hlFld-ContribAuthor ">Filippo  Minutolo</span>, <span class="hlFld-ContribAuthor ">Tiziano  Tuccinardi</span>. </span><span class="cited-content_cbyCitation_article-title">Binding investigation and preliminary optimisation of the 3-amino-1,2,4-triazin-5(2
              H
              )-one core for the development of new Fyn inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2018,</strong> <em>33 </em>
                                    (1)
                                     , 956-961. <a href="https://doi.org/10.1080/14756366.2018.1469017" title="DOI URL">https://doi.org/10.1080/14756366.2018.1469017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2018.1469017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2018.1469017%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DBinding%252Binvestigation%252Band%252Bpreliminary%252Boptimisation%252Bof%252Bthe%252B3-amino-1%25252C2%25252C4-triazin-5%2525282%252BH%252B%252529-one%252Bcore%252Bfor%252Bthe%252Bdevelopment%252Bof%252Bnew%252BFyn%252Binhibitors%26aulast%3DPoli%26aufirst%3DGiulio%26date%3D2018%26date%3D2018%26volume%3D33%26issue%3D1%26spage%3D956%26epage%3D961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Swapnil P.  Bhujbal</span>, <span class="hlFld-ContribAuthor ">Pavithra K.  Balasubramanian</span>, <span class="hlFld-ContribAuthor ">Seung  Joo Cho</span>. </span><span class="cited-content_cbyCitation_article-title">In silico studies on 2-substituted phenol quinazoline derivatives as RET receptor tyrosine kinase antagonists. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2017,</strong> <em>26 </em>
                                    (12)
                                     , 3228-3239. <a href="https://doi.org/10.1007/s00044-017-2016-5" title="DOI URL">https://doi.org/10.1007/s00044-017-2016-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-017-2016-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-017-2016-5%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DIn%252Bsilico%252Bstudies%252Bon%252B2-substituted%252Bphenol%252Bquinazoline%252Bderivatives%252Bas%252BRET%252Breceptor%252Btyrosine%252Bkinase%252Bantagonists%26aulast%3DBhujbal%26aufirst%3DSwapnil%2BP.%26date%3D2017%26date%3D2017%26volume%3D26%26issue%3D12%26spage%3D3228%26epage%3D3239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carine  Maaliki</span>, <span class="hlFld-ContribAuthor ">Emilie  Thiery</span>, <span class="hlFld-ContribAuthor ">Jérôme  Thibonnet</span>. </span><span class="cited-content_cbyCitation_article-title">Emergence of Copper-Mediated Formation of C-C Bonds. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>2017 </em>
                                    (2)
                                     , 209-228. <a href="https://doi.org/10.1002/ejoc.201600540" title="DOI URL">https://doi.org/10.1002/ejoc.201600540</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201600540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201600540%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DEmergence%252Bof%252BCopper-Mediated%252BFormation%252Bof%252BC-C%252BBonds%26aulast%3DMaaliki%26aufirst%3DCarine%26date%3D2017%26date%3D2016%26volume%3D2017%26issue%3D2%26spage%3D209%26epage%3D228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Catalin V.  Maftei</span>, <span class="hlFld-ContribAuthor ">Elena  Fodor</span>, <span class="hlFld-ContribAuthor ">Peter G.  Jones</span>, <span class="hlFld-ContribAuthor ">Constantin G.  Daniliuc</span>, <span class="hlFld-ContribAuthor ">M. Heiko  Franz</span>, <span class="hlFld-ContribAuthor ">Gerhard  Kelter</span>, <span class="hlFld-ContribAuthor ">Heinz-Herbert  Fiebig</span>, <span class="hlFld-ContribAuthor ">Matthias  Tamm</span>, <span class="hlFld-ContribAuthor ">Ion  Neda</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 1,2,4-oxadiazoles and trifluoromethylpyridines related to natural products: synthesis, structural analysis and investigation of their antitumor activity. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2016,</strong> <em>72 </em>
                                    (9)
                                     , 1185-1199. <a href="https://doi.org/10.1016/j.tet.2016.01.011" title="DOI URL">https://doi.org/10.1016/j.tet.2016.01.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2016.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2016.01.011%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DNovel%252B1%25252C2%25252C4-oxadiazoles%252Band%252Btrifluoromethylpyridines%252Brelated%252Bto%252Bnatural%252Bproducts%25253A%252Bsynthesis%25252C%252Bstructural%252Banalysis%252Band%252Binvestigation%252Bof%252Btheir%252Bantitumor%252Bactivity%26aulast%3DMaftei%26aufirst%3DCatalin%2BV.%26date%3D2016%26volume%3D72%26issue%3D9%26spage%3D1185%26epage%3D1199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brendan  Frett</span>, <span class="hlFld-ContribAuthor ">Francesca  Carlomagno</span>, <span class="hlFld-ContribAuthor ">Maria Luisa  Moccia</span>, <span class="hlFld-ContribAuthor ">Annalisa  Brescia</span>, <span class="hlFld-ContribAuthor ">Giorgia  Federico</span>, <span class="hlFld-ContribAuthor ">Valentina  De Falco</span>, <span class="hlFld-ContribAuthor ">Brittany  Admire</span>, <span class="hlFld-ContribAuthor ">Zhongzhu  Chen</span>, <span class="hlFld-ContribAuthor ">Wenqing  Qi</span>, <span class="hlFld-ContribAuthor ">Massimo  Santoro</span>, <span class="hlFld-ContribAuthor ">Hong-yu  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Discovery of a Dual pan-RET/VEGFR2 Kinase Inhibitor Optimized for Single-Agent Polypharmacology. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2015,</strong> <em>127 </em>
                                    (30)
                                     , 8841-8845. <a href="https://doi.org/10.1002/ange.201501104" title="DOI URL">https://doi.org/10.1002/ange.201501104</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201501104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201501104%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DFragment-Based%252BDiscovery%252Bof%252Ba%252BDual%252Bpan-RET%25252FVEGFR2%252BKinase%252BInhibitor%252BOptimized%252Bfor%252BSingle-Agent%252BPolypharmacology%26aulast%3DFrett%26aufirst%3DBrendan%26date%3D2015%26date%3D2015%26volume%3D127%26issue%3D30%26spage%3D8841%26epage%3D8845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brendan  Frett</span>, <span class="hlFld-ContribAuthor ">Francesca  Carlomagno</span>, <span class="hlFld-ContribAuthor ">Maria Luisa  Moccia</span>, <span class="hlFld-ContribAuthor ">Annalisa  Brescia</span>, <span class="hlFld-ContribAuthor ">Giorgia  Federico</span>, <span class="hlFld-ContribAuthor ">Valentina  De Falco</span>, <span class="hlFld-ContribAuthor ">Brittany  Admire</span>, <span class="hlFld-ContribAuthor ">Zhongzhu  Chen</span>, <span class="hlFld-ContribAuthor ">Wenqing  Qi</span>, <span class="hlFld-ContribAuthor ">Massimo  Santoro</span>, <span class="hlFld-ContribAuthor ">Hong-yu  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Discovery of a Dual pan-RET/VEGFR2 Kinase Inhibitor Optimized for Single-Agent Polypharmacology. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2015,</strong> <em>54 </em>
                                    (30)
                                     , 8717-8721. <a href="https://doi.org/10.1002/anie.201501104" title="DOI URL">https://doi.org/10.1002/anie.201501104</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201501104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201501104%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DFragment-Based%252BDiscovery%252Bof%252Ba%252BDual%252Bpan-RET%25252FVEGFR2%252BKinase%252BInhibitor%252BOptimized%252Bfor%252BSingle-Agent%252BPolypharmacology%26aulast%3DFrett%26aufirst%3DBrendan%26date%3D2015%26date%3D2015%26volume%3D54%26issue%3D30%26spage%3D8717%26epage%3D8721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raffaella  Cincinelli</span>, <span class="hlFld-ContribAuthor ">Loana  Musso</span>, <span class="hlFld-ContribAuthor ">Giangiacomo  Beretta</span>, <span class="hlFld-ContribAuthor ">Sabrina  Dallavalle</span>. </span><span class="cited-content_cbyCitation_article-title">4-Quinolone fused heterocyclic ring systems by intramolecular reactions of 4-quinolone-2-carboxamides. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2014,</strong> <em>70 </em>
                                    (52)
                                     , 9797-9804. <a href="https://doi.org/10.1016/j.tet.2014.11.018" title="DOI URL">https://doi.org/10.1016/j.tet.2014.11.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2014.11.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2014.11.018%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3D4-Quinolone%252Bfused%252Bheterocyclic%252Bring%252Bsystems%252Bby%252Bintramolecular%252Breactions%252Bof%252B4-quinolone-2-carboxamides%26aulast%3DCincinelli%26aufirst%3DRaffaella%26date%3D2014%26volume%3D70%26issue%3D52%26spage%3D9797%26epage%3D9804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brendan  Frett</span>, <span class="hlFld-ContribAuthor ">Marialuisa  Moccia</span>, <span class="hlFld-ContribAuthor ">Francesca  Carlomagno</span>, <span class="hlFld-ContribAuthor ">Massimo  Santoro</span>, <span class="hlFld-ContribAuthor ">Hong-yu  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of two novel RET kinase inhibitors through MCR-based drug discovery: Design, synthesis and evaluation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>86 </em>, 714-723. <a href="https://doi.org/10.1016/j.ejmech.2014.09.023" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.09.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.09.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.09.023%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Btwo%252Bnovel%252BRET%252Bkinase%252Binhibitors%252Bthrough%252BMCR-based%252Bdrug%252Bdiscovery%25253A%252BDesign%25252C%252Bsynthesis%252Band%252Bevaluation%26aulast%3DFrett%26aufirst%3DBrendan%26date%3D2014%26volume%3D86%26spage%3D714%26epage%3D723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin  Wang</span>, <span class="hlFld-ContribAuthor ">Hua  Qin</span>, <span class="hlFld-ContribAuthor ">Fengying  Zhang</span>, <span class="hlFld-ContribAuthor ">Yanxing  Jia</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of the cycloheptannelated indole fragment of dragmacidin E. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2014,</strong> <em>55 </em>
                                    (9)
                                     , 1561-1563. <a href="https://doi.org/10.1016/j.tetlet.2014.01.063" title="DOI URL">https://doi.org/10.1016/j.tetlet.2014.01.063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2014.01.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2014.01.063%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DSynthesis%252Bof%252Bthe%252Bcycloheptannelated%252Bindole%252Bfragment%252Bof%252Bdragmacidin%252BE%26aulast%3DWang%26aufirst%3DBin%26date%3D2014%26volume%3D55%26issue%3D9%26spage%3D1561%26epage%3D1563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessia  Lopergolo</span>, <span class="hlFld-ContribAuthor ">Valentina  Nicolini</span>, <span class="hlFld-ContribAuthor ">Enrica  Favini</span>, <span class="hlFld-ContribAuthor ">Laura  Dal Bo</span>, <span class="hlFld-ContribAuthor ">Monica  Tortoreto</span>, <span class="hlFld-ContribAuthor ">Denis  Cominetti</span>, <span class="hlFld-ContribAuthor ">Marco  Folini</span>, <span class="hlFld-ContribAuthor ">Paola  Perego</span>, <span class="hlFld-ContribAuthor ">Vittoria  Castiglioni</span>, <span class="hlFld-ContribAuthor ">Eugenio  Scanziani</span>, <span class="hlFld-ContribAuthor ">Maria Grazia  Borrello</span>, <span class="hlFld-ContribAuthor ">Nadia  Zaffaroni</span>, <span class="hlFld-ContribAuthor ">Giuliana  Cassinelli</span>, <span class="hlFld-ContribAuthor ">Cinzia  Lanzi</span>. </span><span class="cited-content_cbyCitation_article-title">Synergistic Cooperation Between Sunitinib and Cisplatin Promotes Apoptotic Cell Death in Human Medullary Thyroid Cancer. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Clinical Endocrinology & Metabolism</span><span> <strong>2014,</strong> <em>99 </em>
                                    (2)
                                     , 498-509. <a href="https://doi.org/10.1210/jc.2013-2574" title="DOI URL">https://doi.org/10.1210/jc.2013-2574</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1210/jc.2013-2574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1210%2Fjc.2013-2574%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Clinical%2520Endocrinology%2520%2526%2520Metabolism%26atitle%3DSynergistic%252BCooperation%252BBetween%252BSunitinib%252Band%252BCisplatin%252BPromotes%252BApoptotic%252BCell%252BDeath%252Bin%252BHuman%252BMedullary%252BThyroid%252BCancer%26aulast%3DLopergolo%26aufirst%3DAlessia%26date%3D2014%26volume%3D99%26issue%3D2%26spage%3D498%26epage%3D509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria Grazia  Borrello</span>, <span class="hlFld-ContribAuthor ">Elena  Ardini</span>, <span class="hlFld-ContribAuthor ">Laura D  Locati</span>, <span class="hlFld-ContribAuthor ">Angela  Greco</span>, <span class="hlFld-ContribAuthor ">Lisa  Licitra</span>, <span class="hlFld-ContribAuthor ">Marco A  Pierotti</span>. </span><span class="cited-content_cbyCitation_article-title">RET inhibition: implications in cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2013,</strong> <em>17 </em>
                                    (4)
                                     , 403-419. <a href="https://doi.org/10.1517/14728222.2013.758715" title="DOI URL">https://doi.org/10.1517/14728222.2013.758715</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/14728222.2013.758715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F14728222.2013.758715%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DRET%252Binhibition%25253A%252Bimplications%252Bin%252Bcancer%252Btherapy%26aulast%3DBorrello%26aufirst%3DMaria%2BGrazia%26date%3D2013%26date%3D2013%26volume%3D17%26issue%3D4%26spage%3D403%26epage%3D419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A. Stephen K.  Hashmi</span>, <span class="hlFld-ContribAuthor ">Weibo  Yang</span>, <span class="hlFld-ContribAuthor ">Frank  Rominger</span>. </span><span class="cited-content_cbyCitation_article-title">Gold-Catalysis: Highly Efficient and Regio-Selective Carbonyl Migration in Alkynyl-Substituted Indole-3-Carboxamides Leading to Azepino[3,4-b]indol-1-ones. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2012,</strong> <em>354 </em>
                                    (7)
                                     , 1273-1279. <a href="https://doi.org/10.1002/adsc.201200092" title="DOI URL">https://doi.org/10.1002/adsc.201200092</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201200092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201200092%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DGold-Catalysis%25253A%252BHighly%252BEfficient%252Band%252BRegio-Selective%252BCarbonyl%252BMigration%252Bin%252BAlkynyl-Substituted%252BIndole-3-Carboxamides%252BLeading%252Bto%252BAzepino%25255B3%25252C4-b%25255Dindol-1-ones%26aulast%3DHashmi%26aufirst%3DA.%2BStephen%2BK.%26date%3D2012%26date%3D2012%26volume%3D354%26issue%3D7%26spage%3D1273%26epage%3D1279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kuei-Chung  Shih</span>, <span class="hlFld-ContribAuthor ">Chung-Wai  Shiau</span>, <span class="hlFld-ContribAuthor ">Ting-Shou  Chen</span>, <span class="hlFld-ContribAuthor ">Ching-Huai  Ko</span>, <span class="hlFld-ContribAuthor ">Chih-Lung  Lin</span>, <span class="hlFld-ContribAuthor ">Chun-Yuan  Lin</span>, <span class="hlFld-ContribAuthor ">Chrong-Shiong  Hwang</span>, <span class="hlFld-ContribAuthor ">Chuan-Yi  Tang</span>, <span class="hlFld-ContribAuthor ">Wan-Ru  Chen</span>, <span class="hlFld-ContribAuthor ">Jui-Wen  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore modeling and virtual screening to identify potential RET kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (15)
                                     , 4490-4497. <a href="https://doi.org/10.1016/j.bmcl.2011.06.003" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.06.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.06.003%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPharmacophore%252Bmodeling%252Band%252Bvirtual%252Bscreening%252Bto%252Bidentify%252Bpotential%252BRET%252Bkinase%252Binhibitors%26aulast%3DShih%26aufirst%3DKuei-Chung%26date%3D2011%26volume%3D21%26issue%3D15%26spage%3D4490%26epage%3D4497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marina  Gruit</span>, <span class="hlFld-ContribAuthor ">Anahit  Pews-Davtyan</span>, <span class="hlFld-ContribAuthor ">Matthias  Beller</span>. </span><span class="cited-content_cbyCitation_article-title">Platinum-catalyzed cyclization reaction of alkynes: synthesis of azepino[3,4-b]indol-1-ones. </span><span class="cited-content_cbyCitation_journal-name">Org. Biomol. Chem.</span><span> <strong>2011,</strong> <em>9 </em>
                                    (4)
                                     , 1148-1159. <a href="https://doi.org/10.1039/C0OB00728E" title="DOI URL">https://doi.org/10.1039/C0OB00728E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C0OB00728E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC0OB00728E%26sid%3Dliteratum%253Aachs%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26atitle%3DPlatinum-catalyzed%252Bcyclization%252Breaction%252Bof%252Balkynes%25253A%252Bsynthesis%252Bof%252Bazepino%25255B3%25252C4-b%25255Dindol-1-ones%26aulast%3DGruit%26aufirst%3DMarina%26date%3D2011%26date%3D2011%26volume%3D9%26issue%3D4%26spage%3D1148%26epage%3D1159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wiebke  Brandt</span>, <span class="hlFld-ContribAuthor ">Luca  Mologni</span>, <span class="hlFld-ContribAuthor ">Lutz  Preu</span>, <span class="hlFld-ContribAuthor ">Thomas  Lemcke</span>, <span class="hlFld-ContribAuthor ">Carlo  Gambacorti-Passerini</span>, <span class="hlFld-ContribAuthor ">Conrad  Kunick</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors of the RET tyrosine kinase based on a 2-(alkylsulfanyl)-4-(3-thienyl)nicotinonitrile scaffold. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>45 </em>
                                    (7)
                                     , 2919-2927. <a href="https://doi.org/10.1016/j.ejmech.2010.03.017" title="DOI URL">https://doi.org/10.1016/j.ejmech.2010.03.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2010.03.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2010.03.017%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInhibitors%252Bof%252Bthe%252BRET%252Btyrosine%252Bkinase%252Bbased%252Bon%252Ba%252B2-%252528alkylsulfanyl%252529-4-%2525283-thienyl%252529nicotinonitrile%252Bscaffold%26aulast%3DBrandt%26aufirst%3DWiebke%26date%3D2010%26volume%3D45%26issue%3D7%26spage%3D2919%26epage%3D2927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicole  Höttecke</span>, <span class="hlFld-ContribAuthor ">Miriam  Liebeck</span>, <span class="hlFld-ContribAuthor ">Karlheinz  Baumann</span>, <span class="hlFld-ContribAuthor ">Robert  Schubenel</span>, <span class="hlFld-ContribAuthor ">Edith  Winkler</span>, <span class="hlFld-ContribAuthor ">Harald  Steiner</span>, <span class="hlFld-ContribAuthor ">Boris  Schmidt</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of γ-secretase by the CK1 inhibitor IC261 does not depend on CK1δ. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (9)
                                     , 2958-2963. <a href="https://doi.org/10.1016/j.bmcl.2010.02.110" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.02.110</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.02.110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.02.110%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DInhibition%252Bof%252B%2525CE%2525B3-secretase%252Bby%252Bthe%252BCK1%252Binhibitor%252BIC261%252Bdoes%252Bnot%252Bdepend%252Bon%252BCK1%2525CE%2525B4%26aulast%3DH%25C3%25B6ttecke%26aufirst%3DNicole%26date%3D2010%26volume%3D20%26issue%3D9%26spage%3D2958%26epage%3D2963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raffaella  Cincinelli</span>, <span class="hlFld-ContribAuthor ">Sabrina  Dallavalle</span>, <span class="hlFld-ContribAuthor ">Lucio  Merlini</span>, <span class="hlFld-ContribAuthor ">Raffaella  Nannei</span>, <span class="hlFld-ContribAuthor ">Leonardo  Scaglioni</span>. </span><span class="cited-content_cbyCitation_article-title">Intramolecular N-acyliminium ion versus Friedel–Crafts cyclization onto 3-indoles: synthesis of the novel rings pyrrolizino[2,1-b]indole and homologues. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2009,</strong> <em>65 </em>
                                    (17)
                                     , 3465-3472. <a href="https://doi.org/10.1016/j.tet.2009.02.036" title="DOI URL">https://doi.org/10.1016/j.tet.2009.02.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2009.02.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2009.02.036%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DIntramolecular%252BN-acyliminium%252Bion%252Bversus%252BFriedel%2525E2%252580%252593Crafts%252Bcyclization%252Bonto%252B3-indoles%25253A%252Bsynthesis%252Bof%252Bthe%252Bnovel%252Brings%252Bpyrrolizino%25255B2%25252C1-b%25255Dindole%252Band%252Bhomologues%26aulast%3DCincinelli%26aufirst%3DRaffaella%26date%3D2009%26volume%3D65%26issue%3D17%26spage%3D3465%26epage%3D3472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Darrin W.  Hopper</span>, <span class="hlFld-ContribAuthor ">Aimee L.  Crombie</span>, <span class="hlFld-ContribAuthor ">Jeremy J.  Clemens</span>, <span class="hlFld-ContribAuthor ">Soojin  Kwon</span>. </span><span class="cited-content_cbyCitation_article-title">Chapter 6.1: Six-Membered Ring Systems: Pyridine and Benzo Derivatives. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2009,</strong>,, 330-374. <a href="https://doi.org/10.1016/S0959-6380(09)70039-X" title="DOI URL">https://doi.org/10.1016/S0959-6380(09)70039-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S0959-6380(09)70039-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS0959-6380%2809%2970039-X%26sid%3Dliteratum%253Aachs%26atitle%3DChapter%252B6.1%25253A%252BSix-Membered%252BRing%252BSystems%25253A%252BPyridine%252Band%252BBenzo%252BDerivatives%26aulast%3DHopper%26aufirst%3DDarrin%2BW.%26date%3D2009%26spage%3D330%26epage%3D374%26pub%3DElsevier%26date%3D2009%26volume%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/medium/jm-2008-007823_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8007823&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/medium/jm-2008-007823_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0001.jpeg" id="rightTab-gc1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Configurational Equilibrium of RPI-1</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8007823&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/medium/jm-2008-007823_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0002.jpeg" id="rightTab-gc2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. General Structure of the New Compounds</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8007823&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/medium/jm-2008-007823_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Superimposition between RPI-1 (colored green) and the new compounds (<b>1a</b>, <b>2a</b>, and <b>3a</b>, colored cyan, magenta, and gray, respectively). The most important pharmacophoric features are also reported (aromatic and hydrogen bond acceptor and donor features are reported as orange, red, and cyan spheres, respectively).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8007823&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/medium/jm-2008-007823_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0011.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. <sup>a</sup><sup>,</sup><sup>b</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8007823&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p><span class="fn-label">Scheme a</span>Reagents and conditions: (a) β-alanine ethyl ester hydrochloride, WSC, HOBT, TEA, THF, room temp, 24 h, 96%; (b) Mel, CH<sub>3</sub>CN, K<sub>2</sub>C0<sub>3</sub>, reflux, 30 h, 72%; (c) LiOH·H<sub>2</sub>O, EtOH, room temp, 48 h, 89−94%; (d) PPA, 95 °C, 90 min to 6 h, 45−68%; (e) NaH, DMF, PMBCI, room temp, 4 h, 50%. (f) For <b>8b</b>: <b>7a</b>, Mel, NaH, DMF, room temp, 2 h, 40%. For <b>8c</b>: <b>7b</b>, PMBCI, NaH, DMF, room temp, overnight, 33%. (g) (CF<sub>3</sub>SO<sub>2</sub>)<sub>2</sub>O, Na<sub>2</sub>CO<sub>3</sub>, CH<sub>2</sub>CI<sub>2</sub>, room temp, 3−12 h, 26−75%; (h) <i>p</i>-HO-PhB(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, toluene, NaHCO<sub>3</sub>, EtOH, 60−90 min, 12−78%; (i) TFA, reflux, 5 h, 49%.</p><p class="last"><span class="fn-label">Scheme b</span>See Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/medium/jm-2008-007823_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0012.jpeg" id="rightTab-gs2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8007823&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>For R<sub>1</sub>−R<sub>6</sub>, see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. Reagents and conditions: (a) WSC, HOBT, THF, room temp; (b) IBX, EtOAc, 80°C or PCC, CH<sub>2</sub>Cl<sub>2</sub>, 40−50 °C; (c) TFA, CH<sub>3</sub>CN, 80 °C.</p></p></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/medium/jm-2008-007823_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Schematic representation of the main interactions of <i>Z</i>-RPI-1 into the RET binding site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8007823&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/medium/jm-2008-007823_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Inhibition of RET autophosphorylation and expression in NIH3T3<sup>MEN2A</sup> cells treated with compound <b>2b</b> or RPI-1 as reference compound. Cells were exposed to vehicle (DMSO) or to the indicated concentrations of the compounds for 24 h. Whole cell lysates were analyzed by Western blotting with anti-p(Y1062)Ret and anti-Ret antibodies. A cell extract from untreated parental NIH3T3 cells was run in parallel. Anti-actin blot is shown as protein loading control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8007823&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/medium/jm-2008-007823_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0008.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Docking of compounds <b>2a</b> (A), <b>3a</b> (B), and <b>1a</b> (C) into the RET binding site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8007823&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/medium/jm-2008-007823_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0009.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Docking of compounds <b>2b</b> (A), <b>2h</b> (B), and <b>2d</b> (C) into the RET binding site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8007823&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/medium/jm-2008-007823_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0010.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Results of the MD simulation of compounds <b>2b</b> (black) and <b>2d</b> (red) complexed with RET: (A) total energy (kcal/mol) of the system plotted versus time (ps); (B) rmsd in angstroms (Å), between the protein and the starting X-ray structure for all the heavy atoms, versus time (ps).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm8007823/production/images/large/jm-2008-007823_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8007823&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i51">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26214" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26214" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 37 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Arighi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borrello, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sariola, H.</span><span> </span><span class="NLM_article-title">RET tyrosine kinase signaling in development and cancer</span> <span class="citation_source-journal">Cytokine Growth Factor Rev.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">16</span> <span class="NLM_fpage">441</span> <span class="NLM_lpage">467</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm8007823&amp;key=10.1016%2Fj.cytogfr.2005.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm8007823&amp;key=15982921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvVCnu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=441-467&author=E.+Arighiauthor=M.+G.+Borrelloauthor=H.+Sariola&title=RET+tyrosine+kinase+signaling+in+development+and+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">RET tyrosine kinase signaling in development and cancer</span></div><div class="casAuthors">Arighi, Elena; Borrello, Maria Grazia; Sariola, Hannu</div><div class="citationInfo"><span class="NLM_cas:title">Cytokine & Growth Factor Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4-5</span>),
    <span class="NLM_cas:pages">441-467</span>CODEN:
                <span class="NLM_cas:coden">CGFRFB</span>;
        ISSN:<span class="NLM_cas:issn">1359-6101</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The variety of diseases caused by mutations in RET receptor tyrosine kinase provides a classic example of phenotypic heterogeneity.  Gain-of-function mutations of RET are assocd. with human cancer.  Gene rearrangements juxtaposing the tyrosine kinase domain to heterologous gene partners have been found in sporadic papillary carcinomas of the thyroid (PTC).  These rearrangements generate chimeric RET/PTC oncogenes.  In the germline, point mutations of RET are responsible for multiple endocrine neoplasia type 2 (MEN 2A and 2B) and familial medullary thyroid carcinoma (FMTC).  Both MEN 2 mutations and PTC gene rearrangements potentiate the intrinsic tyrosine kinase activity of RET and, ultimately, activate the RET downstream targets.  Loss-of-function mutations of RET cause Hirschsprung's disease (HSCR) or colonic aganglionosis.  A deeper understanding of the mol. signaling of normal vs. abnormal RET activity in cancer will enable the development of potential new treatments for patients with sporadic and inherited thyroid cancer or MEN 2 syndrome.  We now review the role and mechanisms of RET signaling in development and carcinogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozw_crTv66LbVg90H21EOLACvtfcHk0lilVZ6D8cHmNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvVCnu7s%253D&md5=8f664352542b6034d0ca001b9c1c4f16</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.cytogfr.2005.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cytogfr.2005.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DArighi%26aufirst%3DE.%26aulast%3DBorrello%26aufirst%3DM.%2BG.%26aulast%3DSariola%26aufirst%3DH.%26atitle%3DRET%2520tyrosine%2520kinase%2520signaling%2520in%2520development%2520and%2520cancer%26jtitle%3DCytokine%2520Growth%2520Factor%2520Rev.%26date%3D2005%26volume%3D16%26spage%3D441%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Asai, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jijiwa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enomoto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichiahara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakumo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, M.</span><span> </span><span class="NLM_article-title">RET receptor signaling: dysfunction in thyroid cancer and Hirschsprung’s disease</span> <span class="citation_source-journal">Pathol. Int.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">56</span> <span class="NLM_fpage">164</span> <span class="NLM_lpage">172</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm8007823&amp;key=10.1111%2Fj.1440-1827.2006.01942.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm8007823&amp;key=16634961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADC%252BD28XnsFGjtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2006&pages=164-172&author=N.+Asaiauthor=M.+Jijiwaauthor=A.+Enomotoauthor=K.+Hawaiauthor=K.+Maedaauthor=M.+Ichiaharaauthor=Y.+Murakumoauthor=M.+Takahashi&title=RET+receptor+signaling%3A+dysfunction+in+thyroid+cancer+and+Hirschsprung%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">RET receptor signaling: dysfunction in thyroid cancer and Hirschsprung's disease</span></div><div class="casAuthors">Asai, Naoya; Jijiwa, Mayumi; Enomoto, Atsushi; Kawai, Kumi; Maeda, Kengo; Ichiahara, Masatoshi; Murakumo, Yoshiki; Takahashi, Masahide</div><div class="citationInfo"><span class="NLM_cas:title">Pathology International</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">164-172</span>CODEN:
                <span class="NLM_cas:coden">PITEES</span>;
        ISSN:<span class="NLM_cas:issn">1320-5463</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">A review.  Gain-of-function mutations within the receptor tyrosine kinase gene RET cause inherited and non-inherited thyroid cancer.  Somatic gene rearrangements of RET have been found in papillary thyroid carcinoma and germline point mutations in multiple endocrine neoplasia (MEN) types 2A and 2B and familial medullary thyroid carcinoma (FMTC).  Conversely, loss-of-function mutations are responsible for the development of Hirschsprung's disease, a congenital malformation of the enteric nervous system.  Comparison between normal RET signaling activated by the RET ligand glial cell line-derived neurotrophic factor (GDNF) and abnormal RET signaling caused by various mutations has led to a deeper understanding of disease mechanisms.  The focus of the present review is on recent progress in the study of RET signaling dysfunction in human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSGspNKvmRNLVg90H21EOLACvtfcHk0lgBljELlBNB-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnsFGjtL0%253D&md5=752bfaa58e6836866e45d5ef72051eff</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1111%2Fj.1440-1827.2006.01942.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1440-1827.2006.01942.x%26sid%3Dliteratum%253Aachs%26aulast%3DAsai%26aufirst%3DN.%26aulast%3DJijiwa%26aufirst%3DM.%26aulast%3DEnomoto%26aufirst%3DA.%26aulast%3DHawai%26aufirst%3DK.%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DIchiahara%26aufirst%3DM.%26aulast%3DMurakumo%26aufirst%3DY.%26aulast%3DTakahashi%26aufirst%3DM.%26atitle%3DRET%2520receptor%2520signaling%253A%2520dysfunction%2520in%2520thyroid%2520cancer%2520and%2520Hirschsprung%25E2%2580%2599s%2520disease%26jtitle%3DPathol.%2520Int.%26date%3D2006%26volume%3D56%26spage%3D164%26epage%3D172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Murakumo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jijiwa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asai, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichihara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, M.</span><span> </span><span class="NLM_article-title">RET and neuroendocrine tumors</span> <span class="citation_source-journal">Pituitary</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">9</span> <span class="NLM_fpage">179</span> <span class="NLM_lpage">192</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=179-192&author=Y.+Murakumoauthor=M.+Jijiwaauthor=N.+Asaiauthor=M.+Ichiharaauthor=M.+Takahashi&title=RET+and+neuroendocrine+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurakumo%26aufirst%3DY.%26aulast%3DJijiwa%26aufirst%3DM.%26aulast%3DAsai%26aufirst%3DN.%26aulast%3DIchihara%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DM.%26atitle%3DRET%2520and%2520neuroendocrine%2520tumors%26jtitle%3DPituitary%26date%3D2006%26volume%3D9%26spage%3D179%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Rosa, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ismael, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dal Lago, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awada, A.</span><span> </span><span class="NLM_article-title">Molecular-targeted therapies: lessons from years of clinical development</span> <span class="citation_source-journal">Cancer Treat. Rev.</span><span class="NLM_year" style="font-weight: bold;">2008</span> <span class="NLM_volume">34</span> <span class="NLM_fpage">61</span> <span class="NLM_lpage">80</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm8007823&amp;key=10.1016%2Fj.ctrv.2007.07.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm8007823&amp;key=17826917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVKhtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2008&pages=61-80&author=D.+D.+Rosaauthor=G.+Ismaelauthor=L.+Dal+Lagoauthor=A.+Awada&title=Molecular-targeted+therapies%3A+lessons+from+years+of+clinical+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular-targeted therapies: Lessons from years of clinical development</span></div><div class="casAuthors">Rosa, Daniela D.; Ismael, Gustavo; Dal Lago, Lissandra; Awada, Ahmad</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-80</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Summary: Over the past decade, mol.-targeted therapies have been added to cytotoxic and anti-endocrine drugs in the treatment of cancer, with the aim to target the mol. pathways that underlie the carcinogenic process and maintain the cancer phenotype.  Success with some of these agents has suggested that identification and validation of the drug target is the starting point for the route of development of active, safe and effective drugs.  Main mol. targets used to the development of anticancer drugs are cell surface receptors, signal transduction pathways, gene transcription targets, ubiquitin-proteasome/heat shock proteins and tumor microenvironment components (esp. antiangiogenic agents).  Here, we review the development of the main mol. targeted non-cytotoxic agents studied in cancer, highlighting lessons derived from the development of these novel drugs and proposing new horizons for the clin. development of mol.-targeted therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvnza4h4gL1bVg90H21EOLACvtfcHk0lgBljELlBNB-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVKhtL4%253D&md5=548e8f0a529befa67f7e7382cdaf02ec</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2007.07.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2007.07.019%26sid%3Dliteratum%253Aachs%26aulast%3DRosa%26aufirst%3DD.%2BD.%26aulast%3DIsmael%26aufirst%3DG.%26aulast%3DDal%2BLago%26aufirst%3DL.%26aulast%3DAwada%26aufirst%3DA.%26atitle%3DMolecular-targeted%2520therapies%253A%2520lessons%2520from%2520years%2520of%2520clinical%2520development%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2008%26volume%3D34%26spage%3D61%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Drosten, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pützer, B. M.</span><span> </span><span class="NLM_article-title">Mechanisms of disease: cancer targeting and the impact of oncogenic RET for medullary thyroid carcinoma therapy</span> <span class="citation_source-journal">Nat. Clin. Pract.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">3</span> <span class="NLM_fpage">564</span> <span class="NLM_lpage">574</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm8007823&amp;key=10.1038%2Fncponc0610" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm8007823&amp;key=17019434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFKqtb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=564-574&author=M.+Drostenauthor=B.+M.+P%C3%BCtzer&title=Mechanisms+of+disease%3A+cancer+targeting+and+the+impact+of+oncogenic+RET+for+medullary+thyroid+carcinoma+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of disease: cancer targeting and the impact of oncogenic RET for medullary thyroid carcinoma therapy</span></div><div class="casAuthors">Drosten, Matthias; Puetzer, Brigitte M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Clinical Practice Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">564-574</span>CODEN:
                <span class="NLM_cas:coden">NCPOB5</span>;
        ISSN:<span class="NLM_cas:issn">1743-4254</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Growing evidence supports the concept of oncogene dependence for cancer development; inhibition of the initiating oncogene can result in reversion of the neoplastic phenotype.  The outstanding role of the RET proto-oncogene in the development of medullary thyroid carcinoma (MTC) is well established.  With the emerging knowledge concerning the signal transduction pathways leading to subsequent neoplastic transformation, oncogenic activated RET becomes a highly attractive target for selective cancer therapy.  A variety of novel approaches that target RET directly or indirectly have recently emerged and an increasing no. are currently being assessed in clin. trials.  In view of these findings, it becomes strikingly obvious that inhibition of RET oncogene function can be a viable option for the treatment of MTC.  We summarize the current evidence for RET involvement in the etiol. of MTC, and the therapeutic targeting of this process in preclin. and clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1uD4yBa4RELVg90H21EOLACvtfcHk0lh5tVuvC7UvGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFKqtb3O&md5=dccd7e93162fa5750f7b2b3666f60b0f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fncponc0610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncponc0610%26sid%3Dliteratum%253Aachs%26aulast%3DDrosten%26aufirst%3DM.%26aulast%3DP%25C3%25BCtzer%26aufirst%3DB.%2BM.%26atitle%3DMechanisms%2520of%2520disease%253A%2520cancer%2520targeting%2520and%2520the%2520impact%2520of%2520oncogenic%2520RET%2520for%2520medullary%2520thyroid%2520carcinoma%2520therapy%26jtitle%3DNat.%2520Clin.%2520Pract.%26date%3D2006%26volume%3D3%26spage%3D564%26epage%3D574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">De Groot, J. W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Links, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plukker, J. T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lips, C. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofstra, R. M. W.</span><span> </span><span class="NLM_article-title">RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">27</span> <span class="NLM_fpage">535</span> <span class="NLM_lpage">560</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm8007823&amp;key=10.1210%2Fer.2006-0017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm8007823&amp;key=16849421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVelurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=535-560&author=J.+W.+B.+De+Grootauthor=T.+P.+Linksauthor=J.+T.+M.+Plukkerauthor=C.+J.+M.+Lipsauthor=R.+M.+W.+Hofstra&title=RET+as+a+diagnostic+and+therapeutic+target+in+sporadic+and+hereditary+endocrine+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors</span></div><div class="casAuthors">de Groot, Jan Willem B.; Links, Thera P.; Plukker, John T. M.; Lips, Cornelis J. M.; Hofstra, Robert M. W.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">535-560</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  The RET gene encodes a receptor tyrosine kinase that is expressed in neural crest-derived cell lineages.  The RET receptor plays a crucial role in regulating cell proliferation, migration, differentiation, and survival through embryogenesis.  Activating mutations in RET lead to the development of several inherited and noninherited diseases.  Germline point mutations are found in the cancer syndromes multiple endocrine neoplasia (MEN) type 2, including MEN 2A and 2B, and familial medullary thyroid carcinoma.  These syndromes are autosomal dominantly inherited.  The identification of mutations assocd. with these syndromes has led to genetic testing to identify patients at risk for MEN 2 and familial medullary thyroid carcinoma and subsequent implementation of prophylactic thyroidectomy in mutation carriers.  In addn., more than 10 somatic rearrangements of RET have been identified from papillary thyroid carcinomas.  These mutations, as those found in MEN 2, induce oncogenic activation of the RET tyrosine kinase domain via different mechanisms, making RET an excellent candidate for the design of mol. targeted therapy.  Recently, various kinds of therapeutic approaches, such as tyrosine kinase inhibition, gene therapy with dominant neg. RET mutants, monoclonal antibodies against oncogene products, and nuclease-resistant aptamers that recognize and inhibit RET have been developed.  The use of these strategies in preclin. models has provided evidence that RET is indeed a potential target for selective cancer therapy.  However, a clin. useful therapeutic option for treating patients with RET-assocd. cancer is still not available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1ULqQfojz0rVg90H21EOLACvtfcHk0lh5tVuvC7UvGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvVelurc%253D&md5=69053deda18ea7daf973f11828663cc7</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1210%2Fer.2006-0017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2006-0017%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BGroot%26aufirst%3DJ.%2BW.%2BB.%26aulast%3DLinks%26aufirst%3DT.%2BP.%26aulast%3DPlukker%26aufirst%3DJ.%2BT.%2BM.%26aulast%3DLips%26aufirst%3DC.%2BJ.%2BM.%26aulast%3DHofstra%26aufirst%3DR.%2BM.%2BW.%26atitle%3DRET%2520as%2520a%2520diagnostic%2520and%2520therapeutic%2520target%2520in%2520sporadic%2520and%2520hereditary%2520endocrine%2520tumors%26jtitle%3DEndocr.%2520Rev.%26date%3D2006%26volume%3D27%26spage%3D535%26epage%3D560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Cuccuru, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassinelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratesi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortoreto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrangolini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seregni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laccabue, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanchi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunino, F.</span><span> </span><span class="NLM_article-title">Cellular effects and antitumor activity of RET inhibitor RPI-1 on MEN2A-associated medullary thyroid carcinoma</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">96</span> <span class="NLM_fpage">1006</span> <span class="NLM_lpage">1014</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm8007823&amp;key=10.1093%2Fjnci%2Fdjh184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm8007823&amp;key=15240784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsFyisrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2004&pages=1006-1014&author=G.+Cuccuruauthor=C.+Lanziauthor=G.+Cassinelliauthor=G.+Pratesiauthor=M.+Tortoretoauthor=G.+Petrangoliniauthor=E.+Seregniauthor=A.+Martinettiauthor=D.+Laccabueauthor=C.+Zanchiauthor=F.+Zunino&title=Cellular+effects+and+antitumor+activity+of+RET+inhibitor+RPI-1+on+MEN2A-associated+medullary+thyroid+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular Effects and Antitumor Activity of RET Inhibitor RPI-1 on MEN2A-Associated Medullary Thyroid Carcinoma</span></div><div class="casAuthors">Cuccuru, Giuditta; Lanzi, Cinzia; Cassinelli, Giuliana; Pratesi, Graziella; Tortoreto, Monica; Petrangolini, Giovanna; Seregni, Ettore; Martinetti, Antonia; Laccabue, Diletta; Zanchi, Chiara; Zunino, Franco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1006-1014</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: The RET proto-oncogene encodes a receptor tyrosine kinase.  RET oncogenes arise through sporadic and inherited gene mutations and are involved in the etiopathogenesis of medullary thyroid carcinoma, a cancer that responds poorly to conventional chemotherapy.  Medullary thyroid carcinoma is a component of multiple endocrine neoplasia type 2 or MEN2 syndromes.  Methods: We investigated the cellular effects of RPI-1, a novel 2-indolinone Ret tyrosine kinase inhibitor on cells that express RET C634 oncogenic mutants common in the MEN2A syndrome: NIH3T3 fibroblasts transfected with RETC634R and human medullary thyroid carcinoma TT cells that express endogenous RETC634W.  RPI-1 antiproliferative activity was detd. by cell proliferation and anchorage-independent growth assays.  Expression and phosphorylation of Ret and of proteins involved in downstream signaling pathways were examd. by immunoblotting.  Antitumor activity of oral RPI-1 treatment was tested by using two dosing levels in nude mice bearing s.c. TT xenograft tumors.  All statistical tests were two-sided.  Results: The RPI-1 IC50 value for cell proliferation was 3.6 μM (95% confidence interval [CI] = 1.8 to 5.4 μM) in NIH3T3 cells expressing the Ret mutant compared with 16 μM (95% CI = 12.3 to 19.7 μM) in non-transfected NIH3T3 cells, and that for colony formation in soft agar was 2.4 μM (95% CI = 0.8 to 4.0 μM) and 26 μM (95% CI = 17 to 35 μM) in RET mutant-transfected and H-RAS-transfected NIH3T3 cells, resp.  In NIH3T3 cells expressing the Ret mutant, Ret protein and tyrosine phosphorylation were undetectable after 24 h of RPI-1 treatment.  In TT cells, RPI-1 inhibited proliferation, Ret tyrosine phosphorylation, Ret protein expression, and the activation of PLCγ, ERKs and AKT.  In mice, oral daily RPI-1 treatment inhibited the tumor growth of TT xenografts by 81% (P<.001 vs. control mice) and reduced the plasma levels of the specific biomarker calcitonin (P = .01 vs. control mice).  Twenty-five percent of RPI-1-treated mice were tumor-free.  Conclusions: Ret oncoproteins represent exploitable targets for therapeutic intervention in MEN2A-assocd. medullary thyroid carcinoma.  The antitumor efficacy and oral bioavailability of RPI-1 support its therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPDUJ-ksbk9LVg90H21EOLACvtfcHk0lh5tVuvC7UvGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsFyisrk%253D&md5=66cb92214834e20a39e974d0e1009020</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjh184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjh184%26sid%3Dliteratum%253Aachs%26aulast%3DCuccuru%26aufirst%3DG.%26aulast%3DLanzi%26aufirst%3DC.%26aulast%3DCassinelli%26aufirst%3DG.%26aulast%3DPratesi%26aufirst%3DG.%26aulast%3DTortoreto%26aufirst%3DM.%26aulast%3DPetrangolini%26aufirst%3DG.%26aulast%3DSeregni%26aufirst%3DE.%26aulast%3DMartinetti%26aufirst%3DA.%26aulast%3DLaccabue%26aufirst%3DD.%26aulast%3DZanchi%26aufirst%3DC.%26aulast%3DZunino%26aufirst%3DF.%26atitle%3DCellular%2520effects%2520and%2520antitumor%2520activity%2520of%2520RET%2520inhibitor%2520RPI-1%2520on%2520MEN2A-associated%2520medullary%2520thyroid%2520carcinoma%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2004%26volume%3D96%26spage%3D1006%26epage%3D1014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Drosten, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilken, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Böckmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rödicker, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mise, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cranston, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahmen, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponder, B. A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pützer, B. M.</span><span> </span><span class="NLM_article-title">Role of MEN2A-derived RET in maintenance and proliferation of medullary thyroid carcinoma</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">96</span> <span class="NLM_fpage">1231</span> <span class="NLM_lpage">1239</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm8007823&amp;key=15316058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntFamtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2004&pages=1231-1239&author=M.+Drostenauthor=G.+Hilkenauthor=M.+B%C3%B6ckmannauthor=F.+R%C3%B6dickerauthor=N.+Miseauthor=A.+N.+Cranstonauthor=U.+Dahmenauthor=B.+A.+J.+Ponderauthor=B.+M.+P%C3%BCtzer&title=Role+of+MEN2A-derived+RET+in+maintenance+and+proliferation+of+medullary+thyroid+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Role of MEN2A-derived RET in maintenance and proliferation of medullary thyroid carcinoma</span></div><div class="casAuthors">Drosten, Matthias; Hilken, Gero; Boeckmann, Miriam; Roedicker, Florian; Mise, Nikica; Cranston, Aaron N.; Dahmen, Uta; Ponder, Bruce A. J.; Puetzer, Brigitte M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1231-1239</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Dominant-activating mutations in the RET protooncogene, a receptor tyrosine kinase, have been identified as a cause of medullary thyroid carcinoma.  Such oncogenic RET mutations induce its ligand-independent constitutive trans-autophosphorylation.  We investigated the role of endogenous oncogenic RET autophosphorylation in maintaining the neoplastic phenotype in medullary thyroid carcinoma cells and orthotopic medullary thyroid carcinomas in RET transgenic mice.  We constructed adenoviral vectors expressing a dominant-neg. truncated form of RET, termed RETΔTK, and analyzed its effect on cell viability, apoptosis, and proliferation of TT medullary thyroid carcinoma cells.  We investigated the effect of RETΔTK on downstream signaling by assessing alterations in phosphorylation or in gene expression.  The effect of RETΔTK in primary medullary thyroid carcinomas in transgenic mice was assessed by monitoring tumor growth.  All statistical tests were two-sided.  Cell viability was reduced.  Phosphorylation of Akt and extracellular signal-regulated kinase (ERK), components of downstream signal transduction pathways, was abolished, and cell cycle progression was reduced.  Expression of cell cycle regulator cyclin D1 was decreased, and expression of cell cyle regulators p21CIP1/WAF1 and p27KIP1 was increased.  Apoptosis was stimulated and concurrently the expression of BCL-2 was decreased.  All in vitro expts. compared TT cells expressing RETΔTK with untreated control cells or control vector-treated cells.  Furthermore, 2 wk after injecting adenovirus-carrying RETΔTK into thyroid glands of transgenic mice with orthotopic medullary thyroid carcinoma, tumors were statistically significantly smaller than their initial size in mice treated with RETΔTK (43.6%, 95% confidence interval [CI] = 30.7% to 56.5%; P = .010; two-sided unpaired Student's t test), whereas tumors in mice treated with a control vector were larger than their initial size (139.8%, 95% CI = 120.3% to 159.3%; P<.001).  Selective disruption of oncogenic RET signaling in medullary thyroid carcinoma in vitro and in vivo is assocd. with loss of the neoplastic phenotype of medullary thyroid carcinoma and should be investigated further as the basis for new therapeutic approaches for this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAgWjjNIpa6LVg90H21EOLACvtfcHk0lgOj4mRIQT8NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntFamtrc%253D&md5=e3fd5d63197d694180b13d2bbec88a3c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDrosten%26aufirst%3DM.%26aulast%3DHilken%26aufirst%3DG.%26aulast%3DB%25C3%25B6ckmann%26aufirst%3DM.%26aulast%3DR%25C3%25B6dicker%26aufirst%3DF.%26aulast%3DMise%26aufirst%3DN.%26aulast%3DCranston%26aufirst%3DA.%2BN.%26aulast%3DDahmen%26aufirst%3DU.%26aulast%3DPonder%26aufirst%3DB.%2BA.%2BJ.%26aulast%3DP%25C3%25BCtzer%26aufirst%3DB.%2BM.%26atitle%3DRole%2520of%2520MEN2A-derived%2520RET%2520in%2520maintenance%2520and%2520proliferation%2520of%2520medullary%2520thyroid%2520carcinoma%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2004%26volume%3D96%26spage%3D1231%26epage%3D1239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Petrangolini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuccuru, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortoreto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratesi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassinelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunino, F.</span><span> </span><span class="NLM_article-title">Apoptotic cell death induction and angiogenesis inhibition in large established medullary thyroid carcinoma xenografts by Ret inhibitor RPI-1</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">72</span> <span class="NLM_fpage">405</span> <span class="NLM_lpage">414</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2006&pages=405-414&author=G.+Petrangoliniauthor=G.+Cuccuruauthor=C.+Lanziauthor=M.+Tortoretoauthor=S.+Bellucoauthor=G.+Pratesiauthor=G.+Cassinelliauthor=F.+Zunino&title=Apoptotic+cell+death+induction+and+angiogenesis+inhibition+in+large+established+medullary+thyroid+carcinoma+xenografts+by+Ret+inhibitor+RPI-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPetrangolini%26aufirst%3DG.%26aulast%3DCuccuru%26aufirst%3DG.%26aulast%3DLanzi%26aufirst%3DC.%26aulast%3DTortoreto%26aufirst%3DM.%26aulast%3DBelluco%26aufirst%3DS.%26aulast%3DPratesi%26aufirst%3DG.%26aulast%3DCassinelli%26aufirst%3DG.%26aulast%3DZunino%26aufirst%3DF.%26atitle%3DApoptotic%2520cell%2520death%2520induction%2520and%2520angiogenesis%2520inhibition%2520in%2520large%2520established%2520medullary%2520thyroid%2520carcinoma%2520xenografts%2520by%2520Ret%2520inhibitor%2520RPI-1%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2006%26volume%3D72%26spage%3D405%26epage%3D414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Sharma, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Settleman, J.</span><span> </span><span class="NLM_article-title">Oncogene addiction: setting the stage for molecularly targeted cancer therapy</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">21</span> <span class="NLM_fpage">3214</span> <span class="NLM_lpage">3231</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm8007823&amp;key=10.1101%2Fgad.1609907" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm8007823&amp;key=18079171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVOrsb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=3214-3231&author=S.+V.+Sharmaauthor=J.+Settleman&title=Oncogene+addiction%3A+setting+the+stage+for+molecularly+targeted+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogene addiction: setting the stage for molecularly targeted cancer therapy</span></div><div class="casAuthors">Sharma, Sreenath V.; Settleman, Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">3214-3231</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review.  In pugilistic parlance, the one-two punch is a devastating combination of blows, with the first punch setting the stage and the second delivering the knock-out.  This analogy can be extended to molecularly targeted cancer therapies, with oncogene addiction serving to set the stage for tumor cell killing by a targeted therapeutic agent.  While in vitro and in vivo examples abound documenting the existence of this phenomenon, the mechanistic underpinnings that govern oncogene addiction are just beginning to emerge.  Our current inability to fully exploit this weakness of cancer cells stems from an incomplete understanding of oncogene addiction, which nonetheless represents one of the rare chinks in the formidable armor of cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk4ia5nlRCDbVg90H21EOLACvtfcHk0lgOj4mRIQT8NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVOrsb7J&md5=e367eb201f849ecac6c29ce7f80138fa</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1101%2Fgad.1609907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.1609907%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DS.%2BV.%26aulast%3DSettleman%26aufirst%3DJ.%26atitle%3DOncogene%2520addiction%253A%2520setting%2520the%2520stage%2520for%2520molecularly%2520targeted%2520cancer%2520therapy%26jtitle%3DGenes%2520Dev.%26date%3D2007%26volume%3D21%26spage%3D3214%26epage%3D3231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Cassinelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pensa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambetta, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuccuru, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassinis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratesi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polizzi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortoreto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunino, F.</span><span> </span><span class="NLM_article-title">Clavilactones, a novel class of tyrosine kinase inhibitors of fungal origin</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">59</span> <span class="NLM_fpage">1539</span> <span class="NLM_lpage">1547</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2000&pages=1539-1547&author=G.+Cassinelliauthor=C.+Lanziauthor=T.+Pensaauthor=R.+A.+Gambettaauthor=G.+Nasiniauthor=G.+Cuccuruauthor=M.+Cassinisauthor=G.+Pratesiauthor=D.+Polizziauthor=M.+Tortoretoauthor=F.+Zunino&title=Clavilactones%2C+a+novel+class+of+tyrosine+kinase+inhibitors+of+fungal+origin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCassinelli%26aufirst%3DG.%26aulast%3DLanzi%26aufirst%3DC.%26aulast%3DPensa%26aufirst%3DT.%26aulast%3DGambetta%26aufirst%3DR.%2BA.%26aulast%3DNasini%26aufirst%3DG.%26aulast%3DCuccuru%26aufirst%3DG.%26aulast%3DCassinis%26aufirst%3DM.%26aulast%3DPratesi%26aufirst%3DG.%26aulast%3DPolizzi%26aufirst%3DD.%26aulast%3DTortoreto%26aufirst%3DM.%26aulast%3DZunino%26aufirst%3DF.%26atitle%3DClavilactones%252C%2520a%2520novel%2520class%2520of%2520tyrosine%2520kinase%2520inhibitors%2520of%2520fungal%2520origin%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2000%26volume%3D59%26spage%3D1539%26epage%3D1547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Kundra, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burman, K. D.</span><span> </span><span class="NLM_article-title">Thyroid cancer molecular signaling pathways and use of targeted therapy</span> <span class="citation_source-journal">Endocrinol. Metab. Clin. N. Am.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">36</span> <span class="NLM_fpage">839</span> <span class="NLM_lpage">853</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm8007823&amp;key=10.1016%2Fj.ecl.2007.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm8007823&amp;key=17673131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFCgsrjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2007&pages=839-853&author=P.+Kundraauthor=K.+D.+Burman&title=Thyroid+cancer+molecular+signaling+pathways+and+use+of+targeted+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Thyroid cancer molecular signaling pathways and use of targeted therapy</span></div><div class="casAuthors">Kundra, Priya; Burman, Kenneth D.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology and Metabolism Clinics of North America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">839-853</span>CODEN:
                <span class="NLM_cas:coden">ECNAER</span>;
        ISSN:<span class="NLM_cas:issn">0889-8529</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review on agents targeted to inhibit crit. pathways in thyroid tumorigenesis or progression, including agents with different but often overlapping mechanisms of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8mlbwWPKI97Vg90H21EOLACvtfcHk0lg6HKAa8hEd3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFCgsrjI&md5=ea1c97b89043ce83614fdde1cff4dbd0</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.ecl.2007.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ecl.2007.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DKundra%26aufirst%3DP.%26aulast%3DBurman%26aufirst%3DK.%2BD.%26atitle%3DThyroid%2520cancer%2520molecular%2520signaling%2520pathways%2520and%2520use%2520of%2520targeted%2520therapy%26jtitle%3DEndocrinol.%2520Metab.%2520Clin.%2520N.%2520Am.%26date%3D2007%26volume%3D36%26spage%3D839%26epage%3D853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Deshpande, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gettinger, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sosa, J. A.</span><span> </span><span class="NLM_article-title">Novel chemotherapy options for advanced thyroid tumors: small molecules offer great hope</span> <span class="citation_source-journal">Curr. Opin. Oncol.</span><span class="NLM_year" style="font-weight: bold;">2008</span> <span class="NLM_volume">20</span> <span class="NLM_fpage">19</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm8007823&amp;key=18043252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGns7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2008&pages=19-24&author=H.+A.+Deshpandeauthor=S.+N.+Gettingerauthor=J.+A.+Sosa&title=Novel+chemotherapy+options+for+advanced+thyroid+tumors%3A+small+molecules+offer+great+hope"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Novel chemotherapy options for advanced thyroid tumors: small molecules offer great hope</span></div><div class="casAuthors">Deshpande, Hari A.; Gettinger, Scott N.; Sosa, Julie Ann</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Oncology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-24</span>CODEN:
                <span class="NLM_cas:coden">CUOOE8</span>;
        ISSN:<span class="NLM_cas:issn">1040-8746</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: Endocrine tumors are often overlooked in medical oncol. discussions, as many of them are effectively cured by surgery alone or surgery plus an ablative radiation therapy.  For the rare aggressive endocrine cancers that are widely metastatic or rapidly progressive, however, the role of the medical oncologist becomes more important.  To date, conventional chemotherapy has not had a significant impact on the natural history of these malignancies.  This has led to the evaluation of novel compds.; some of which have already entered into randomized clin. trials.  This review will focus on the advances made in the treatment of advanced thyroid cancer, the commonest of endocrine malignancies.  Recent findings: A growing understanding of mol. oncol. has allowed the development of targeted agents in different types of thyroid cancer.  Some agents presently being evaluated in clin. trials include inhibitors of angiogenesis (sorafenib, CA4P, axitinib and vandetanib), the epidermal growth factor receptor (gefitinib, vandetanib) and RET protein (vandetanib).  Preliminary results from these studies will be reviewed in this paper.  Summary: The recent explosion of targeted agents available for study has generated enthusiasm for oncologists treating thyroid cancer.  Antiangiogenesis strategies in particular appear promising.  RET inhibition in medullary thyroid cancer is also being explored.  Further clin. trials will det. which of these will enter the clinic in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8ujCfb0WIgrVg90H21EOLACvtfcHk0lg6HKAa8hEd3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGns7zP&md5=02dfdd36fea65d8c74a8407254f6313a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeshpande%26aufirst%3DH.%2BA.%26aulast%3DGettinger%26aufirst%3DS.%2BN.%26aulast%3DSosa%26aufirst%3DJ.%2BA.%26atitle%3DNovel%2520chemotherapy%2520options%2520for%2520advanced%2520thyroid%2520tumors%253A%2520small%2520molecules%2520offer%2520great%2520hope%26jtitle%3DCurr.%2520Opin.%2520Oncol.%26date%3D2008%26volume%3D20%26spage%3D19%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Schlumberger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlomagno, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baudin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bidart, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santoro, M.</span><span> </span><span class="NLM_article-title">New therapeutic approaches to treat medullary thyroid carcinoma</span> <span class="citation_source-journal">Nat. Clin. Pract.</span><span class="NLM_year" style="font-weight: bold;">2008</span> <span class="NLM_volume">4</span> <span class="NLM_fpage">22</span> <span class="NLM_lpage">32</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm8007823&amp;key=10.1038%2Fncpendmet0717" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVegtbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=22-32&author=M.+Schlumbergerauthor=F.+Carlomagnoauthor=E.+Baudinauthor=J.+M.+Bidartauthor=M.+Santoro&title=New+therapeutic+approaches+to+treat+medullary+thyroid+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">New therapeutic approaches to treat medullary thyroid carcinoma</span></div><div class="casAuthors">Schlumberger, Martin; Carlomagno, Francesca; Baudin, Eric; Bidart, Jean Michel; Santoro, Massimo</div><div class="citationInfo"><span class="NLM_cas:title">Nature Clinical Practice Endocrinology & Metabolism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-32</span>CODEN:
                <span class="NLM_cas:coden">NCPEDB</span>;
        ISSN:<span class="NLM_cas:issn">1745-8366</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Medullary thyroid carcinoma (MTC) accounts for up to 8% of all thyroid cancers.  Although primary surgery is curative in the vast majority of patients treated at an early stage, disease can persist or recur with deleterious effects on quality of life.  Local and distant metastases can occur and are the major causes of mortality.  Reoperation, embolization, and perhaps radiotherapy can improve the outcome for some patients who are not cured by primary surgery, but there is a need for novel treatments.  No comprehensive clin. trial data are available on conventional cytotoxic agents for the treatment of MTC.  Patients with distant metastases, in particular, might benefit from several novel compds. directed against angiogenesis and mol. targets in tumor cells, such as products of the proto-oncogene RET and mutants of it, and other signaling components.  Well-conducted clin. trials are needed to assess and optimize these treatment strategies, and this article outlines how such trials should be conducted.  Although RET mutations are common in hereditary MTC and can occur in some cases of sporadic MTC, knowledge of other mol. defects assocd. with the development of MTC should reveal new targets for therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjZeeRyLjygbVg90H21EOLACvtfcHk0lg6HKAa8hEd3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVegtbfL&md5=11806d18927f568bd963791a65d9e662</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fncpendmet0717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncpendmet0717%26sid%3Dliteratum%253Aachs%26aulast%3DSchlumberger%26aufirst%3DM.%26aulast%3DCarlomagno%26aufirst%3DF.%26aulast%3DBaudin%26aufirst%3DE.%26aulast%3DBidart%26aufirst%3DJ.%2BM.%26aulast%3DSantoro%26aufirst%3DM.%26atitle%3DNew%2520therapeutic%2520approaches%2520to%2520treat%2520medullary%2520thyroid%2520carcinoma%26jtitle%3DNat.%2520Clin.%2520Pract.%26date%3D2008%26volume%3D4%26spage%3D22%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">App, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">1998</span> <span class="NLM_volume">41</span> <span class="NLM_fpage">2588</span> <span class="NLM_lpage">2603</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980123i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADyaK1cXkt12jtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=2588-2603&author=L.+Sunauthor=N.+Tranauthor=F.+Tangauthor=H.+Appauthor=P.+Hirthauthor=G.+McMahonauthor=C.+Tang&title=Synthesis+and+biological+evaluations+of+3-substituted+indolin-2-ones%3A+a+novel+class+of+tyrosine+kinase+inhibitors+that+exhibit+selectivity+toward+particular+receptor+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluations of 3-Substituted Indolin-2-ones: A Novel Class of Tyrosine Kinase Inhibitors That Exhibit Selectivity toward Particular Receptor Tyrosine Kinases</span></div><div class="casAuthors">Sun, Li; Tran, Ngoc; Tang, Flora; App, Harald; Hirth, Peter; McMahon, Gerald; Tang, Cho</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2588-2603</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">3-Substituted indolin-2-ones have been designed and synthesized as a novel class of tyrosine kinase inhibitors which exhibit selectivity toward different receptor tyrosine kinases (RTKs).  These compds. have been evaluated for their relative inhibitory properties against a panel of RTKs in intact cells.  By modifying the 3-substituted indolin-2-ones, we have identified compds. which showed selective inhibition of the ligand-dependent autophosphorylation of various RTKs at submicromolar levels in cells.  Structure-activity anal. for these compds. and their relative potency and selectivity to inhibit particular RTKs has detd. that (1) 3-[(five-membered heteroaryl ring)methylidenyl]indolin-2-ones are highly specific against the VEGF (Flk-1) RTK activity, (2) 3-(substituted benzylidenyl)indolin-2-ones contg. bulky group(s) in the Ph ring at the C-3 position of indolin-2-ones showed high selectivity toward the EGF and Her-2 RTKs, and (3) the compd. contg. an extended side chain at the C-3 position of the indolin-2-one exhibited high potency and selectivity when tested against the PDGF and VEGF (Flk-1) RTKs.  Recent published crystallog. data for two of these 3-substituted indolin-2-ones provides a rationale to suggest that these compds. may bind in the ATP binding pocket of RTKs.  The structure-activity anal. supports the use of subsets of these compds. as specific chem. leads for the development of RTK-specific drugs with broad application for the treatment of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJoPixq8Am5rVg90H21EOLACvtfcHk0lgrtg1Ct64HBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkt12jtrw%253D&md5=536302b717170a630008dac14832204c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm980123i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980123i%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26aulast%3DTran%26aufirst%3DN.%26aulast%3DTang%26aufirst%3DF.%26aulast%3DApp%26aufirst%3DH.%26aulast%3DHirth%26aufirst%3DP.%26aulast%3DMcMahon%26aufirst%3DG.%26aulast%3DTang%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520biological%2520evaluations%2520of%25203-substituted%2520indolin-2-ones%253A%2520a%2520novel%2520class%2520of%2520tyrosine%2520kinase%2520inhibitors%2520that%2520exhibit%2520selectivity%2520toward%2520particular%2520receptor%2520tyrosine%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D2588%26epage%3D2603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Lanzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassinelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuccuru, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaffaroni, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supino, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vignati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanchi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunino, F.</span><span> </span><span class="NLM_article-title">Inactivation of Ret/Ptc1 oncoprotein and inhibition of papillary thyroid carcinoma cell proliferation by indolinone RPI-1</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">60</span> <span class="NLM_fpage">1449</span> <span class="NLM_lpage">1459</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm8007823&amp;key=10.1007%2Fs00018-003-2381-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm8007823&amp;key=12943231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1Witrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2003&pages=1449-1459&author=C.+Lanziauthor=G.+Cassinelliauthor=G.+Cuccuruauthor=N.+Zaffaroniauthor=R.+Supinoauthor=S.+Vignatiauthor=C.+Zanchiauthor=M.+Yamamotoauthor=F.+Zunino&title=Inactivation+of+Ret%2FPtc1+oncoprotein+and+inhibition+of+papillary+thyroid+carcinoma+cell+proliferation+by+indolinone+RPI-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Inactivation of Ret/Ptc1 oncoprotein and inhibition of papillary thyroid carcinoma cell proliferation by indolinone RPI-1</span></div><div class="casAuthors">Lanzi, C.; Cassinelli, G.; Cuccuru, G.; Zaffaroni, N.; Supino, R.; Vignati, S.; Zanchi, C.; Yamamoto, M.; Zunino, F.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1449-1459</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">Genetic alterations causing oncogenic activation of the RET gene are recognized as pathogenic events in papillary and medullary thyroid carcinomas.  Inhibition of Ret oncoprotein functions could thereby represent a specific therapeutic approach.  We previously described the inhibitory activity of the 2-indolinone deriv. RPI-1 (formerly Cpd1) on the tyrosine kinase activity and transforming ability of the products of the RET/PTC1 oncogene exogenously expressed in murine cells.  In the present study, we investigated the effects of RPI-1 in the human papillary thyroid carcinoma cell line TPC-1 spontaneously harboring the RET/PTC1 rearrangement.  Treatment with RPI-1 inhibited cell proliferation and induced accumulation of cells at the G2 cell cycle phase.  In treated cells, Ret/Ptc1 tyrosine phosphorylation was abolished along with its binding to She and phospholipase Cγ, thereby indicating abrogation of constitutive signaling mediated by the oncoprotein.  Activation of JNK2 and AKT was abolished, thus supporting the drug inhibitory efficacy on downstream pathways.  In addn., cell growth inhibition was assocd. with a redn. in telomerase activity by nearly 85%.  These findings in a cellular context relevant to the pathol. function of RET oncogenes support the role of Ret oncoproteins as useful targets for therapeutic intervention, and suggest RPI-1 as a promising candidate for preclin. development in the treatment of thyroid tumors expressing RET oncogenes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8QuJL5hq3jrVg90H21EOLACvtfcHk0lgrtg1Ct64HBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1Witrg%253D&md5=91e9670ba82a723adb005d7ac1a72e9f</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1007%2Fs00018-003-2381-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-003-2381-8%26sid%3Dliteratum%253Aachs%26aulast%3DLanzi%26aufirst%3DC.%26aulast%3DCassinelli%26aufirst%3DG.%26aulast%3DCuccuru%26aufirst%3DG.%26aulast%3DZaffaroni%26aufirst%3DN.%26aulast%3DSupino%26aufirst%3DR.%26aulast%3DVignati%26aufirst%3DS.%26aulast%3DZanchi%26aufirst%3DC.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DZunino%26aufirst%3DF.%26atitle%3DInactivation%2520of%2520Ret%252FPtc1%2520oncoprotein%2520and%2520inhibition%2520of%2520papillary%2520thyroid%2520carcinoma%2520cell%2520proliferation%2520by%2520indolinone%2520RPI-1%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2003%26volume%3D60%26spage%3D1449%26epage%3D1459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Lanzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassinelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pensa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassinis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambetta, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borrello, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menta, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierotti, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunino, F.</span><span> </span><span class="NLM_article-title">Inhibition of transforming activity of the ret/ptc1 oncoprotein by a 2-indolinone derivative</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">85</span> <span class="NLM_fpage">384</span> <span class="NLM_lpage">390</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm8007823&amp;key=10.1002%2F%28SICI%291097-0215%2820000201%2985%3A3%3C384%3A%3AAID-IJC15%3E3.0.CO%3B2-Y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm8007823&amp;key=10652431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsVCgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2000&pages=384-390&author=C.+Lanziauthor=G.+Cassinelliauthor=T.+Pensaauthor=M.+Cassinisauthor=R.+A.+Gambettaauthor=M.+G.+Borrelloauthor=E.+Mentaauthor=M.+A.+Pierottiauthor=F.+Zunino&title=Inhibition+of+transforming+activity+of+the+ret%2Fptc1+oncoprotein+by+a+2-indolinone+derivative"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of transforming activity of the ret/ptc1 oncoprotein by a 2-indolinone derivative</span></div><div class="casAuthors">Lanzi, Cinzia; Cassinelli, Giuliana; Pensa, Tiziana; Cassinis, Marco; Gambetta, Romolo A.; Borrello, Maria G.; Menta, Ernesto; Pierotti, Marco A.; Zunino, Franco</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">384-390</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Ret-derived oncogenes are frequently and specifically expressed in thyroid tumors.  In contrast to the ret receptor, ret oncoproteins are characterized by ligand-independent tyrosine-kinase activity and tyrosine phosphorylation.  In this study, novel synthetic arylidene 2-indolinone compds. were evaluated as inhibitors of the ret/ptc1 tyrosine kinase.  Four compds. inhibited ret/ptc1 activity in immunokinase assay (IC50 27-42 μM) including one (1,3-dihydro-5,6-dimethoxy-3-[(4-hydroxyphenyl) methylene]-2H-indol-2-one) (Cpd I) that selectively inhibited the anchorage-independent growth of NIH3T3 transformants expressing the ret/ptc1 gene (NIH3T3ptc1 cells).  Following exposure to Cpd I, the transformed phenotype of NIH3T3ptc1 cells was reverted, within 24 h, to a normal fibroblast-like morphol. in adherent-cell culture.  In these cells, the constitutive tyrosine phosphorylation of ret/ptc1, of the transducing adaptor protein shc and of a series of co-immunopptd. peptides became much reduced, as demonstrated by immunopptn./Western-blot analyses.  Data presented provide addnl. evidence that ret/ptc1 is directly implicated in malignant transformation, and demonstrate the ability of Cpd I to interfere in the signal transduction pathway constitutively activated by the ret/ptc1 oncoprotein.  These results confirm the interest of the arylidene 2-indolinone class of tyrosine-kinase inhibitors as tools for the study of ret signaling and the control of cell proliferation in ret- and ret/ptcs-assocd. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf0GmslFY4ZbVg90H21EOLACvtfcHk0lgrtg1Ct64HBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsVCgtA%253D%253D&md5=f549ad7108c6d55d0d6473f25656d3fd</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0215%2820000201%2985%3A3%3C384%3A%3AAID-IJC15%3E3.0.CO%3B2-Y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0215%252820000201%252985%253A3%253C384%253A%253AAID-IJC15%253E3.0.CO%253B2-Y%26sid%3Dliteratum%253Aachs%26aulast%3DLanzi%26aufirst%3DC.%26aulast%3DCassinelli%26aufirst%3DG.%26aulast%3DPensa%26aufirst%3DT.%26aulast%3DCassinis%26aufirst%3DM.%26aulast%3DGambetta%26aufirst%3DR.%2BA.%26aulast%3DBorrello%26aufirst%3DM.%2BG.%26aulast%3DMenta%26aufirst%3DE.%26aulast%3DPierotti%26aufirst%3DM.%2BA.%26aulast%3DZunino%26aufirst%3DF.%26atitle%3DInhibition%2520of%2520transforming%2520activity%2520of%2520the%2520ret%252Fptc1%2520oncoprotein%2520by%2520a%25202-indolinone%2520derivative%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2000%26volume%3D85%26spage%3D384%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Cassinelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrangolini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortoreto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratesi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuccuru, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laccabue, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supino, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poletti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunino, F.</span><span> </span><span class="NLM_article-title">Inhibition of c-Met and prevention of spontaneous metastatic spreading by the 2-indolinine RPI-1</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">5</span> <span class="NLM_fpage">2388</span> <span class="NLM_lpage">2397</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm8007823&amp;key=10.1158%2F1535-7163.MCT-06-0245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm8007823&amp;key=16985073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1ynsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=2388-2397&author=C.+Cassinelliauthor=C.+Lanziauthor=G.+Petrangoliniauthor=M.+Tortoretoauthor=G.+Pratesiauthor=G.+Cuccuruauthor=D.+Laccabueauthor=R.+Supinoauthor=S.+Bellucoauthor=E.+Faviniauthor=A.+Polettiauthor=F.+Zunino&title=Inhibition+of+c-Met+and+prevention+of+spontaneous+metastatic+spreading+by+the+2-indolinine+RPI-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of c-Met and prevention of spontaneous metastatic spreading by the 2-indolinone RPI-1</span></div><div class="casAuthors">Cassinelli, Giuliana; Lanzi, Cinzia; Petrangolini, Giovanna; Tortoreto, Monica; Pratesi, Graziella; Cuccuru, Giuditta; Laccabue, Diletta; Supino, Rosanna; Belluco, Sara; Favini, Enrica; Poletti, Anna; Zunino, Franco</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2388-2397</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Hepatocyte growth factor (HGF) and its tyrosine kinase receptor Met play a pivotal role in the tumor metastatic phenotype and represent attractive therapeutic targets.  We investigated the biochem. and biol. effects of the tyrosine kinase inhibitor RPI-1 on the human lung cancer cell lines H460 and N592, which express constitutively active Met.  RPI-1-treated cells showed down-regulation of Met activation and expression, inhibition of HGF/Met-dependent downstream signaling involving AKT, signal transducers and activators of transcription 3 and paxillin, as well as a reduced expression of the proangiogenic factors vascular endothelial growth factor and basic fibroblast growth factor.  Cell growth in soft agar of H460 cells was strongly reduced in the presence of the drug.  Furthermore, RPI-1 inhibited both spontaneous and HGF-induced motility/invasiveness of both H460 and human endothelial cells.  Targeting of Met signaling by alternative methods (Met small interfering RNA and anti-phosphorylated Met antibody intracellular transfer) produced comparable biochem. and biol. effects.  Using the spontaneously metastasizing lung carcinoma xenograft H460, daily oral treatment with well-tolerated doses of RPI-1 produced a significant redn. of spontaneous lung metastases (-75%; P < 0.001, compared with control mice).  In addn., a significant inhibition of angiogenesis in primary s.c. tumors of treated mice was obsd., possibly contributing to limit the development of metastases.  The results provide preclin. evidence in support of Met targeting pharmacol. approach as a new option for the control of tumor metastatic dissemination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphBviSKcvNcLVg90H21EOLACvtfcHk0lh73jglB8yyTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1ynsbs%253D&md5=cdaf5e8491e31a4e72e52bedc4a16f6d</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0245%26sid%3Dliteratum%253Aachs%26aulast%3DCassinelli%26aufirst%3DC.%26aulast%3DLanzi%26aufirst%3DC.%26aulast%3DPetrangolini%26aufirst%3DG.%26aulast%3DTortoreto%26aufirst%3DM.%26aulast%3DPratesi%26aufirst%3DG.%26aulast%3DCuccuru%26aufirst%3DG.%26aulast%3DLaccabue%26aufirst%3DD.%26aulast%3DSupino%26aufirst%3DR.%26aulast%3DBelluco%26aufirst%3DS.%26aulast%3DFavini%26aufirst%3DE.%26aulast%3DPoletti%26aufirst%3DA.%26aulast%3DZunino%26aufirst%3DF.%26atitle%3DInhibition%2520of%2520c-Met%2520and%2520prevention%2520of%2520spontaneous%2520metastatic%2520spreading%2520by%2520the%25202-indolinine%2520RPI-1%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D2388%26epage%3D2397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">App, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">1998</span> <span class="NLM_volume">41</span> <span class="NLM_fpage">2588</span> <span class="NLM_lpage">2603</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980123i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADyaK1cXkt12jtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=2588-2603&author=L.+Sunauthor=N.+Tranauthor=F.+Tangauthor=H.+Appauthor=P.+Hirthauthor=G.+McMahonauthor=C.+Tang&title=Synthesis+and+biological+evaluations+of+3-substituted+indolin-2-ones%3A+a+novel+class+of+tyrosine+kinase+inhibitors+that+exhibit+selectivity+toward+particular+receptor+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluations of 3-Substituted Indolin-2-ones: A Novel Class of Tyrosine Kinase Inhibitors That Exhibit Selectivity toward Particular Receptor Tyrosine Kinases</span></div><div class="casAuthors">Sun, Li; Tran, Ngoc; Tang, Flora; App, Harald; Hirth, Peter; McMahon, Gerald; Tang, Cho</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2588-2603</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">3-Substituted indolin-2-ones have been designed and synthesized as a novel class of tyrosine kinase inhibitors which exhibit selectivity toward different receptor tyrosine kinases (RTKs).  These compds. have been evaluated for their relative inhibitory properties against a panel of RTKs in intact cells.  By modifying the 3-substituted indolin-2-ones, we have identified compds. which showed selective inhibition of the ligand-dependent autophosphorylation of various RTKs at submicromolar levels in cells.  Structure-activity anal. for these compds. and their relative potency and selectivity to inhibit particular RTKs has detd. that (1) 3-[(five-membered heteroaryl ring)methylidenyl]indolin-2-ones are highly specific against the VEGF (Flk-1) RTK activity, (2) 3-(substituted benzylidenyl)indolin-2-ones contg. bulky group(s) in the Ph ring at the C-3 position of indolin-2-ones showed high selectivity toward the EGF and Her-2 RTKs, and (3) the compd. contg. an extended side chain at the C-3 position of the indolin-2-one exhibited high potency and selectivity when tested against the PDGF and VEGF (Flk-1) RTKs.  Recent published crystallog. data for two of these 3-substituted indolin-2-ones provides a rationale to suggest that these compds. may bind in the ATP binding pocket of RTKs.  The structure-activity anal. supports the use of subsets of these compds. as specific chem. leads for the development of RTK-specific drugs with broad application for the treatment of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJoPixq8Am5rVg90H21EOLACvtfcHk0lh73jglB8yyTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkt12jtrw%253D&md5=536302b717170a630008dac14832204c</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm980123i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980123i%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26aulast%3DTran%26aufirst%3DN.%26aulast%3DTang%26aufirst%3DF.%26aulast%3DApp%26aufirst%3DH.%26aulast%3DHirth%26aufirst%3DP.%26aulast%3DMcMahon%26aufirst%3DG.%26aulast%3DTang%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520biological%2520evaluations%2520of%25203-substituted%2520indolin-2-ones%253A%2520a%2520novel%2520class%2520of%2520tyrosine%2520kinase%2520inhibitors%2520that%2520exhibit%2520selectivity%2520toward%2520particular%2520receptor%2520tyrosine%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D2588%26epage%3D2603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Tuccinardi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botta, M.</span><span> </span><span class="NLM_article-title">Construction and validation of a RET TK catalytic domain by homology modeling</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">47</span> <span class="NLM_fpage">644</span> <span class="NLM_lpage">655</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci6004383" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsFOlu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=644-655&author=T.+Tuccinardiauthor=F.+Manettiauthor=S.+Schenoneauthor=A.+Martinelliauthor=M.+Botta&title=Construction+and+validation+of+a+RET+TK+catalytic+domain+by+homology+modeling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Construction and Validation of a RET TK Catalytic Domain by Homology Modeling</span></div><div class="casAuthors">Tuccinardi, Tiziano; Manetti, Fabrizio; Schenone, Silvia; Martinelli, Adriano; Botta, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">644-655</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">RET tyrosine kinase (TK) oncoproteins are potential targets for anticancer therapy.  However, the search for novel RET inhibitors has been hampered by the lack of a 3D structure of the receptor.  In this study, the "open" and the "closed" structure of the RET TK catalytic domain have been built by homol. modeling techniques.  The structures were validated by extensive docking studies with practically all the inhibitors reported in the literature and through mol. dynamics simulations of the resulting complexes.  All the expected major interactions between the active domain amino acids and the inhibitors have been reproduced in their details.  Furthermore, the proposed 3D models are in agreement with the results of available mutation studies.  Therefore, these models could be profitably used to filter off from large libraries new potential hit compds. able to target this enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpajtbODoG4DrVg90H21EOLACvtfcHk0li2SAm31SejyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsFOlu78%253D&md5=3d0e569c592ec6f060f3416ef739b0d6</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fci6004383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci6004383%26sid%3Dliteratum%253Aachs%26aulast%3DTuccinardi%26aufirst%3DT.%26aulast%3DManetti%26aufirst%3DF.%26aulast%3DSchenone%26aufirst%3DS.%26aulast%3DMartinelli%26aufirst%3DA.%26aulast%3DBotta%26aufirst%3DM.%26atitle%3DConstruction%2520and%2520validation%2520of%2520a%2520RET%2520TK%2520catalytic%2520domain%2520by%2520homology%2520modeling%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2007%26volume%3D47%26spage%3D644%26epage%3D655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Mohammadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span> </span><span class="NLM_article-title">Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors</span> <span class="citation_source-journal">Science</span><span class="NLM_year" style="font-weight: bold;">1997</span> <span class="NLM_volume">276</span> <span class="NLM_fpage">955</span> <span class="NLM_lpage">960</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm8007823&amp;key=10.1126%2Fscience.276.5314.955" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm8007823&amp;key=9139660" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADyaK2sXjt1ans7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=1997&pages=955-960&author=M.+Mohammadiauthor=G.+McMahonauthor=L.+Sunauthor=C.+Tangauthor=P.+Hirthauthor=B.+K.+Yehauthor=S.+R.+Hubbardauthor=J.+Schlessinger&title=Structures+of+the+tyrosine+kinase+domain+of+fibroblast+growth+factor+receptor+in+complex+with+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors</span></div><div class="casAuthors">Mohammadi, Moosa; McMahon, Gerald; Sun, Li; Tang, Cho; Hirth, Peter; Yeh, Brian K.; Hubbard, Stevan R.; Schlessinger, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">5314</span>),
    <span class="NLM_cas:pages">955-960</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A new class of protein tyrosine kinase inhibitors was identified that is based on an oxindole core (indolinones).  Two compds. from this class inhibited the kinase activity of fibroblast growth factor receptor 1 (FGFR1) and showed differential specificity toward others receptor tyrosine kinases.  Crystal structures of the tyrosine kinase domain of FGFR1 in complex with the two compds. were detd.  The oxindole occupies the sites in which the adenine of ATP binds, whereas the moieties that extend from the oxindole contact residues in the hinge region between the two kinase lobes.  The more specific inhibitor of FGFR1 induces a conformational change in the nucleotide-binding loop.  This structural information will facilitate the design of new inhibitors for use in the treatment of cancer and other diseases in which cell signaling by tyrosine kinases plays a crucial role in disease pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDwP7A-FMgDLVg90H21EOLACvtfcHk0li2SAm31SejyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjt1ans7w%253D&md5=fdbedba79850d11771677e6d25f3842f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1126%2Fscience.276.5314.955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.276.5314.955%26sid%3Dliteratum%253Aachs%26aulast%3DMohammadi%26aufirst%3DM.%26aulast%3DMcMahon%26aufirst%3DG.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DHirth%26aufirst%3DP.%26aulast%3DYeh%26aufirst%3DB.%2BK.%26aulast%3DHubbard%26aufirst%3DS.%2BR.%26aulast%3DSchlessinger%26aufirst%3DJ.%26atitle%3DStructures%2520of%2520the%2520tyrosine%2520kinase%2520domain%2520of%2520fibroblast%2520growth%2520factor%2520receptor%2520in%2520complex%2520with%2520inhibitors%26jtitle%3DScience%26date%3D1997%26volume%3D276%26spage%3D955%26epage%3D960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span> </span><span class="NLM_article-title">3-Aryl beta-carbolin-1-ones as a new class of potent inhibitors of tumor cell proliferation: synthesis and biological evaluation</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">3</span> <span class="NLM_fpage">911</span> <span class="NLM_lpage">916</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2005&pages=911-916&author=S.+Wangauthor=Y.+Dongauthor=X.+Wangauthor=X.+Huauthor=J.+O.+Liuauthor=Y.+Hu&title=3-Aryl+beta-carbolin-1-ones+as+a+new+class+of+potent+inhibitors+of+tumor+cell+proliferation%3A+synthesis+and+biological+evaluation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DJ.%2BO.%26aulast%3DHu%26aufirst%3DY.%26atitle%3D3-Aryl%2520beta-carbolin-1-ones%2520as%2520a%2520new%2520class%2520of%2520potent%2520inhibitors%2520of%2520tumor%2520cell%2520proliferation%253A%2520synthesis%2520and%2520biological%2520evaluation%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2005%26volume%3D3%26spage%3D911%26epage%3D916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Chacun-Lefèvre, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mérour, J.-Y.</span><span> </span><span class="NLM_article-title">Synthesis and reactivity of azepino[3,4-<i>b</i>]indol-5-yl trifluoromethanesulfonate</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">56</span> <span class="NLM_fpage">4491</span> <span class="NLM_lpage">4499</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2000&pages=4491-4499&author=B.+Chacun-Lef%C3%A8vreauthor=B.+Josephauthor=J.-Y.+M%C3%A9rour&title=Synthesis+and+reactivity+of+azepino%5B3%2C4-b%5Dindol-5-yl+trifluoromethanesulfonate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChacun-Lef%25C3%25A8vre%26aufirst%3DB.%26aulast%3DJoseph%26aufirst%3DB.%26aulast%3DM%25C3%25A9rour%26aufirst%3DJ.-Y.%26atitle%3DSynthesis%2520and%2520reactivity%2520of%2520azepino%255B3%252C4-b%255Dindol-5-yl%2520trifluoromethanesulfonate%26jtitle%3DTetrahedron%26date%3D2000%26volume%3D56%26spage%3D4491%26epage%3D4499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Cincinelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dallavalle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlini, L.</span><span> </span><span class="NLM_article-title">Intramolecular Friedel−Crafts reaction of indoles with carbonyl groups: a simple synthesis of 3- and 4-substituted β-carbolin-1-ones</span> <span class="citation_source-journal">Synlett</span><span class="NLM_year" style="font-weight: bold;">2008</span> <span class="NLM_fpage">1309</span> <span class="NLM_lpage">1312</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=1309-1312&author=R.+Cincinelliauthor=S.+Dallavalleauthor=L.+Merlini&title=Intramolecular+Friedel%E2%88%92Crafts+reaction+of+indoles+with+carbonyl+groups%3A+a+simple+synthesis+of+3-+and+4-substituted+%CE%B2-carbolin-1-ones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCincinelli%26aufirst%3DR.%26aulast%3DDallavalle%26aufirst%3DS.%26aulast%3DMerlini%26aufirst%3DL.%26atitle%3DIntramolecular%2520Friedel%25E2%2588%2592Crafts%2520reaction%2520of%2520indoles%2520with%2520carbonyl%2520groups%253A%2520a%2520simple%2520synthesis%2520of%25203-%2520and%25204-substituted%2520%25CE%25B2-carbolin-1-ones%26jtitle%3DSynlett%26date%3D2008%26spage%3D1309%26epage%3D1312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Rizzi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassinelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dallavalle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cincinelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nannei, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuccuru, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunino, F.</span><span> </span><span class="NLM_article-title">Synthesis and RET protein kinase inhibitory activity of 3-arylureidobenzylidene-indolin-2-ones</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">17</span> <span class="NLM_fpage">3962</span> <span class="NLM_lpage">3968</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3962-3968&author=E.+Rizziauthor=G.+Cassinelliauthor=S.+Dallavalleauthor=C.+Lanziauthor=R.+Cincinelliauthor=R.+Nanneiauthor=G.+Cuccuruauthor=F.+Zunino&title=Synthesis+and+RET+protein+kinase+inhibitory+activity+of+3-arylureidobenzylidene-indolin-2-ones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRizzi%26aufirst%3DE.%26aulast%3DCassinelli%26aufirst%3DG.%26aulast%3DDallavalle%26aufirst%3DS.%26aulast%3DLanzi%26aufirst%3DC.%26aulast%3DCincinelli%26aufirst%3DR.%26aulast%3DNannei%26aufirst%3DR.%26aulast%3DCuccuru%26aufirst%3DG.%26aulast%3DZunino%26aufirst%3DF.%26atitle%3DSynthesis%2520and%2520RET%2520protein%2520kinase%2520inhibitory%2520activity%2520of%25203-arylureidobenzylidene-indolin-2-ones%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3962%26epage%3D3968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Knowles, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray-Rust, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kjaer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanrahan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santoro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibáñez, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, N. Q.</span><span> </span><span class="NLM_article-title">Structure and chemical inhibition of the RET tyrosine kinase domain</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">281</span> <span class="NLM_fpage">33577</span> <span class="NLM_lpage">33587</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm8007823&amp;key=10.1074%2Fjbc.M605604200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm8007823&amp;key=16928683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFegsb3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=33577-33587&author=P.+P.+Knowlesauthor=J.+Murray-Rustauthor=S.+Kjaerauthor=R.+P.+Scottauthor=S.+Hanrahanauthor=M.+Santoroauthor=C.+F.+Ib%C3%A1%C3%B1ezauthor=N.+Q.+McDonald&title=Structure+and+chemical+inhibition+of+the+RET+tyrosine+kinase+domain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and Chemical Inhibition of the RET Tyrosine Kinase Domain</span></div><div class="casAuthors">Knowles, Phillip P.; Murray-Rust, Judith; Kjaer, Svend; Scott, Rizaldy P.; Hanrahan, Sarah; Santoro, Massimo; Ibanez, Carlos F.; McDonald, Neil Q.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">33577-33587</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The RET proto-oncogene encodes a receptor tyrosine kinase for the glial cell line-derived neurotrophic factor family of ligands.  Loss-of-function mutations in RET are implicated in Hirschsprung disease, whereas activating mutations in RET are found in human cancers, including familial medullar thyroid carcinoma and multiple endocrine neoplasias 2A and 2B.  We report here the biochem. characterization of the human RET tyrosine kinase domain and the structure detn. of the non-phosphorylated and phosphorylated forms.  Both structures adopt the same active kinase conformation competent to bind ATP and substrate and have a pre-organized activation loop conformation that is independent of phosphorylation status.  In agreement with the structural data, enzyme kinetic data show that autophosphorylation produces only a modest increase in activity.  Longer forms of RET contg. the juxtamembrane domain and C-terminal tail exhibited similar kinetic behavior, implying that there is no cis-inhibitory mechanism within the RET intracellular domain.  Our results suggest the existence of alternative inhibitory mechanisms, possibly in trans, for the autoregulation of RET kinase activity.  We also present the structures of the RET tyrosine kinase domain bound to two inhibitors, the pyrazolopyrimidine PP1 and the clin. relevant 4-anilinoquinazoline ZD6474.  These structures explain why certain multiple endocrine neoplasia 2-assocd. RET mutants found in patients are resistant to inhibition and form the basis for design of more effective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2p2bSJFNWxbVg90H21EOLACvtfcHk0lhn15O53DYUKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFegsb3K&md5=005ddc426f2c1a0a48bf7dc6c6083c88</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M605604200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M605604200%26sid%3Dliteratum%253Aachs%26aulast%3DKnowles%26aufirst%3DP.%2BP.%26aulast%3DMurray-Rust%26aufirst%3DJ.%26aulast%3DKjaer%26aufirst%3DS.%26aulast%3DScott%26aufirst%3DR.%2BP.%26aulast%3DHanrahan%26aufirst%3DS.%26aulast%3DSantoro%26aufirst%3DM.%26aulast%3DIb%25C3%25A1%25C3%25B1ez%26aufirst%3DC.%2BF.%26aulast%3DMcDonald%26aufirst%3DN.%2BQ.%26atitle%3DStructure%2520and%2520chemical%2520inhibition%2520of%2520the%2520RET%2520tyrosine%2520kinase%2520domain%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D33577%26epage%3D33587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R.</span><span> </span><span class="NLM_article-title">Development and validation of a genetic algorithm for flexible docking</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_year" style="font-weight: bold;">1997</span> <span class="NLM_volume">267</span> <span class="NLM_fpage">727</span> <span class="NLM_lpage">748</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm8007823&amp;key=10.1006%2Fjmbi.1996.0897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm8007823&amp;key=9126849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1997&pages=727-748&author=G.+Jonesauthor=P.+Willettauthor=R.+C.+Glenauthor=A.+R.+Leachauthor=R.+Taylor&title=Development+and+validation+of+a+genetic+algorithm+for+flexible+docking"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a genetic algorithm for flexible docking</span></div><div class="casAuthors">Jones, Gareth; Willett, Peter; Glen, Robert C.; Leach, Andrew R.; Taylor, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">727-748</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Prediction of small mol. binding modes to macromols. of known three-dimensional structure is a problem of paramount importance in rational drug design (the "docking" problem).  We report the development and validation of the program GOLD (Genetic Optimization for Ligand Docking).  GOLD is an automated ligand docking program that uses a genetic algorithm to explore the full range of ligand conformational flexibility with partial flexibility of the protein and satisfies the fundamental requirement that the ligand must displace loosely bound water on binding.  Numerous enhancements and modifications have been applied to the original technique resulting in a substantial increase in the reliability and the applicability of the algorithm.  The advanced algorithm has been tested on a dataset of 100 complexes extd. from the Brookhaven Protein Data Bank.  When used to dock the ligand back into the binding site, GOLD achieved a 71% success rate in identifying the exptl. binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP3I60Rl2uorVg90H21EOLACvtfcHk0lhn15O53DYUKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D&md5=476a2b1d8f80f3ba418052fe29d735ca</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1996.0897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1996.0897%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DTaylor%26aufirst%3DR.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%2520genetic%2520algorithm%2520for%2520flexible%2520docking%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D267%26spage%3D727%26epage%3D748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Toledo, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lydon, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elbaum, D.</span><span> </span><span class="NLM_article-title">The structure-based design of ATP-site directed protein kinase inhibitors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">6</span> <span class="NLM_fpage">775</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm8007823&amp;key=10495352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADyaK1MXlvFWqtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=775&author=L.+M.+Toledoauthor=N.+B.+Lydonauthor=D.+Elbaum&title=The+structure-based+design+of+ATP-site+directed+protein+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The structure-based design of ATP-site directed protein kinase inhibitors</span></div><div class="casAuthors">Toledo, Leticia M.; Lydon, Nicholas B.; Elbaum, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">775-805</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review with 158 refs.  The protein kinase family represents both a huge opportunity and a challenge for drug development.  The conservation of structural features within the ATP binding cleft initially led to the belief that specificity would be difficult to achieve.  This dogma has now been clearly dispelled with the discovery and clin. testing of a group of first generation compds., which are characterized by a high degree of selectivity towards a variety of oncol. targets.  The structural basis for selectivity and potency has now been clarified with the crystn. of a no. of such targets in complex with inhibitors.  The protein kinase inhibitor field is now ripe for the structure based exploitation of addnl. highly validated targets from a variety of therapeutic areas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJg9ofbUmOprVg90H21EOLACvtfcHk0lhQVrEUqsqJxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvFWqtL0%253D&md5=9a916ac8f6ca8c28162c0c85b693cbed</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DToledo%26aufirst%3DL.%2BM.%26aulast%3DLydon%26aufirst%3DN.%2BB.%26aulast%3DElbaum%26aufirst%3DD.%26atitle%3DThe%2520structure-based%2520design%2520of%2520ATP-site%2520directed%2520protein%2520kinase%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D1999%26volume%3D6%26spage%3D775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Traxler, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mett, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sequin, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span> </span><span class="NLM_article-title">Use of a pharmacophore model for the design of EGFR tyrosine kinase inhibitors: isoflavones and 3-phenyl-4(1<i>H</i>)-quinolones</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">42</span> <span class="NLM_fpage">1018</span> <span class="NLM_lpage">1026</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980551o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=1018-1026&author=P.+Traxlerauthor=J.+Greenauthor=H.+Mettauthor=U.+Sequinauthor=P.+Furet&title=Use+of+a+pharmacophore+model+for+the+design+of+EGFR+tyrosine+kinase+inhibitors%3A+isoflavones+and+3-phenyl-4%281H%29-quinolones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm980551o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980551o%26sid%3Dliteratum%253Aachs%26aulast%3DTraxler%26aufirst%3DP.%26aulast%3DGreen%26aufirst%3DJ.%26aulast%3DMett%26aufirst%3DH.%26aulast%3DSequin%26aufirst%3DU.%26aulast%3DFuret%26aufirst%3DP.%26atitle%3DUse%2520of%2520a%2520pharmacophore%2520model%2520for%2520the%2520design%2520of%2520EGFR%2520tyrosine%2520kinase%2520inhibitors%253A%2520isoflavones%2520and%25203-phenyl-4%25281H%2529-quinolones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D1018%26epage%3D1026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Massova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollman, P. A.</span><span> </span><span class="NLM_article-title">Combined molecular mechanical and continuum solvent approach (MM-PBSA/GBSA) to predict ligand binding</span> <span class="citation_source-journal">Perspect. Drug Discovery Des.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">18</span> <span class="NLM_fpage">113</span> <span class="NLM_lpage">135</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm8007823&amp;key=10.1023%2FA%3A1008763014207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADC%252BD3cXis12ju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2000&pages=113-135&author=I.+Massovaauthor=P.+A.+Kollman&title=Combined+molecular+mechanical+and+continuum+solvent+approach+%28MM-PBSA%2FGBSA%29+to+predict+ligand+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Combined molecular mechanical and continuum solvent approach (MM-PBSA/GBSA) to predict ligand binding</span></div><div class="casAuthors">Massova, Irina; Kollman, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">Perspectives in Drug Discovery and Design</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">Hydrophobicity and Solvation in Drug Design, Pt. II</span>),
    <span class="NLM_cas:pages">113-135</span>CODEN:
                <span class="NLM_cas:coden">PDDDEC</span>;
        ISSN:<span class="NLM_cas:issn">0928-2866</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">Significant progress has been achieved in computational methods to treat solvent effects in recent years.  Among various techniques, the continuum solvent approach appears to be practically promising because it can be used to calc. reliable interaction and solvation energies in complex systems.  A computational scanning mutagenesis method, one of such new approaches, has been recently developed.  It combines the mol. mech. and continuum solvent approaches and allows one to identify the "hot spots" in binding interfaces from a single trajectory of a wild type complex.  Such techniques can be also used as a tool to optimize the interacting species for the binding, or as a ranking procedure in high throughput screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4IQPgMmXRBbVg90H21EOLACvtfcHk0lhQVrEUqsqJxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXis12ju7Y%253D&md5=520df05a7c7ed02fdf76d3e1e6f377f9</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1023%2FA%3A1008763014207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1008763014207%26sid%3Dliteratum%253Aachs%26aulast%3DMassova%26aufirst%3DI.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26atitle%3DCombined%2520molecular%2520mechanical%2520and%2520continuum%2520solvent%2520approach%2520%2528MM-PBSA%252FGBSA%2529%2520to%2520predict%2520ligand%2520binding%26jtitle%3DPerspect.%2520Drug%2520Discovery%2520Des.%26date%3D2000%26volume%3D18%26spage%3D113%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Rizzo, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toba, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuntz, I. D.</span><span> </span><span class="NLM_article-title">A molecular basis for the selectivity of thiadiazole urea inhibitors with stromelysin-1 and gelatinase-A from generalized Born molecular dynamics simulations</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">47</span> <span class="NLM_fpage">3065</span> <span class="NLM_lpage">3074</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030570k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=3065-3074&author=R.+C.+Rizzoauthor=S.+Tobaauthor=I.+D.+Kuntz&title=A+molecular+basis+for+the+selectivity+of+thiadiazole+urea+inhibitors+with+stromelysin-1+and+gelatinase-A+from+generalized+Born+molecular+dynamics+simulations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm030570k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030570k%26sid%3Dliteratum%253Aachs%26aulast%3DRizzo%26aufirst%3DR.%2BC.%26aulast%3DToba%26aufirst%3DS.%26aulast%3DKuntz%26aufirst%3DI.%2BD.%26atitle%3DA%2520molecular%2520basis%2520for%2520the%2520selectivity%2520of%2520thiadiazole%2520urea%2520inhibitors%2520with%2520stromelysin-1%2520and%2520gelatinase-A%2520from%2520generalized%2520Born%2520molecular%2520dynamics%2520simulations%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D3065%26epage%3D3074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><a href="http://www.pdb.org/" class="extLink">http://www.pdb.org/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.pdb.org%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Case, D. A.; Darden, T. A.; Cheatham, T. E.,  III; Simmerling, C. L.; Wang, J.; Duke, R. E.; Luo, R.; Merz, K. M.; Pearlman, D. A.; Crowley, M.; Walker, R. C.; Zhang, W.; Wang, B.; Hayik, S.; Roitberg, A.; Seabra, G.; Wong, K. F.; Paesani, F.; Wu, X.; Brozell, S.; Tsui, V.; Gohlke, H.; Yang, L.; Tan, C.; Mongan, J.; Hornak, V.; Cui, G.; Beroza, P.; Mathews, D. H.; Schafmeister, C.; Ross, W. S.; Kollman, P. A.</span> <span class="citation_source-book">AMBER 9</span>; <span class="NLM_publisher-name">University of California</span>: <span class="NLM_publisher-loc">San Francisco, CA</span>, <span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=D.+A.+Case&author=T.+A.+Darden&author=T.+E.+Cheatham&author=C.+L.+Simmerling&author=J.+Wang&author=R.+E.+Duke&author=R.+Luo&author=K.+M.+Merz&author=D.+A.+Pearlman&author=M.+Crowley&author=R.+C.+Walker&author=W.+Zhang&author=B.+Wang&author=S.+Hayik&author=A.+Roitberg&author=G.+Seabra&author=K.+F.+Wong&author=F.+Paesani&author=X.+Wu&author=S.+Brozell&author=V.+Tsui&author=H.+Gohlke&author=L.+Yang&author=C.+Tan&author=J.+Mongan&author=V.+Hornak&author=G.+Cui&author=P.+Beroza&author=D.+H.+Mathews&author=C.+Schafmeister&author=W.+S.+Ross&author=P.+A.+Kollman&title=AMBER+9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCase%26aufirst%3DD.%2BA.%26btitle%3DAMBER%25209%26pub%3DUniversity%2520of%2520California%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span> <span class="citation_source-book">Maestro</span>, version 7.5; <span class="NLM_publisher-name">Schrödinger, Inc.</span>: <span class="NLM_publisher-loc">Portland, OR</span>, <span class="NLM_year">1999</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Maestro%2C+version+7.5%3B+Schr%C3%B6dinger%2C+Inc.%3A+Portland%2C+OR%2C+1999."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMaestro%26pub%3DSchr%25C3%25B6dinger%252C%2520Inc%26date%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span> <span class="citation_source-book">Macromodel</span>, version 8.5; <span class="NLM_publisher-name">Schrödinger, Inc.</span>: <span class="NLM_publisher-loc">Portland, OR</span>, <span class="NLM_year">1999</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Macromodel%2C+version+8.5%3B+Schr%C3%B6dinger%2C+Inc.%3A+Portland%2C+OR%2C+1999."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMacromodel%26pub%3DSchr%25C3%25B6dinger%252C%2520Inc%26date%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Essman, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perela, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berkowitz, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darden, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, L. G.</span><span> </span><span class="NLM_article-title">A smooth particle mesh Ewald method</span> <span class="citation_source-journal">J. Chem. Phys.</span><span class="NLM_year" style="font-weight: bold;">1995</span> <span class="NLM_volume">103</span> <span class="NLM_fpage">8577</span> <span class="NLM_lpage">8592</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm8007823&amp;key=10.1063%2F1.470117" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=1995&pages=8577-8592&author=U.+Essmanauthor=L.+Perelaauthor=M.+L.+Berkowitzauthor=T.+Dardenauthor=H.+Leeauthor=L.+G.+Pedersen&title=A+smooth+particle+mesh+Ewald+method"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1063%2F1.470117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.470117%26sid%3Dliteratum%253Aachs%26aulast%3DEssman%26aufirst%3DU.%26aulast%3DPerela%26aufirst%3DL.%26aulast%3DBerkowitz%26aufirst%3DM.%2BL.%26aulast%3DDarden%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DPedersen%26aufirst%3DL.%2BG.%26atitle%3DA%2520smooth%2520particle%2520mesh%2520Ewald%2520method%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1995%26volume%3D103%26spage%3D8577%26epage%3D8592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Weiser, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenkin, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Still, W. C.</span><span> </span><span class="NLM_article-title">Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO)</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">20</span> <span class="NLM_fpage">217</span> <span class="NLM_lpage">230</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm8007823&amp;key=10.1002%2F%28SICI%291096-987X%2819990130%2920%3A2%3C217%3A%3AAID-JCC4%3E3.0.CO%3B2-A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm8007823&amp;key=1%3ACAS%3A528%3ADyaK1MXltVCltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1999&pages=217-230&author=J.+Weiserauthor=P.+S.+Shenkinauthor=W.+C.+Still&title=Approximate+atomic+surfaces+from+linear+combinations+of+pairwise+overlaps+%28LCPO%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO)</span></div><div class="casAuthors">Weiser, Jorg; Shenkin, Peter S.; Still, W. Clark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">217-230</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A fast anal. formula was derived for the calcn. of approx. at. and mol. van der Waals (vdWSA), and solvent-accessible surface areas (SASAs), as well as the first and second derivs. of these quantities with respect to at. coordinates.  This method makes use of linear combinations of terms composed from pairwise overlaps of hard spheres; therefore, we term this the LCPO method for linear combination of pairwise overlaps.  For higher performance, neighbor-list redn. (NLR) was applied as a preprocessing step.  Eighteen compds. of different sizes (8-2366 atoms) and classes (org., proteins, DNA, and various complexes) were chosen as representative test cases.  LCPO/NLR computed the SASA and first derivs. of penicillopepsin, a protein with 2366 atoms, in 0.87 s (0.22 s for the creation of the neighbor list, 0.35 s for NLR, and 0.30 s for SASA and first derivs.) on an SGI R10000/194 Mhz processor.  This appears comparable to or better than timings reported previously for other algorithms.  The vdWSAs were in good agreement with the numerical results: relative errors for total mol. surface areas ranged from 0.1 to 2.0% and av. abs. at. surface area deviations from 0.3 to 0.7 Å2.  For SASAs without NLR, the LCPO method exhibited relative errors in the range of 0.4-9.2% for total mol. surface areas and av. abs. at. surface area deviations of 2.0-2.7 Å2; with NLR the relative mol. errors ranged from 0.1 to 7.8% and the av. abs. at. surface area deviation from 1.6 to 3.0 Å2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmPQhEyS_vfLVg90H21EOLACvtfcHk0li2omJUlIYgaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltVCltQ%253D%253D&md5=1c6cf923fe089cf61a1952fdcf55f788</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291096-987X%2819990130%2920%3A2%3C217%3A%3AAID-JCC4%3E3.0.CO%3B2-A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291096-987X%252819990130%252920%253A2%253C217%253A%253AAID-JCC4%253E3.0.CO%253B2-A%26sid%3Dliteratum%253Aachs%26aulast%3DWeiser%26aufirst%3DJ.%26aulast%3DShenkin%26aufirst%3DP.%2BS.%26aulast%3DStill%26aufirst%3DW.%2BC.%26atitle%3DApproximate%2520atomic%2520surfaces%2520from%2520linear%2520combinations%2520of%2520pairwise%2520overlaps%2520%2528LCPO%2529%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1999%26volume%3D20%26spage%3D217%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ivu" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ivu','PDB','2ivu'); return false;">PDB: 2ivu</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i50"><a href="/doi/suppl/10.1021/jm8007823">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_27357"></div></div></div></div></div><hr /></hr><p class="last">Elemental analysis of analysis data of the compounds. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm8007823/suppl_file/jm8007823_si_001.pdf">jm8007823_si_001.pdf (46.99 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm8007823&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2008.51.issue-24%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm8007823%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm8007823" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799e3f73cbd3c7c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
